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Abstract  
Since its first use to solve the structure of sodium chloride in 1915 X-ray crystallography 
has developed significantly to become the premier technique for obtaining 3D structural information 
of small molecules and macromolecules alike. As the technique continues to develop and focus its 
attention on weak diffraction from the likes of micro-crystals and poorly packed crystals of 
membrane proteins and large protein complexes; as well as ultra-high resolution data and weak 
anomalous signal from native atoms, data quality is becoming more and more important. Data 
quality is particularly important in the wake of long wavelength macromolecular crystallography 
(MX) for phasing using anomalous signal from native sulphur and phosphorous atoms in proteins 
and DNA.  
This thesis first investigated the use of a new sample handling technique using a humidity 
controlled stream to preserve macromolecular crystals while excess surrounding solvent is removed 
(Chapter 2). Following the successful development of this technique the effects of excess 
surrounding solvent on data quality was assessed when collecting at standard MX X-ray wavelengths 
(~ 1 Å) and longer X-ray wavelengths (~ 2 Å). Datasets were collected from large populations of 
control and test crystals at standard and longer wavelengths to allow robust statistical methods to 
be applied; a practice not widely adopted in method development studies in X-ray crystallography. 
This made it possible to assess the small differences in data quality in the presence and absence of 
excess surrounding solvent. The effects of surrounding solvent at longer wavelengths appear to be 
protein dependent with some proteins tested showing no significant difference and others a 
significant decrease in data quality at longer wavelengths (Chapter 3).   
Originally this project aimed to use the new long wavelength in-vacuum MX beamline, I23, 
at Diamond Light Source UK to carry out phasing experiments using native sulphurs for structure 
solution. However, the considerable complexity involved in developing in-vacuum MX meant these 
experiments could not be carried out during the time frame of this thesis. Chapters 4 and 5 outline 
the production of a novel cancer protein (cancerous inhibitor of protein phosphatase 2A) and two 
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protein targets from the Achromobacter xylosoxidans (Ax) genome intended for sulphur single 
wavelength anomalous dispersion phasing experiments on I23. Of these proteins the structure of Ax-
α/β hydrolase was solved by conventional methods, the structure of which is discussed in Chapter 5. 
Of the protein crystals used in long wavelength data quality experiments in Chapter 3 the 
molecular biology of PA3825-EAL, a biofilm regulating protein essential to the swarming ability of 
Pseudomonas aeruginosa, was investigated further. The crystal structure of PA3825-EAL was solved 
in the resting, substrate bound and product bound states to high resolution. Comparison of the 
crystal structures of monomeric and dimeric PA3825-EAL with the inactive dimeric structure of 
MucR-EAL suggests dimerisation via helix 8 plays a role in inhibition of EAL domains. Prior to this, 
dimerisation was thought to be an activating factor in EAL domains. The product bound state of 
PA3825-EAL showed the presence of a previously unreported third metal binding site which may 
form an essential component of the reaction mechanism of EAL domains. Inability of MucR-EAL to 
incorporate this third metal due to dimerisation may explain the lack of activity despite possessing 
the conserved catalytic residues necessary.  
The fast detector technology and improvements in automated data processing software 
that allowed diffraction data for large populations of crystals to be collected in Chapters 2 and 3 
have also been applied to development of a serial data collection technique. Of 159 datasets 
collected from 8 crystals of a copper nitrite reductase from Achromobacter cycloclastes, 45 datasets 
from a single crystal were analysed to observe the reaction mechanism using high resolution crystal 
structures. X-ray radiolysis initiated the reaction and high resolution data allowed the conversion of 
nitrite (NO2) to nitric oxide (NO) to be observed in the crystal. Other aspects of the reaction were 
investigated from the data series including a conserved water chain connecting the copper sites 
which may act as a proton wire to donate a proton and produce NO. This technique may have wide 
applications to the study of the reaction mechanisms of other metallo-proteins.  
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FAP Functional amyloids in Pseudomonas 
FMS Free-mounting system  
GST Glutathione S-transferase 
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HC1 Humidity control device  
HC-T Humidity control transferred 
HEWL Hen egg white lysozyme  
HRL High resolution limit  
HTH Helix turn helix  
IP (site) Primary inhibition site 
keV Kilo-electron volts 
MAD Multi-wavelength anomalous dispersion  
MALS Multi-angle light scattering  
MBP Maltose binding protein  
MGy Mega grey 
MIR Multiple isomorphous replacement  
MR Molecular replacement  
MX Macromolecular crystallography  
PDB Protein data bank 
NLS Nuclear localisation sequence  
PAD PP2A activating drug  
PDE Phosphodiesterase 
PEEK polyetheretherketone 
PEG Polyethylene glycol 
pGpG 5’- Phosphoguanylyl- (3’ −> 5’)- guanosine 
PP2A Protein phosphatase 2A 
PULSA Pulsed UV laser soft ablation 
Rmease  Redundancy independent merging factor  
Rmerge  Linear merging factor  
Rp.i.m. Precision-indicating merging factor 
SAD Single-wavelength anomalous dispersion  
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S-SAD Sulphur single-wavelength anomalous dispersion  
SDS-PAGE Sodium dodecyl sulphate polyacrylamide agarose gel electrophoresis  
SEC Size exclusion chromatography  
siRNA Small interfering RNA  
SUMO Small ubiquitin-related modifier 
T1Cu Type one copper 
T2Cu Type two copper 
TIM Triosephosphate isomerase   
UTR Untranslated region  
XAS X-ray absorption spectroscopy  
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Preface  
This Thesis presents original research carried out by the author submitted in accordance 
with the requirements of the University of Liverpool for the degree of Doctor in Philosophy to the 
University of Liverpool  
This research consists of a number of studies using X-ray crystallography to (1) assess the 
effects of humid air streams, sample handling and excess surrounding solvent on data quality in long 
wavelength data collection using robust statistical analysis; (2) produce protein crystals with a view 
to perform in-vacuum S-SAD phasing experiments; (3) investigate the structure of a novel α/β 
hydrolase enzyme from the Alcaligenes xylosoxidans genome; (4) better understand the regulation 
of cyclic di-GMP cleavage by PA3825-EAL and other EAL domain containing proteins and (5) to 
develop the use of fast detectors and automatic processing pipelines for serial data collection of 
metallo-proteins to analyse their reaction mechanisms and produce structural movies.   
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Chapter 1 - X-ray Crystallography Theory 
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1.1. Introduction  
X-ray crystallography is the premier technique for obtaining three dimensional structural 
information for chemical and biological molecules. The method involves measurement of the 
intensity of X-rays diffracted by a crystal made up of a regular repeating lattice of macromolecules or 
other small molecules. There are several textbooks that cover the principles of X-ray diffraction 
(Glusker and Trueblood, 1985; Blundell and Johnson, 1976; Blow, 2002 and Rupp, 2010) so will only 
be discussed briefly here.  
  When X-rays are scattered by electrons they are either scattered elastically, with no 
energy loss and X-ray photons are emitted at the same frequency as it entered, or inelastically, 
where electrons accept some energy from incoming X-ray photon reducing the energy of the 
emitted photon. When X-rays diffract from a crystal the contribution of the molecules in the regular 
lattice amplifies the signal you would see from a single molecule to produce discrete diffraction 
spots. Using Bragg’s law (equation 1.1) we can quantify the angle at which X-rays are scattered (θ) 
relative to the distance between points in the crystal lattice (dhkl), as shown in Figure 1.1 where X-
rays are seen to be reflected from a set of planes in a crystal.   
𝑛𝜆 = 2𝑑ℎ𝑘𝑙 sin 𝜃 
     (1.1) 
When X-rays scattered from a crystal satisfy the diffraction condition defined by Bragg’s 
law we observe discrete diffraction spots. Fulfilment of the diffraction condition is elegantly depicted 
by superposition of the Ewald sphere with a reciprocal lattice where the lattice origin (000) is in line 
with the incoming X-ray beam (Fig. 1.2). Wherever a reciprocal lattice point intersects with the 
Ewald sphere the diffraction condition is fulfilled. By rotating the crystals we cause other reciprocal 
lattice points to intersect with the Ewald sphere allowing us to measure a complete diffraction 
dataset.  
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Analysis of X-rays scattered by electrons allows us to calculate how the electrons are 
distributed through a crystal using the electron density equation, which expresses electron density 
at any point (x,y,z) in the unit cell as a Fourier series; a representation of a function as the sum of 
sine wave.      
𝜌(𝑥, 𝑦, 𝑧) =  
1
𝑉
∑ ∑ ∑ 𝐹(ℎ𝑘𝑙) exp(−2𝜋𝑖(ℎ𝑥 + 𝑘𝑦 + 𝑙𝑧))
𝑙𝑘ℎ
 
(1.2) 
The structure factors F(hkl) represent the information obtained through the 
crystallographic experiment which is defined as, 
𝐹(ℎ𝑘𝑙) = ∑ 𝑓𝑗exp (2𝜋𝑖(ℎ𝑥𝑗 + 𝑘𝑦𝑗 + 𝑙𝑧𝑗))
𝑁
𝑗=1
 
(1.3) 
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where V represents the volume of the unit cell, h, k, and l represent the Miller indices (reciprocal 
index vectors representing 3D crystallographic lattice planes) of any particular reflection, xj, yj and zj 
represent the coordinates of the jth atom and fj is the scattering factor of the jth atom. The 
structure factors can be simplified to,  
𝐹(ℎ𝑘𝑙) =  𝐹ℎ𝑘𝑙  exp (𝑖𝛼ℎ𝑘𝑙) 
(1.4) 
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where Fhkl represents the measured amplitude obtained during crystallographic experiments as 
intensities and αhkl is the phase of the structure factor for all measured reflections which must be 
determined mathematically to “solve” the structure of the crystallised molecule.  
1.2. Data Collection 
Diffraction data for all test crystals and structures solved in this thesis were collected at 
Diamond Light Source, UK, on beamlines I02, I03, I04, I04-1 and I24 on Dectris Pilatus 6M detectors. 
All data were collected using fine phi data collection strategies to minimise the contribution of 
background noise, allow 3D profile fitting of partial observations to reconstruct full reflections and 
reduce overlap in reflections from intersecting lunes (Mueller et al., 2012). To determine the amount 
of data required for a complete dataset the space group of the macromolecular crystal must be 
determined.  
1.3. Space Groups  
Space groups represent a group of mathematical symmetry opperations including 
translational, rotational (two-, three-, four- and six-fold operation) and translational-rotational 
operations (screw-axes and glide planes). Translation opperations result in fourteen Bravais lattices 
which give 230 unique space groups when combined with up to three other symmetry opperators. 
Due to the chirality of proteins and the need to maintain handedness in protein crystals, mirror 
planes, glide planes, improper rotations and inversion opperations are not allowed; leaving 65 chrial 
space groups in MX.  
In most cases space groups are determined through the presence of systematic absences in 
diffraction data, these result from translational symmetry elements caused by Bravais translations 
and screw-axes which give reflections with zero intensity along specific directions in the reciprocal 
lattice. The exception to this are polar space groups with a single unique rotation/screw axis, such as 
P6 or P61, whose symmetry opperators do not fix the unit cell origin on a crystallographic axis. To 
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correctly identify the anantiomorph of these space groups an atomic position is required to fix the 
origin. Crystal structures may need to be reindexed if processed in the wrong anantiomorph.     
1.4. Data reduction  
Data reduction is a two-step process consisting of, (1) indexing diffraction spots to assign 
consistent unit cell vectors (h,k,l) to the diffraction pattern and (2) calculating reflection intensities. 
All data in this thesis were processed with XDS. XDS uses a robust auto-indexing system which 
derives reciprocal cell axis lengths from difference vectors between pairs of neighbouring reciprocal 
lattice vectors to produce a “reduced cell” in P1 and the lattice is fitted to the strongest 3000 
reflections (Kabsch, 2010b, Kabsch, 2010a). The lattice is then refined against the strongest 3000 
reflections followed by all found reflections and the Bravais lattice is calculated and fitted to possible 
space groups.   
Integration involves accurate measurement of reflection intensities over multiple frames as 
all data collected in this thesis were collected using fine phi slicing so only partial reflections were 
recorded. XDS first calculates the frames and pixel positions which contribute to each reflection and 
generates a coordinate system. An average profile of strong reflections is then generated and the 
intensity is estimated by determining the background level and generating 3D profiles of 
contributing pixels for each reflection (Kabsch, 2010b, Kabsch, 2010a). 
Individual images are then scaled to account for variations in the intensity of the beam, the 
illuminated crystal volume, absorption of the beam, radiation damage, detector sensitivity and 
differences in crystal size/order when scaling multiple crystals (Kabsch, 2010a). Correction factors 
are defined by,  
𝛹ℎ𝑙 = (𝐼ℎ𝑙 − 𝑔𝑙𝐺𝑙𝐼ℎ)/𝜎ℎ𝑙  
(1.5) 
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where h represents a unique reflection, hl represents symmetry-related reflections to h that are 
corrected by the reciprocal scaling factor gl. Ihl is the reflection’s and symmetry related reflection’s 
weighted mean and σhl their standard deviation. Ih represents the “true” intensities as defined in 
detail in Kabsch (2010a). Finally data are merged into a single dataset and structure factors are 
calculated.  
1.5. Data Quality  
A number of metrics are applied to merged diffraction data to determine the relative error 
between measured reflections in individual resolution shells and the overall dataset. The signal-to-
noise ratio, commonly referred to as the I/σ(I) is defined as,  
 
|𝐼|
𝜎(𝐼)
=  
1
𝑁
∑
𝐼(ℎ)
𝜎(𝐼(ℎ))
𝑁
ℎ
 
(1.6) 
where N is the number of reflections in a given resolution shell and I(h) is the intensity of a given 
reflection. A variety of merging R values are commonly used to measure the error between 
individual reflections in defined resolution shell and over the whole dataset. As resolution increases 
reflections become weaker and relative error increases which is represented as an increase in these 
R values. The most common data quality indicator is the linear merging R factor (Rmerge). However, 
Rmerge fails to account for redundancy making low redundancy data appear better than high 
redundancy data (Diederichs and Karplus, 1997). As a result Rmerge has been altered to give the 
redundancy independent merging R value (Rmeas) with,  
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𝑅𝑚𝑒𝑎𝑠 =  
∑ (
𝑁
𝑁 − 1)
1
2
∑ |𝐼(𝑖ℎ) − 𝐼(̅ℎ)|
𝑁
𝑖=1ℎ
∑ ∑ 𝐼(𝑖ℎ)
𝑁
𝑖=1ℎ
 
 (1.7) 
where h is any given reflection, Ih is the intensity of an individual reflection, 𝐼(̅ℎ) is the average 
intensity of symmetry related reflections and N is the total number of reflections in the defined 
resolution bin. The precision-indicating merging factor (Rp.i.m.), which adds (
1
𝑁−1
)
1
2
 to the summation 
of reflection in the Rmerge function in a similar vein to Rmeas, has also been adopted as it shows 
increasing precision of intensity measurements with increasing redundancy (Weiss and Hilgenfeld, 
1997, Weiss, 2001).   
Another indicator becoming more common place is the use of correlation coefficients as a 
measure of data quality and maximum high resolution limit. Unmerged data is separated into two 
randomly selected half sets of unique reflections and calculate the correlation coefficient between 
averages half sets to give the CC1/2 (Karplus and Diederichs, 2012). The correlation between the 
CC1/2 and the CCtrue (the correlation of the averaged dataset with noise-free true signal), CC*, is 
calculated by, 
𝐶𝐶∗ =  √
2𝐶𝐶1/2
1 + 𝐶𝐶1/2
 
(1.8) 
1.6. Phasing  
As defined earlier in equation 1.4, structure factors consist of a magnitude and a phase 
term; of which the magnitude is measured from the diffraction pattern while the phase information 
is lost. Determining the phase is essential to obtaining accurate structural information, as is elegantly 
shown in Kevin Cowtan’s example of the Fourier Duck and Fourier Cat (Taylor, 2010); where 
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combining the magnitude from the Fourier transform of a duck (Fig. 1.3a) with the phase from the 
Fourier transform of a cat (Fig.1.3b) results in reconstruction of the image of the cat (Fig. 1.3c). 
There are several different methods that have been developed for determination of phases for 
macromolecular structures. The first used being multiple isomorphous replacement (MIR) by Perutz 
on the structure of haemoglobin using two bound mercury atoms (Green et al., 1954).  
1.6.1. Multiple Isomorphous Replacement  
Scatter from heavy atoms dominates the scattering pattern with scatter roughly 
proportional to atomic number. By introducing heavy atoms into a protein crystal we can introduce 
differences into to the diffraction pattern and the Patterson map (a 2D or 3D representation of all 
possible interatomic vectors calculated from intensities with a phase of zero) when compared with 
the native crystal. By subtracting the contribution of the native structure from the heavy atom 
structure we generate difference intensity data which represents the substructure of the heavy 
atoms. Using this much smaller number of atoms the heavy atom position can be determined using a 
difference Patterson map/direct methods to generate initial phases and electron density maps.   
 23 
 
 
 
 
 24 
 
1.6.2. Molecular Replacement  
Molecular replacement (MR) involves the use of a known homologous structure, preferably with 
30% or higher sequence identity and similar secondary structure, to determine the initial phases for 
an unknown structure. As of 2010 structures solved by MR account for over 95% of structures in the 
PDB (Vagin and Teplyakov, 2010b). Six parameters are applied to homologous structures, a 3D 
rotation search and a 3D translation search, to position the known structure on top of the unknown 
crystal structure and calculate initial phases. MR depends heavily on the Patterson function, which is 
used to calculate a vector map of a structure through a Fourier transform of intensities and 
amplitudes with a phase of zero. These maps represent the interatomic vectors of the structure 
which can be used to orientate a model in the unit cell of the unknown crystal structure. The self-
Patterson of a known structure can be calculated in any orientation (rotation) and compared with 
the self-Patterson of the unknown structure. When these self-Pattersons match, the correct 
orientation of intramolecular parts of the structure have been determined and the fit is measured 
with the cross rotation function developed by Rossmann and Blow (1962), 
𝑅 =  ∫ 𝑃2(𝑋2)𝑃1(𝑋1) 𝑑𝑥1
𝑈
 
(1.9) 
where P1(X1) represents the Patterson from the diffraction data, P2(X2) the Patterson of the rotated 
model. The integration is carried out over the unit cell volume, U.  Once the rotation function has 
been found the translation function orientates the structure with respect to the origin of the crystal. 
In a similar manner to the rotation function, the model is moved, a new Patterson generated and 
compared to the unknown structure for overlaps.  
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1.6.3. Phasing With Anomalous Signal  
Much like the differences introduced into the diffraction pattern and Patterson map in 
multiple isomorphous replacement, anomalous signal can be utilised in a similar manner by altering 
the atomic scattering factor. The atomic scattering factor consists of three terms, (1) the normal 
scattering term (f0) which is dependent on the Bragg angle; (2) the dispersive term (f’) which affects 
the normal scattering factor and (3) the absorption term (f”) which causes a phase change of +90°. 
Both f’ and f” contribute to the anomalous scattering factor and are wavelength dependent; 
appearing at the absorption edge of an element when an electrons is ejected from a lower shell 
leaving a space for higher shell electrons to fill. Descending electrons produce X-ray emissions 
specific to absorbing elements which is measured as anomalous signal (Taylor, 2010).   
𝑓(𝑺,𝜆) =  𝑓(𝑠)
0 + 𝑓(𝜆)
′ + 𝑖𝑓(𝜆)
"   
(1.10) 
The presence of this anomalous signal causes a breakdown in Friedel’s law (|Fhkl| = |F-h-k-l|) 
as shown in Figure 1.4. Without anomalous signal Friedel’s law holds with the sum of all normal and 
anomalous scattering atoms (FPA and F-PA) being symmetrical over the real axis (Fig. 1.4a). In the 
presence of anomalous signal (FA) the combination of the dispersive term (green) and absorption 
term (purple) (Fig. 1.4b) cause a significant difference between FPA and F-PA (dark blue) over the real 
axis (Fig. 1.4c). Much like isomorphous replacement, this results in differences in the diffraction 
pattern and Patterson map which can be interpreted for phasing; without potentially introducing 
non-isomorphism with large disruptive heavy atoms.  
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1.6.4. MAD Phasing  
Multiwavelength Anomalous dispersion (MAD) data are collected from a single crystal at 
several wavelengths to generate the strongest differences in anomalous data. Wavelengths used 
generally include the absorption peak where f” is at its maximum, the point of inflection where f’ is 
at its minimum and a remote dataset either before or after the absorption peak to maximise the 
difference in anomalous signal. By collecting these data from a single crystal problems with non-
isomorphism can be avoided. However, the changes resulting from anomalous signal can be very 
small and require very high accuracy measurements of the intensities to distinguish them so 
radiation damage must be avoided. Many MAD structures have been solved by replacing native 
methionines with selenomethionines which have a strong anomalous signal around standard MX 
energies (12.4 keV); but this can be detrimental to protein expression, purification, crystallisation 
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and gives a non-native representation of the protein which may affect interpretation of the 
biological function.  
 1.6.5. SAD Phasing  
The first demonstration of single-wavelength anomalous dispersion (SAD) phasing was the 
structure of crambin by Hendrickson and Teeter (1981) using six native sulphur atoms. SAD 
experiments measure the differences in intensity between a Bijvoet pair (Eqn. 1.11) from a single 
crystal collected above or at an energy above an absorption edge.  
∆𝐹± =  |𝐹𝑃𝐻(+)| − |𝐹𝑃𝐻(−)| 
(1.11) 
As with soaked heavy atoms these differences between Bijvoet mates (equivalent to native 
and heavy atom intensities) are used to determine the heavy atom substructure by direct or 
Patterson methods. However, SAD data presents with an ambiguity in the phase angle as 
demonstrated in Figure 1.5. Using the heavy atom substructure the amplitude and phase can be 
calculated (FH), giving an origin for f” and the measured intensities of the Bijvoet pairs (F+PH and F-PH). 
Using a Harker construction to draw circles of radius FPH and F-PH at origins f”(±) we see two potential 
solutions for the phases (Fig. 1.5). The phase ambiguity can be resolved by density modification 
which should produce an outline of a map distinguishable from the background noise when using 
the correct enantiomorph.  
 28 
 
 
1.6.6. Long Wavelength MX for Sulphur-SAD 
As discussed earlier for MAD phasing, the largest anomalous signal for any element is 
measured at or above its absorption edge. The absorption edge of sulphur is around 5 Å, a much 
longer wavelength than most standard MX beamlines can reach (0.8-2.5 Å). However, it has been 
shown that anomalous differences from native sulphurs can be measured using 1.54 Å X-rays from a 
copper rotating anode (Hendrickson and Teeter, 1981) and using synchrotron radiation between 
1.54 Å (Dauter et al., 1999) and 2.5 Å (Liu et al., 2000). However, automated S-SAD phasing is still not 
routinely successful on standard MX beamlines (Doutch et al., 2012). An estimate of the anomalous 
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signal that can be obtained from native sulphurs in a protein crystal at different X-ray energies can 
be determined using the Bijvoet ratio,  
𝐵𝑅 = (
𝑁𝐴
2𝑁𝑇
)
1
2
(
2𝑓"𝐴
𝑍𝑒𝑓𝑓
) 
(1.12) 
where NA is the number of anomalous scatterers in the unit cell, NT is the total number of atoms in 
the unit cell, f” is the anomalous scattering factor at a set energy and Zeff is the normal scattering 
power (6.7 e- at 2θ = 0). It has been suggested that a Bijvoet ratio of at least 0.6% is necessary for 
successful phasing by SAD (Wang, 1985). Although use of longer wavelength (1.5-3 Å) and long 
wavelength (>3 Å) X-rays have the advantage of increased anomalous signal for lighter atoms such as 
sulphur, phosphorous, calcium and chlorine there are several downsides that must be taken into 
account.  
 As wavelength increases scattering increases proportional to λ2 but absorption by the 
crystal, surrounding solvent, sample mount and air also increase proportional to λ3 (Djinovic Carugo 
et al., 2005). Based on this ratio it has been argued that smaller crystals will scatter much more 
efficiently at longer wavelengths, providing radiation damage does not occur (Teplyakov et al., 
1998). However, reducing radiation damage can prove difficult as measurement of the weak 
anomalous signal from native sulphur requires highly redundant data (Dauter and Adamiak, 2001, 
Weiss, 2001). The advent of fast Pixel array detectors (Broennimann et al., 2006b) means highly 
accurate data can now be collected before the onset of radiation damage (Owen et al., 2014b), as 
well as with minimal readout noise. Significant improvements in data processing software have also 
helped get the most out of the small anomalous signal measured (Kabsch, 2010b, Adams et al., 2010, 
Sheldrick, 2010). These developments have brought about a resurgence in S-SAD phasing with the 
use of multi-crystal averaging (Liu et al., 2012, El Omari et al., 2014) and multiple low dose data 
collections on a single crystal (Weinert et al., 2015). Although the state of S-SAD has drastically 
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improved over the years, standard MX beamlines are unable to use long wavelength X-rays to their 
full potential due to absorption and scattering of X-rays in air, absorption in the crystal and the 
larger diffraction angles from the X-rays (Djinovic Carugo et al., 2005). In an attempt to harness the 
power of long wavelength X-rays, Diamond Light Source have developed the first in vacuum 
beamline for long wavelength MX, I23.  
1.7. I23 – In-vacuum MX 
To reduce the effects of background noise on the detector from air scatter as well as the 
absorption of the X-ray beam in air I23 has been designed to operate in vacuum, with the entire 
experimental setup in a large vacuum chamber. By performing diffraction experiments in vacuum 
scattering of X-rays by air is eliminated, leaving only background scatter from the crystal and sample 
mount. The signal-to-noise ratio can also be improved by removing non-crystalline solvent 
surrounding the crystal which causes water rings to appear on the diffraction image. Chapters Two 
and Three of this thesis deal with the effects of longer wavelength X-rays in the presence and 
absence of excess surrounding solvent on data quality. Performing diffraction experiments in 
vacuum means conventional cooling of protein crystals with a stream of liquid nitrogen is not 
possible so I23 has adopted a conductive cooling mechanism. Extensive work has been carried out 
on the viability of cooling by conductance through the goniometer and specially designed sample 
mounts (Warren et al., 2013). Cooling by conductance also has the added benefit of minimising 
sample vibrations from the cryo-stream which can have a negative effect on the signal-to-noise ratio 
(Alkire et al., 2008, Alkire et al., 2013). Finally, with respect to improving signal-to-noise, a semi-
cylindrical Pilatus 12M detector has been designed to allow rapid data collections with minimal 
readout noise and to account for the large scattering angles from long wavelength X-rays.   
Although absorption has been limited through removal of air and surrounding solvent 
absorption is still a limiting factor for long wavelength MX with respect to the crystal itself. 
Absorption correction accounts for the attenuation of X-rays travelling through the crystal, however, 
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most absorption correction programs use a rough estimation of crystal volume. I23 will employ an X-
ray tomography system to allow accurate measurement of the crystal volume post data collection 
for more accurate absorption correction. Tomographic reconstruction of macromolecular crystals 
has been demonstrated by Brockhauser et al. (2008) on lysozyme and DNA crystals. X-ray 
tomography has also been used as a low dose alternative to the grid scans for location of small 
membrane protein crystals cooled in opaque lipidic cubic phase mother liquor (Warren et al., 2013).   
As of the writing of this thesis (July 2015) I23 has not entered user operation and only 
limited work has been done in house for MX. This thesis is concerned with the development of 
sample handling techniques to allow collection of superior quality data in the face of increased 
absorption and background scatter when approaching longer wavelengths for native S-SAD phasing. 
Chapters two and three cover the use of a humidity controlled device (HC1) (Sanchez-Weatherby et 
al., 2009b) and a custom built sample handling setup to remove excess surrounding solvent from 
macromolecular crystals for diffraction experiments at standard and longer wavelengths. Robust 
statistical tests were applied to assess the effects of solvent on data quality. Chapters four and five 
concern the expression, purification and crystallisation of novel protein targets for S-SAD phasing on 
I23. However, due to the technical difficulties in development of the beamline these crystals were 
not tested on I23 but can be reproduced for testing at a later date. Chapter six presents the 
structural and biochemical analysis of a novel EAL domain protein from Pseudomonas aeruginosa 
involved in the regulation of biofilm formation. EAL domain protein crystals were also used in data 
quality tests presented in chapter three. Finally, Chapter seven demonstrated the advantages of high 
quality diffraction data by investigating the reaction mechanism of Achromonacter cycloclastese 
nitrite reductase with atomic resolution crystal structures collected using serial data collection on a 
single protein crystal to observe conversion of nitrite to NO in the crystal.  
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Chapter 2 – Sample Preparation for Long 
Wavelength MX 
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2.1. Introduction  
As modern macromolecular crystallography (MX) is used to tackle more and more 
difficult projects, there is a pressing need to improve the quality of diffraction data. 
Development of synchrotron instrumentation has greatly improved the reliability, accuracy 
and speed of data collection to the point that sample quality is becoming the more 
significant stumbling block. The major limiting factors affecting diffraction data include 
crystal quality, radiation damage and the signal-to-noise ratio. Improving crystal quality 
requires the systematic optimisation of crystallisation conditions and cryo-protection which 
can be very time consuming and may require rescreening to find alternative crystallisation 
conditions. Radiation damage results from interactions of the X-ray beam with the electrons 
in the crystal. Although X-ray diffraction is an elastic process, X-ray absorption and Compton 
scattering deposit energy in crystals, causing damage and a reduction in diffracting power 
(Teng and Moffat, 2000, Garman and Weik, 2015). These effects are wavelength dependent 
at typical MX energies (12.4 keV), with damage proportional to absorbed X-ray dose (Owen 
et al., 2006a, Murray et al., 2005, Henderson, 1990). The development of X-FEL technology 
allows a “collect-before-destroy” approach to overcome the effects of primary radiation 
damage caused by direct interaction of X-ray radiation with electrons to break chemical 
bonds (Neutze et al., 2000, Teng and Moffat, 2000). However, access to X-FELs is very 
limited so does not present a feasible alternative to synchrotron radiation for the MX 
community. Secondary damage results from chemical reactions of highly reactive species 
produced by ionising radiation, such as hydroxyl radicals, hydrated electrons and H atoms 
(Burmeister, 2000, Teng and Moffat, 2000, Garman, 2003a, Murray et al., 2004, Owen et al., 
2006a). These effects can be reduced by slowing the thermal diffusion of radicals through 
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data collection performed at cryo temperatures (Hope et al., 1989) or by outrunning 
damage with fast detectors and very short exposure times (Owen et al., 2014a).  
Maximising the signal-to-noise ratio has been addressed through improved data 
collection techniques, largely enabled by modern synchrotron instrumentation such as pixel 
array detectors (Broennimann et al., 2006a) and microfocus beams (Evans et al., 2007). The 
combination of the fine φ-slicing method (Mueller et al., 2012) and precise targeting with 
microbeams (Sanishvili et al., 2008) have both contributed to a significant reduction in 
background scatter from surrounding solvent and sample mounts. In addition to exploiting 
these advances in synchrotron technology, careful sample preparation can go a long way 
towards improving the signal-to-noise ratio during diffraction experiments.  
The principal causes of background scatter are the excess solvent around frozen 
crystals and the sample mounts. Although this background scatter is not usually considered 
a critical issue in standard MX experiments, for the long wavelength experiments required 
for accurate phasing and in microcrystal MX, where signals are significantly weaker, 
background scatter becomes a limiting factor. As a result, in an effort to improve the signal 
to noise ratio, a variety of sample handling techniques have been developed as alternatives 
to traditional nylon and Kapton mounts.  
The “capillary-top mounting” or “loopless method” was developed to exploit the 
use of Cr Κα radiation (2.29 Å) and reduced background scatter to measure the weak signals 
associated with S-SAD phasing (Kitago et al., 2005b, Watanabe et al., 2006, Kitago et al., 
2010b). Capillary mounts with removable nylon loops (Fig. 2.1c-d) were incorporated into a 
semi-automated setup, which removes surrounding solvent by aspiration and flash freezes 
protein crystals in the cryostream in one motion (Fig 2.1a and b) (Kitago et al., 2010b). This 
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method has seen some success in structure solution by S-SAD and presents a good case for 
phasing by in-house Cr Κα radiation (Watanabe et al., 2006).  
Another technique designed to improve the signal-to-noise ratio is the Crystal 
Catcher, designed by Kitatani et al. (2008b) and further tested by Mazzorana et al. (2014). 
The Crystal Catcher allows loop free mounting of crystals on an adhesive ejected from a 
quasi-SPINE standard pin using a mechanical pencil type mechanism (Fig. 2.2) (Kitatani et al., 
2008a, Kitatani et al., 2008b, Kitatani et al., 2009).  
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Wierman et al. (2013) have also developed a technique using atomically thin 
graphene sheets to coat protein crystals. Crystals are wrapped by pipetting crystals into a 
drop with a graphene sheet floating at the water air interface of the drop (Fig. 2.3a). As the 
crystal floats to the bottom of the drop a nylon loop is used to position the crystal in the 
graphene sheet which wraps around the crystal as it is pulled from the drop (Fig. 2.3b) 
(Wierman et al., 2013).  
 
 
 
 37 
 
 
 38 
 
The use of lasers has also been explored for sample preparation in an effort to 
increase the signal to noise ratio. Pulsed UV laser soft ablation (PULSA) has been used on 
crystals of soluble protein to cut and shape crystals, minimising surrounding solvent without 
damaging the structure of the crystal (Kitano et al., 2004, Kitano et al., 2005a, Watanabe et 
al., 2006). The technique has been extended to processing of membrane proteins and the 
removal of nylon loops using PULSA (Kitano et al., 2005b). CrystalDirect (Cipriani et al., 
2012) also employs laser-induced photoablation for sample preparation with a femtosecond 
laser used to excise protein crystals grown on ultrathin films. This technique aims to 
completely automate crystal harvesting and reduce background scatter in the process (Fig. 
2.5) (Cipriani et al., 2012). The work by Cipriani et al. (2012) corroborates the findings that 
the use of PULSA has no detrimental effects of crystal quality.  
Although not originally designed for the purpose of reducing background scatter to 
improve the signal-to-noise ratio, both the free mounting system (FMS) (Kiefersauer et al., 
1996, Kiefersauer et al., 2000) and humidity controlled device (HC1) (Sanchez-Weatherby et 
al., 2009a) allow removal of excess surrounding solvent while maintaining protein crystals in 
a humid air stream. Both were designed to exploit the dynamic nature of protein crystals by 
using dehydration to alter crystal packing and improve the diffraction power of crystals; 
with an ever growing list of success stories (Russo Krauss et al., 2012, Deng et al., 2012, 
Newman, 2006, Bowler et al., 2006b, Heras et al., 2003, Heras and Martin, 2005, Kalinin et 
al., 2005). The FMS removes a crystal from a nylon loop using a micropipette; the crystal is 
maintained within a stream of humid air to allow online dehydration experiments (Fig. 2.6). 
The relative humidity of the air stream is regulated by mixing two air streams of 0 and 100% 
relative humidity (Kiefersauer et al., 2000). Solvent is removed by aspiration in a similar 
 39 
 
fashion to the capillary top mounting 
method. Although the FMS has been 
successful in many cases, it has proven 
difficult to routinely or easily 
incorporate its bulk into the crowded 
synchrotron beamline environment.  
This has led to the development 
of a more suitable online device, the 
HC1, which uses a nozzle based on 
standard cryostream technology for 
delivery of the humid air stream (Fig. 
2.7) (Sanchez-Weatherby et al., 2009a, 
Russi et al., 2011). Protein crystals can 
be harvested on standard sample 
mounts and placed in the humid air 
stream, where excess solvent can be 
removed to allow more efficient 
dehydration (Sanchez-Weatherby et al., 
2009a). The HC1 regulates humidity in a 
similar manner to the FMS, using 
calculation of the dew point to set the final relative humidity (Kiefersauer et al., 2000). 
However, differences arise between the two systems in how the dew point is achieved. 
Instead of mixing two air streams, the HC1 use a condenser paired with a Peltier device (Fig. 
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2.7b) to cool the incoming air to the calculated temperature and remove excess water 
though the condenser (Sanchez-Weatherby et al., 2009a). In this study the HC1 has been 
used to maintain protein crystals, as done previously (Sjogren et al., 2002, Sjogren and 
Hajdu, 2001b, Sjogren and Hajdu, 2001a), to allow removal of excess surrounding solvent, to 
assess the effects of manual handling and frozen solvent on data quality.  
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All of the studies mentioned above have presented findings based on comparison 
of a very small number of (or even just single) protein crystals between treatments, without 
validation by an appropriate statistical test (Kitago et al., 2010a, Kitago et al., 2005b, Kitatani 
et al., 2008b, Mazzorana et al., 2014, Wierman et al., 2013, Cipriani et al., 2012). However, 
studying and accurately evaluating relatively small effects on data quality is very difficult to 
achieve due to radiation damage and the intrinsic variability of crystals, even if grown and 
harvested under the same conditions and in the same drop (Nowak et al., 2009).  
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In this study, a systematic statistical approach was used to determine whether 
manual handling and manipulation of crystals in a humidity-controlled stream can be 
performed at no cost to the integrity of the sample. To prove this concept, large populations 
of macromolecular crystals were transferred between conventional sample mounts, using 
micromanipulators to allow precise movement, and the HC1 to preserve the integrity of 
macromolecular crystals and enable removal of excess surrounding solvent. crystal transfer 
was facilitated by the removal of excess surrounding solvent with a fine paper wick 
(Warkentin and Thorne, 2009), giving the added benefits of reduced background scatter and 
improved cooling rates during cryo-protection. To assess the effects of manual handling and 
the presence of excess solvent, two statistical tests were applied to the crystal/data 
populations: Student’s t-test (Student, 1908) and the Mann-Witney-U-test (Mann and 
Whitney, 1947). Both tests examine the null hypothesis that the population of transferred 
crystals and the population of crystals fished and mounted by conventional methods show 
no significant differences in data quality. Initially, experiments during data collection were 
conducted at λ = 1 Å, a typical wavelength used in MX, to ensure that sample handling, 
exposure to the humid air stream and wicking of excess solvent can be performed at 
standard conditions without damaging macromolecular crystals. These experiments and 
tests were a precursor and background to testing the effects of excess solvent using long 
wavelength data collection (see Chapter 3). At λ = 1 Å it is expected that absorption will be 
negligible, so any detrimental effects on data quality will be the result of manual handling 
and/or exposure to the humid air stream.  
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2.2. Methods  
2.2.1. Protein Crystallisation  
Hen egg white lysozyme (HEWL), porcine insulin, Thaumatococcus daniellii 
thaumatin and horse-spleen ferritin were selected to study the effects of manipulating 
protein crystals and removing excess solvent in a humidity controlled environment. These 
proteins are all commercially available, have well defined crystallisation protocols and are 
grown in optimised cryo-protection conditions, thus eliminating the additional manual step 
of determining cryo-protection conditions, which could introduce random errors into this 
systematic study. All proteins were purchased from Sigma-Aldritch (St Louis, Missouri, USA) 
and underwent no further purification. Crystals were grown in sitting drops by the vapour 
diffusion method at 19°C over several days (Fig. 2.8).  
Tetragonal HEWL crystals were grown in 0.8-1.2 M NaCl, 50 mM sodium acetate pH 
4.6 and 25% ethylene glycol (v/v) following the protocol by Murray and Garman (2002). 30% 
PEG 5K (w/v) was substituted for 25% (v/v) ethylene glycol for cryo-protection. Porcine 
insulin was suspended in 50 mM sodium phosphate with 10 mM EDTA pH 10.2 and 
equilibrated against 30% ethylene glycol and 50 mM sodium phosphate with 10 mM EDTA 
pH 10.2  in a 1:1 ratio to produce cubic crystals, adapted from the batch method by Meents 
et al. (2007). Tetragonal thaumatin crystals were grown by equilibrating 80 mg/ml 
thaumatin in 100 mM phosphate buffer pH 6.5 against 30% (w/v) Na/K tartrate, 100 mM 
phosphate buffer pH 7 and 20% glycerol, adapted from the modified gel acupuncture 
method (Lopez-Jaramillo et al., 2001). Cubic ferritin crystals were grown in 0.1 M NaCl, 0.8 
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M ammonium sulphate, 10 mM cadmium chloride and 25% glycerol (v/v) as detailed by 
Murray and Garman (2002).  
2.2.2. The Humidity Control Device (HC1)  
The main purpose of humidity control devices to date has been to 
dehydrate/rehydrate protein crystals to subtly alter crystal packing and ultimately improve 
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diffraction quality (Sanchez-Weatherby et al., 2009a, Bowler et al., 2006c, Russi et al., 2011). 
In my case the HC1 (Arinax, ZI de Centr’Alp, France) was used to (i) maintain protein crystals 
in as near a native environment as possible for the physical transfer from one mount to 
another and (ii) allow controlled removal of excess surrounding solvent.   
2.2.3. Defining Relative Humidity  
To prevent protein crystals dissolving, drying out or losing cryo protection when 
introduced to the humid air stream their relative humidity must be measured. Relative 
humidity was measured by loading a drop of reservoir solution on an empty loop in the 
humid air stream and monitoring the change in drop size over time. Too high a relative 
humidity causes the drop to grow while too low will cause the drop to shrink. The relative 
humidity was adjusted accordingly and the process repeated with a new drop of reservoir 
solution until equilibrium was reached and drop size stabilises (Sanchez-Weatherby et al., 
2009a). A fresh drop was used after each humidity adjustment as the concentration of 
buffer components may have changed with loss or gain of water from the humid air stream. 
All crystal transfer experiments, described later, were carried out under these equilibrium 
conditions. The relative humidities of several common crystallisation compounds have been 
measured (Table 2.1) (Wheeler et al., 2012) and these can provide initial relative humidity 
targets. However, reservoir solutions with a combination of buffers, salts and PEGs, etc, 
were observed to vary considerably from these measured ‘pure’ values (Table 2.1) and 
thorough experimentation was therefore required.  
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Table 2.1: Relative humidity measurements of individual chemicals and crystallisation buffers. All 
protein crystals reqired no further cryo-protection. For crystals where two populations were 
produced (lysozyme and ferritin) measured relative humidities are presented as population 1/ 
population 2.    
Individual buffers Relative 
Humidity (%) 
Crystal Buffers 
Relative 
Humidity (%) 
0.1 M NaCl 100.00 
Ferritin: 0.1 M NaCl, 0.8 
M ammonium sulphate, 
10 mM cadmium chloride 
and 25% glycerol (v/v) 
89.50/90.00 0.8 M AmSO4 99.25 
25% Glycerol 
(v/v) 
95.00 
1.0 M NaCl 99.00 
Lysozyme: 0.8-1.2 M 
NaCl, 50 mM sodium 
acetate pH 4.6 and 25% 
ethylene glycol (v/v) 
89.00/89.00 
25% Ethylene 
Glycol (v/v) 
92.00 
20% Glycerol 
(v/v) 
97.00 
Thaumatin: 30% Na/K 
tartrate (w/v), 100 mM 
phosphate buffer pH 7 
and 20% glycerol 
86.00 
30% Ethylene 
Glycol (v/v) 
89.50 
Insulin: 30% ethylene 
glycol and 50 mM sodium 
phosphate with 10 mM 
EDTA pH 10.2 
91.00 
 
2.2.4. Humidity Control Crystal Transfer Method  
In order to genly transfer crystals from one mount to another while removing 
excess solvent I constructed and tested the crystal transfer setup (Fig. 2.9), which consists of 
two micromanipulator stages, a stationary stage, a light microscope and the HC1. 
Macromolecular crystals are transferred from a donor sample mount (Fig. 2.10a) on the 
stationary stage (Fig. 2.10b) to an acceptor sample mount loaded with reservoir solution 
(Fig. 2.10c) on micromanipulator 1 (Fig. 2.10d). The process is viewed from above using the 
light microscope (Fig 2.10e). Both donor and acceptor sample mounts are placed 
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approximately 1cm from the HC1 nozzle (Fig. 2.10f), within the laminar humid air stream. A 
fine paper wick (Fig. 2.10g) attached to micromanipulator 2 (Fig. 2.10h) is used to gently 
remove excess solvent.  
 
The step by step transfer is depicted in Figure 2.12. A crystal is harvested from its 
drop using the donor mount and placed in the humid air stream opposite the acceptor 
mount loaded with reservoir solution (Fig. 2.12a). The acceptor mount is brought into 
contact with the donor mount using micromanipulator 1 (Fig. 2.12b) and the excess solvent 
removed by wicking (Fig. 2.12c-d). Removing the solvent from the donor mount transfers 
the crystal to the acceptor mount leaving minimal surrounding solvent (Fig. 2.12e-f). The 
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acceptor mount is then removed from micromanipulator 1 and the crystal flash frozen in the 
adjacent dewar of liquid nitrogen (Fig. 2.10i).  
 
Control crystals were harvested directly from their drops using MicroMounts or 
LithoLoops and immediately flash frozen in liquid nitrogen. The crystals harvested for 
control and HC-transfer were of comparable size for each protein crystal type (Tables 2.3-5). 
Crystal sizes were measured from images taken with the beamline centring microscopes. 
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2.2.5. Crystallographic Data Collection and Processing 
Crystallographic data were collected over 6 visits on Diamond Light Source 
beamlines I03 (lysozyme 11, insulin and ferritin 11) and I02 (lysozyme 2, thaumatin and 
ferritin 2). The total number of individual datasets obtained during all visits for [control/HC-
transferred] crystals were as follows; lysozyme 1 [8/12], lysozyme 2 [18/16], insulin [16/13], 
thaumatin [7/14], ferritin 1 [16/19] and ferritin 2 [10/14]. Thus a total of 75 control and 88 
HC-transferred crystals were measured on four proteins. All datasets were collected in a 
                                                          
1 Lysozyme and ferritin populations were collected on two separate occasions and are 
named lysozyme 1 (I03), lysozyme 2 (I02), ferritin 1 (I03) and ferritin 2 (I02). Populations are 
not compared between primary and secondary populations (i.e. comparing lysozyme 1 with 
lysozyme 2) as crystals were harvested from different batches and data collection 
parameters varied between beamlines (Table 2.2).  
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single sweep to the total angular rotation stated in table 2.2, which summarises the data 
collection parameters.  
Table 2.2: Data collection parameters.  
All crystals were collected using a Pilatus 6M detector with a 0.1° step and 0.1 s exposure times. 
*Maximum resolution as defined by the detector edge at wavelengths and detector distances stated 
above.  
All data were indexed, integrated and scaled using the Xia2 3dii pipeline (Winter et 
al., 2013), XDS_ASCII.HKL files were then re-scaled with XSCALE (Kabsch, 2010a, 
Kabsch, 2010b) and merged with AIMLESS (Evans and Murshudov, 2013). Maximum high 
resolution limits were determined based on mean I/σ(I) > 2 in the highest resolution bin. All 
data were then processed through a second round of AIMLESS using a common high 
resolution cut-off specific to each protein crystal type and visit (Table 2.3-5). The lowest 
average maximum high resolution limit of the control and HC-transferred populations was 
used as the common high resolution limit for final processing and statistical analysis of each 
Test Crystal Lysozyme 1 Lysozyme 2 Thaumatin Insulin Ferritin 1 Ferritin 2 
Beamline I03 I02 I02 I03 I03 I02 
Number of 
crystals 
20 34 21 29 35 24 
Wavelength (Å) 0.9763 0.8500 0.9795 0.9763 0.9763 0.9795 
Beam Size (μm) 80 x 20 100 x 25 100 x 25 80 x 20 80 x 20 100 x 25 
Detector 
Distance (mm) 
175 147 189 177 177 230 
Max. 
Resolution* (Å) 
1.15 0.96 1.20 1.16 1.16 1.34 
Total Angular 
Range (°) 
120 120 120 90 90 90 
Space Group P41212 P41212 P41212 I213 F432 F432 
Transmission 
(%) 
20 20 20 20 20 20 
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protein type. All processing was performed using simple bash scripts to process all datasets in 
one sweep using the Diamond Light Source cluster (Appendix: Script Examples). Both 
lysozyme 1 and lysozyme 2 crystal poopulations diffracted beyond the resolution limit set by 
detector distance and wavelength so were processed to the maximum resolution limit 
available with data over 80% complete in the highest resolution bin.  In both visits, ferritin 
data processed to the average maximum high resolution limit presented with high Rmerge 
(>150%) and Rpim (>50%) values, despite having an average I/σ(I) > 2, so the high resolution 
limit in these cases was reduced to give an average Rmerge around 100%, as used by Xia2 
(Winter et al., 2013). Merging statistics for both control and HC-transferred crystals for all 
protein types were analysed to provide averages and standard deviations (Table 2.3-5) for a 
formal statistical treatment of the data. 
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2.2.6. Statistical Analysis  
Owing to the effects of radiation damage and the intrinsic variability of most 
macromolecular crystals it is not possible to study with any certainty the small effect that 
crystal handling or manipulation has on diffraction data quality using only one or a small 
number of samples. Historically a significant number of method development studies have 
drawn sometimes far reaching conclusions based on single crystal measurements or from 
small populations of X-ray diffraction datasets (Kitago et al., 2010a, Kitago et al., 2005b, 
Kitatani et al., 2008b, Mazzorana et al., 2014, Wierman et al., 2013, Cipriani et al., 2012). 
However, with the advent of hybrid pixel array detectors (Broennimann et al., 2006a) it is 
now possible to collect large enough numbers of datasets in a single synchrotron visit to 
allow robust statistical analysis techniques to be applied. Using this technology in the present 
study, formal statistical analysis was performed on both the control and HC1-transferred 
crystal populations, as described below.  
The Mann-Whitney U-test was used to compare the distributions of the data quality 
indicators Rmerge, Rp.i.m., mean I/σ(I), maximum high resolution limit, mosaicity and unit cell 
parameters between control and HC-transferred crystals.  Data were analysed by testing the 
null hypothesis that data quality is the same between the two populations (i.e. remains 
unchanged by treatment in the humid air stream). The Mann-Whitney U-test is a 
nonparametric test so makes no assumptions about the defining properties of the data, such as 
being normally distributed (Mann and Whitney, 1947). However, nonparametric tests are less 
likely to reject a false null hypothesis and most of our data are normally, or at least weakly 
normally, distributed; so an independent sample two tailed Student’s t-test assuming equal 
variance between populations was also conducted (Student, 1908). Both statistical tests were 
applied independently to all protein crystal types (further details are provided in Appendix: 
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Statistical Tests). Lysozyme and ferritin populations collected on beamlines I02 and I03 were 
analysed separately as crystals originated from different crystallisation batches.    
2.3. Results 
Owing to the fragile nature of protein crystals, excessive manipulation can have a 
negative effect on their physical integrity and the quality of diffraction data. To minimise the 
effects of manual handling, micromanipulators were used to carefully position the donor 
and acceptor mounts and to wick excess solvent without touching the protein crystal. This 
ensured the process was as gentle as possible on the crystals, while mechanical and osmotic 
stresses were kept to a minimum. During the transfer, none of the crystals showed signs of 
physical damage (breaking, cracking etc), dissolving or drying out while being transferred in 
the relative humidity stream. The measured relative humidities, using the loop method 
described in the earlier section “Defining Relative Humidity”, are listed for each crystal type 
in tables 2.3-5. The averaged data collection parameters and their corresponding standard 
deviations, for both the control and HC-transferred samples, are presented for lysozyme 
(Table 2.3), insulin and thaumatin (Table 2.4) and ferritin (Table 2.4).   
2.3.1. Crystal Integrity 
Exposure to a relative humidity stream can have significant effects on the crystal 
lattice, with naked crystals being particularly susceptible to the effects of the humid air 
stream (Sanchez-Weatherby et al., 2009a). These effects have been demonstrated for 
various protein crystals where controlled dehydration (Chotiyarnwong et al., 2007, Bowler 
et al., 2006c, Takayama and Nakasako, 2011, Awad et al., 2013, Adachi et al., 2009, Bowler 
et al., 2007, Bowler et al., 2006a, Engel et al., 2003, Henrich et al., 2003, Kyrieleis et al., 
 54 
 
2005, Hu et al., 2011) and other more serendipitous methods (Abergel, 2004, Cramer et al., 
2000, Esnouf et al., 1998, Gupta et al., 2010, Heras et al., 2003, Kuo et al., 2003, Nakamura 
et al., 2007, Vijayalakshmi et al., 2008, Yap et al., 2007) have been used to alter crystal 
packing and improve the diffracting power. Having determined the relative humidity with 
the loop method described above, the crystals should remain unchanged while in the humid 
air stream. To test the effects of the humid stream and wicking on the crystal lattice, 
average mosaicity (as defined by XDS (Kabsch, 2010b)) and unit cell parameters were 
analysed between treatments using the Mann-Whitney U-test and Student’s t-test.  
2.3.1.1. Unit Cell Parameters 
Lysozyme 1, lysozyme 2, insulin and thaumatin all showed no significant difference 
in average unit cell parameters between control and HC-transferred crystals by the Mann-
Whitney U-test (Table 2.6) or Student’s t-test (Table 2.7). However, ferritin 1 and ferritin 2 
showed a statistically significant increase (Table 2.6 and 2.7) in unit cell parameters of 0.34 
Å and 0.61 Å (Table 2.5), respectively, following transfer in the humid air stream.  
2.3.1.2. Mosaicity  
The average mosaicity of lysozyme 1, lysozyme 2, insulin and ferritin 2 also show no 
significant difference between control and HC-transferred crystals. Although lysozyme 2 
shows a statistically significant improvement in HC-transferred sample mosaicity, closer 
inspection of individual lysozyme 2 datasets reveals two control data sets with greatly 
increased mosaicity (Fig. 2.14). Analysis with the Grubb’s test for outliers (Grubbs, 1950) 
determined the two control datasets to be significant outliers for mosaicity within the 
control population (circled in red in Figure 2.14). However, as their increased mosaicity has 
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no effect on the other data quality indicators under investigation they were kept in the 
control population. Both the Mann-Whitney U-test and Student’s t-test reported a 
statistically significant difference in mosaicity for control and HC-transferred ferritin 1 data 
(Table 2.6 and 2.7). HC-transferred crystals showed an average decrease in mosaicity of 
0.018° compared to the control samples.  
For the thaumatin data, contradictory results were obtained with the Mann-
Whitney U-test suggesting no significant difference and Student’s t-test suggesting a 
significant improvement in mosaicity from the HC-transferred population. This discrepancy 
between the statistical tests may be the result of the small control population (7 crystals) 
and the control populations having almost double the variance of HC-transferred samples 
(Table 2.4), preventing accurate determination of the Z-value (Equation #3: Appendix). The 
spread of individual mosaicity between control and HC-transferred samples suggests HC-
transferred samples have a lower mosaicity, with the control population spanning 0.041-
0.097° while the HC-transferred population cover 0.029-0.071° (Fig. 2.16). Of the 14 HC-
transferred samples, 7 are lower than or approximately equal to the lowest mosaicity value 
for the control population (Fig. 2.16). A plot of the average mosaicity for both thaumatin 
populations also demonstrates a clear difference between populations with HC-transferred 
samples having a lower mosaicity by well over one standard deviation (Fig. S.#). Based on 
this it stands to reason that Student’s t-test is correct to identify these populations as 
significantly different.  
2.3.2. Data Quality Indicators 
The effects on data quality of both exposure to the humid air stream and the 
wicking to facilitate crystal transfer, were assessed by comparing the average data quality 
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indicators (Rmerge, Rp.i.m., mean I/σ(I), and maximum high resolution limit) between control 
and HC-transferred crystals. To quantify the differences/similarities between control and 
HC-transferred samples these individual data quality indicators have been plotted against 
mosaicity and correlation coefficients have been calculated. Average data quality indicators 
were also plotted against the average maximum high resolution limit, with standard 
deviations in horizontal and vertical directions.  
2.3.2.1. Lysozyme  
Individual lysozyme 1 data quality indicators are plotted against mosaicity in figure 
2.13. All data quality indicators show a similar spread between treatments and the 
correlation coefficients (Table 2.A1) show a similar positive linear relationship between 
treatments, with increasing Rmerge, Rp.i.m. and high resolution limit with increasing mosaicity; 
and a negative linear relationship between decreasing I/σ(I) and increasing mosaicity. 
Average Lysozyme 1 data quality indicators calculated from 8 control samples and 12 HC-
transferred samples (Table 2.3) showed no significant difference in overall or high resolution 
Rmerge, Rp.i.m., I/ σ(I) or maximum high resolution limit based on the Mann-Whitney U test or 
Student’s t-test (Table 2.6 and 2.7). This is consistent with the data presented in Figure 2.19, 
where average values of all data quality indicators for both treatments are within one 
standard deviation in horizontal and vertical directions.  
Lysozyme 2 data mirrors the patterns observed in lysozyme 1 populations. Similar 
distributions of control and HC-transferred data are observed (Fig 2.14) and correlation 
coefficients (Table 2.A1) agree with the positive and negative trends described above. 
Average lysozyme 2 data calculated from 18 control samples and 16 HC-transferred samples 
(Table 2.3) also show no statistically significant differences by either statistical test (Table 
 57 
 
2.6 and 2.7), with both data points within on standard deviation of each other in vertical and 
horizontal directions (Fig. 2.19). 
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Table 2.3: Average data-collection statistics for tetragonal lysozyme. Values in parentheses 
show one standard deviation. Values for multiplicity, completeness, Rmerge, Rp.i.m., mean I 
/σ(I) and CC* are shown as overall statistics followed by the highest resolution bin below. 
‡Maximum high resolution limit defined by AIMLESS using an I/σ(I) > 2 in the highest resolution shell. ▼Highest resolution 
bin based on I/σ(I) > 2. +Rmerge = ∑ ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/ ∑ ∑ (ℎ𝑘𝑙)𝑖ℎ𝑘𝑙𝑖ℎ𝑘𝑙  and *Rp.i.m. = ∑ √
1
𝑛−1
∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/𝑖ℎ𝑘𝑙
∑ ∑ (ℎ𝑘𝑙)𝑖ℎ𝑘𝑙 , where 𝐼𝑖(ℎ𝑘𝑙) represents observed intensity of the ith measurement of the reflection hkl and 〈𝐼(ℎ𝑘𝑙)〉 
represent the mean intensity of reflection hkl after scaling. ¥𝐶𝐶∗ =  √
2𝐶𝐶1/2
1+𝐶𝐶1/2
 
 
 
Test Crystal Lysozyme 1 Lysozyme 2 
Method Control HC-
Transferred 
Control HC-
Transferred 
No. Crystals 8 12 18 16 
Crystal Size (mm) 0.26 (0.02) x 
0.24 (0.04) x 
0.13(0.02) 
0.28 (0.07) x 
0.23 (0.04) x 
0.16 (0.03) 
0.23 (0.06) x 
0.19 (0.03) x 
0.16 (0.03) 
0.23 (0.04) x 
0.20 (0.03) x 
0.14 (0.03) 
Relative Humidity (%) N/A 89 N/A 89 
Space Group P412121 P412121 P412121 P412121 
Unit-cell      
Parameters (Å) 
a = b = 78.95 
(0.10), c = 
36.94 (0.04) 
a = b =78.99 
(0.06), c = 
36.96 (0.07) 
a = b = 78.96 
(0.08), c = 
36.89 (0.04) 
a = b = 78.97 
(0.04), c = 
36.91 (0.03) 
Mosaicity (°) 0.098 (0.036) 0.095 (0.041) 0.09 (0.038) 0.06 (0.02) 
Maximum High 
Resolution Limit (Å)‡ 
1.04 (0.03) 1.04 (0.04) 0.94 (0.02) 0.95 (0.03) 
High Resolution        
Bin Range (Å) ▼ 
1.04-1.06 1.04-1.06 0.95-0.97 0.95-0.97 
Multiplicity 7.3 (0.1) 7.3 (0.3) 8.4 (0.9) 8.3 (0.1) 
 3.0 (0.2) 2.9 (0.3) 7.6 (0.6) 7.6 (0.5) 
Completeness (%) 98.2 (0.8) 98.1 (1.0) 99.6 (1.0) 99.3 (1.5) 
 81.8 (6.3) 81.4 (6.9) 99.3 (2.5) 98.1 (3.8) 
Rmerge+ (%) 4.4 (0.7) 5.1 (1.2) 4.1 (0.9) 4.2 (0.7) 
 43.3 (14.9) 48.4 (27.9) 81.2 (29.8) 91.2 (33.6) 
Rp.i.m.* (%) 1.6 (0.2) 1.9 (0.5) 1.5 (0.4) 1.5 (0.3) 
 27.4 (9.4) 31.8 (19.6) 31.0 (10.9) 34.8 (12.0) 
〈𝐈/𝛔(𝐈)〉 22.0 (5.4) 20.8 (4.9) 23.5 (5.1) 22.7 (4.0) 
 2.5 (1.2) 2.5 (1.2) 2.3 (0.7) 2.3 (0.9) 
CC*¥ 0.9991 
(0.0003) 
0.9986  
(0.0010) 
0.9995  
(0. 0005) 
0.9992 
(0.0006) 
 0.7821 
(0.1082) 
0.7418 
(0.2049) 
0.7680 
(0.1187) 
0.7377 
(0.1346) 
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2.3.2.2. Insulin  
Individual insulin data quality indicators show comparable distributions when 
plotted against mosaicity (Fig 2.15), with correlation coefficients indicating similar trends 
with increasing mosaicity as observed in lysozyme 1 and 2 presented in the appendix (Table 
2.A1). Average data quality indicators for insulin were calculated from 16 control and 13 HC-
transferred crystals (Table 2.4). Overall Rmerge, Rp.i.m. and mean I/σ(I) all show significant 
differences between populations, with HC-transferred populations having significantly lower 
Rmerge and Rp.i.m. and higher mean I/σ(I) by both statistical tests (Table 2.6 and 2.7). This is 
clearly seen in figure 2.19a and 2.19c where overall insulin data points (royal blue) are over 
one standard deviation apart in the vertical direction. Despite this discrepancy in the overall 
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data, high resolution shell data quality indicators are statistically the same (Table 2.6 and 
2.7). Analysis of low resolution shell data (~7-55 Å) show a statistically significant 
improvement in I/σ(I) in HC-transferred samples. This may explain the improvement in 
overall data while high resolution shell data remain unaffected. Despite this difference in 
overall data quality indicators the maximum high resolution limit between treatments show 
no significant differences (Table 2.6 and 2.7).   
2.3.2.3. Thaumatin  
Individual thaumatin data show distinct distribution of data quality indicators 
relative to mosaicity. A small group in the HC-transferred population presents with 
increased Rmerge and Rp.i.m. and decreased I/σ(I) towards the lower end of the mosaicity axis 
(Fig. 2.16a-c). This group skews the calculation of correlation coefficients for HC-transferred 
populations giving merging R factors a negative correlation and I/σ(I) a positive correlation 
with increasing mosaicity; contrary to all other data (Table 2.A1). Average data quality 
indicators for thaumatin were calculated from a control population of 7 crystals and a HC-
transferred population of 14 crystals. No statistically significant differences in overall or high 
resolution data quality indicators were found by either statistical tests (Table 2.6 and 
2.7).This correlates well with thaumatin data in figure 2.19, with all averages within one 
standard deviation in vertical and horizontal directions.    
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Table 2.4: Average values for data collection and processing statistics of insulin and 
thaumatin crystals. Values in parentheses show standard deviation. Values for multiplicity, 
completeness, Rmerge, Rp.i.m., mean I /σ(I) and CC(1/2) are shown as overall statistics followed 
by the highest resolution bin below.   
Test Crystal Insulin Thaumatin 
Method Control HC-
Transferred 
Control HC-
Transferred 
No. Crystals 16 13 7 14 
Crystal Size (mm) 0.17 (0.03) x 
0.15 (0.03) x 
0.12 (0.02) 
0.17 (0.02) x 
0.15 (0.02) x 
0.13 (0.02) 
0.20 (0.01) x 
0.12 (0.02) x 
0.11 (0.01) 
0.20 (0.04) x 
0.12 (0.02) x 
0.10 (0.02) 
Relative Humidity (%) N/A 91 N/A 86 
Space Group I213 I213 P412121 P412121 
Unit-cell       
Parameters (Å) 
a = b = c 
78.24 (0.13) 
a = b = c = 
78.29 (0.08) 
a  = b = 57.85 
(0.03)  c = 
150.23 (0.06) 
a  = b = 57.84 
(0.05) c = 
150.27 (0.13) 
Mosaicity (°) 0.084 (0.023) 0.072 (0.035) 0.067 (0.017) 0.045 (0.012) 
Maximum High 
Resolution Limit (Å)‡ 
1.20 (0.05) 1.21 (0.06) 1.08 (0.04) 1.09 (0.02) 
Highest Resolution   
Bin Range (Å) ▼ 
1.21-1.23 1.21-1.23 1.08 -1.10 1.08 -1.10 
Multiplicity 9.6 (0.1) 9.6 (0.1) 7.5 (0.2) 7.4 (0.1) 
 8.9 (0.1) 8.9 (0.1) 3.2 (0.5) 2.7 (0.5) 
Completeness (%) 100.0 (0.0) 100.0 (0.0) 96.8 (1.9) 97.0 (4.0) 
 100.0 (0.1) 100.0 (0.1) 74.0 (10.5) 77.6 (17.8) 
Rmerge+ (%) 3.8 (0.6) 3.2 (0.3) 3.8 (0.8) 4.2 (0.8) 
 103.3 (51.4) 123.3 (57.2) 56.0 (33.8) 50.2 (16.9) 
Rp.i.m.* (%) 1.3 (0.2) 1.1 (0.13) 1.4 (0.3) 1.6 (0.3) 
 36.4 (18.1) 43.6 (20.3) 34.5 (20.4) 33.6 (9.8) 
Mean I/σ(I) 26.0 (3.3) 30.7 (4.6) 25.5 (4.2) 22.7 (3.8) 
 2.3 (1.1) 2.2 (1.4) 2.3 (0.9) 2.0 (0.6) 
CC*¥ 0.9994 
(0.0005) 
0.9998 
(0.0004) 
0.9997 
(0.0005) 
0.9995 
(0.0005) 
 0.7341 
(0.1545) 
0.6653 
(0.1843) 
0.7510 
(0.2150) 
0.7506 
(0.1119) 
•Refer to Table 2.3 for definitions  
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2.3.2.4. Ferritin 
Individual ferritin 1 Rmerge, Rp.i.m. and high resolution limit show similar positive 
linear relationships with increasing mosaicity between treatments based on correlation 
coefficients (Table 2.A1), however; there is a clear skew towards lower mosaicity, Rmerge, 
Rp.i.m., high resolution limit and higher high resolution limit in HC-transferred samples (Fig. 
2.17). Average data quality indicators for ferritin 1 were calculated from 16 control crystals 
and 19 HC-transferred crystals. Average overall and high resolution Rmerge, Rp.i.m. and high 
resolution limit show no significant difference between treatments, along with overall mean 
I/σ(I) (Table 2.6 and 2.7). However, high resolution mean I/σ(I) does show a significant 
improvement in HC-transferred samples. These differences and similarities can be seen in 
Figure 2.19.  
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Individual ferritin 2 dataset data quality indicators present with a similar spread to 
ferritin 1 based on correlation coefficients (Table 2.A1). However, the skew towards lower 
mosaicity seen in ferritin 1 is not observed in ferritin 2; with both control and HC-transferred 
samples clustered close together (Fig 2.18). Average overall and high resolution data quality 
indicators for ferritin two show no significant differences by both statistical tests and all 
data points in figure 2.19 (light blue) are within one standard deviation in horizontal and 
vertical directions.  
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Table 2.5: Average data-collection statistics for Cubic ferritin. Values in parentheses show 
one standard deviation. Values for multiplicity, completeness, Rmerge, Rp.i.m., mean I /σ(I) and 
CC(1/2) are shown as overall statistics followed by the highest resolution bin. 
Test Crystal Ferritin 1 Ferritin 2  
Method Control HC-
Transferred 
Control HC-Transferred 
No. Crystals  16 19 10 14 
Crystal Size (mm) 0.09 (0.01) x 
0.08 (0.01) x 
0.08 (0.01) 
0.084 (0.006) x 
0.076 (0.006) x 
0.078 (0.012) 
0.15 (0.02) x 
0.14 (0.01) x 
0.12 (0.01) 
0.15 (0.02) x 
0.14 (0.01) x 
0.12 (0.02) 
Relative Humidity (%) N/A 89.5 N/A 90.0 
Space Group F432 F432 F432 F432 
Unit-cell       
Parameters (Å) 
a = b = c = 
181.37 (0.17) 
a = b = c = 
181.71 (0.14) 
a  = b = c = 
181.13 (0.17) 
a  = b = c = 
181.74 (0.32) 
Mosaicity (°) 0.099 (0.006) 0.081 (0.017) 0.189 (0.064) 0.175 (0.023) 
Maximum High 
Resolution Limit (Å)‡   
1.61 (0.06) 1.56 (0.11) 1.75 (0.09) 1.67 (0.09) 
Highest Resolution   
Bin Range (Å) ▼ 
1.75-1.78 1.75-1.78 1.80 -1.84 1.80 -1.84 
Multiplicity  19.0 (0.1) 19.0 (0.1) 18.9 (0.6) 19.4 (2.9) 
 19.3 (0.0) 19.3 (0.1) 19.3 (1.7) 20.2 (2.7) 
Completeness (%) 100.0 (0.0) 99.9 (0.3) 100.0 (0.1) 99.4 (0.7) 
 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) 100.0 (0.1) 
Rmerge+ (%) 9.0 (1.3) 8.4 (2.5) 9.4 (1.6) 9.9 (2.9) 
 98.2 (24.3) 75.4 (41.4) 131.9 (61.1) 108.3 (34.7) 
Rp.i.m.* (%) 2.1 (0.3) 2.0 (0.6) 2.2 (0.4) 2.5 (0.8) 
 22.8 (5.7) 17.9 (9.9) 31.5 (17.4) 26.1 (8.2) 
Mean I/σ(I) 29.8 (4.0) 32.1 (6.4) 30.9 (5.2) 28.6 (10.6) 
 3.9 (1.1) 5.6 (2.0) 3.0 (1.1) 4.3 (1.7) 
CC*¥ 1.00 (0.00) 1.00 (0.00) 0.9999 
(0.0003) 
0.9992  
(0.0006) 
 0.88  
(0.05) 
0.92  
(0.07) 
0.8103 
(0.1292) 
0.8686 
(0.0532) 
 
•Refer to Table 2.3 for definitions  
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Table 2.6: Mann-Whitney U-test results for all data quality indicators. + represents 
populations that are statistically the same and - represents populations that are statistically 
different. Symbols in parentheses are for data in the highest resolution bin ranges defined in 
Table 2.3-5.   
Test Crystal Lysozyme 1 Lysozyme 2 Insulin Thaumatin Ferritin 1 Ferritin 2 
Unit Cell 
Parameter 
(a=b=) (Å) 
+ + + + - - 
Unit Cell 
Parameter 
(c=) (Å) 
+ + N/A + N/A N/A 
Mosaicity (°) + - + + - + 
Rmerge+ (%) + (+) + (+) - (+) + (+) + (+) + (+) 
Rp.i.m.* (%) + (+) + (+) - (+) + (+) + (-) + (+) 
I/σ(I) + (+) + (+) - (+) + (+) + (-) + (+) 
Maximum 
High 
Resolution 
Limit (Å) ‡ 
+ + + + - + 
‡Maximum high resolution limit defined by AIMLESS using an I/σ(I) > 2 in the highest resolution shell. ▼Highest 
resolution bin based on I/σ(I) > 2. +Rmerge = ∑ ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/ ∑ ∑ (ℎ𝑘𝑙)𝑖ℎ𝑘𝑙𝑖ℎ𝑘𝑙  and *Rp.i.m. = 
∑ √
1
𝑛−1
∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/ ∑ ∑ (ℎ𝑘𝑙)𝑖ℎ𝑘𝑙𝑖ℎ𝑘𝑙 , where 𝐼𝑖(ℎ𝑘𝑙) represents observed intensity of the ith 
measurement of the reflection hkl and 〈𝐼(ℎ𝑘𝑙)〉 represent the mean intensity of reflection hkl after scaling. 
Table 2.7: Student’s t-test results for all data quality indicators from an independent two-
tailed t-test assuming equal variance between populations. + represents populations that 
are statistically the same and - represents populations that are statistically different. 
Symbols in parentheses are for data in the highest resolution bin ranges defined in Table 
2.3-5.  
Test Crystal Lysozyme 1 Lysozyme 2 Insulin Thaumatin Ferritin 1 Ferritin 2 
Unit Cell 
Parameter  
(a = b =) (Å) 
+ + + + - - 
Unit Cell 
Parameter  
(c =) (Å) 
+ + N/A + N/A N/A 
Mosaicity (°) + - + - - + 
Rmerge+ (%) + (+) + (+) - (+) + (+) + (+) + (+) 
Rp.i.m* + (+) + (+) -  (+) + (+) + (+) + (+) 
I/σ(I)   + (+) + (+) - (+) + (+) + (-) + (+) 
Maximum 
High 
Resolution 
Limit (Å) 
+ + + + + + 
‡Maximum high resolution limit defined by AIMLESS using an I/σ(I) > 2 in the highest resolution shell. ▼Highest 
resolution bin based on I/σ(I) > 2. +Rmerge = ∑ ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/ ∑ ∑ (ℎ𝑘𝑙)𝑖ℎ𝑘𝑙𝑖ℎ𝑘𝑙  and *Rp.i.m. = 
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∑ √
1
𝑛−1
∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/ ∑ ∑ (ℎ𝑘𝑙)𝑖ℎ𝑘𝑙𝑖ℎ𝑘𝑙 , where 𝐼𝑖(ℎ𝑘𝑙) represents observed intensity of the ith 
measurement of the reflection hkl and 〈𝐼(ℎ𝑘𝑙)〉 represent the mean intensity of reflection hkl after scaling. 
2.4. Discussion  
This work aimed to assess the use of a tuneable humid air stream to preserve 
macromolecular crystals in preparation for long wavelength X-ray crystallography. Datasets 
from large populations of control and HC-transferred crystals were collected and subjected 
to robust statistical tests, with a view to assess any detrimental effects caused by exposure 
to the humid air stream and/or extra manual handling to remove excess solvent. 
Macromolecular crystals, being typically ~50% solvent (Matthews, 1968, Matthews, 1976), 
are sensitive to changes in their relative humidity and can result in changes to crystal 
packing (Russi et al., 2011). Lysozyme, insulin, thaumatin and ferritin have solvent contents 
of 30%, 26%, 57% and 60%, respectively. To monitor crystal packing between control and 
HC-transferred samples, changes in unit cell parameters and mosaicity were assessed, while 
assuming that these parameters and crystal packing would remain constant at the correct 
relative humidity (Sjogren et al., 2002, Sjogren and Hajdu, 2001b, Sjogren and Hajdu, 
2001a). In these circumstances we would expect diffraction data quality to be unaffected by 
HC-transfer at the ‘standard’ X-ray crystallography data collection wavelengths (~1 Å), 
where X-ray absorption is negligible (Arndt, 1984, Polikarpov et al., 1997).  
2.4.1. Crystal Integrity  
The average unit cell parameters of lysozyme 1, lysozyme 2, thaumatin and insulin 
remained constant between treatments, and are comparable with published data (Murray 
and Garman, 2002, Lopez-Jaramillo et al., 2001, Meents et al., 2007); suggesting the correct 
relative humidity was measured by the loop method, and mechanical/osmotic stresses were 
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kept to a minimum. The same can be said for the mosaicity of lysozyme 1, lysozyme 2 (after 
taking the outliers into account) and insulin. However, thaumatin crystals showed a 
statistically significant decrease in mosaicity following HC-transfer. The exact reasons behind 
this apparent increase in order remains unknown, but may stem from more efficient flash 
cooling by removing surrounding solvent, or exposure to the humidity controlled stream 
altering the solvent content of crystals. Ferritin 1 and 2 both showed a statistically 
significant increase in unit cell parameters following HC-transfer. Relative humidity tests by 
the loop method gave a relative humidity of 89.5% and 90% for ferritin 1 and 2, respectively. 
An increase in unit cell parameters may result from exposure to too high a relative humidity, 
leading to incorporation of water, which increased in volume upon plunge cooling in liquid 
nitrogen. Although the effects of this increase in unit cell parameters on data quality 
indicators was negligible, discussed in the following section, it suggests the correct relative 
humidity for ferritin was not determined. For future experiments a higher resolution 
microscope may be necessary to observe the small changes in drop size for more accurate 
relative humidities. Ferritin crystals may also be sensitive to the oscillating nature of the 
humid air stream which moves approximately ± 0.5% around the set relative humidity; as 
the packing essentially forms a hollow sphere which may contract or expand with rising and 
falling humidity.  
2.4.2. Data Quality indicators 
Overall and high resolution shell data quality indicators show no significant 
differences between treatments for lysozyme 1, lysozyme 2, thaumatin, ferritin 1 and 
ferritin 2, with the exception of high resolution mean I/σ(I) in ferritin 1, which shows a 
significant improvement in HC-transferred samples. High resolution I/σ(I) is highly 
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dependent on the resolution limit. Although HC-transferred samples were found to have a 
higher resolution limit than control samples (1.56 Å and 1.61 Å, respectively) this difference 
was not found to be statistically significant. Reduced background scatter as a result of 
removing excess solvent may have improved the signal-to-noise ratio leading to a stronger 
high resolution I/σ(I); however, if this were the case it would likely be seen in other test 
crystals.  
Although there was no statistically significant effect on the overall averages 
between HC-transferred and control populations, a small population of datasets with lower 
mosaicity, increased Rmerge and Rp.i.m. and decreased mean I/σ(I) was observed in HC-
transferred thaumatin crystals (Fig 2.16). It has been reported that lower mosaicity crystals 
are more susceptible to gas-induced loop motion caused by movement of flexible sample 
mounts in the cryo stream, which can have detrimental effects on data quality (Alkire et al., 
2008, Thorne et al., 2003, Alkire et al., 2013). This effect is enhanced by removing excess 
solvent, which reduces the stiffness of a sample mount (Alkire et al., 2013). This would 
explain the subset of poor quality thaumatin crystals following HC-transfer. Despite this 
poor quality subset as a result of low mosaicity there were no statistically significant 
differences between treatments as the large population studied accounted for these 
outliers.  
Overall data quality indicators in HC-transferred insulin crystals also showed a 
significant improvement over control samples. Low resolution I/σ(I) significantly increases in 
HC-transferred samples but a similar decrease in low resolution Rmerge and Rp.i.m. is not 
observed despite being related to the intensities of a reflection (Karplus and Diederichs, 
2012, Weiss, 2001, Arndt et al., 1968). The exact nature of this improvement in low 
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resolution and overall data quality following HC-transfer is unknown. Improvements could 
stem from a decrease in background scatter and absorption by reducing surrounding 
solvent, as discussed previously (Kiefersauer et al., 2000, Kitago et al., 2005a, Kitago et al., 
2010a). Improvements in data quality could also be the result of more efficient flash cooling 
after removing surrounding solvent, or by exposure to the humidity controlled stream 
altering the solvent content of crystals.  
2.5. Conclusions 
As modern MX is addressing increasingly challenging projects, there is a greater 
need to improve the quality of diffraction data. This is of particular importance with weak 
signals such as native anomalous diffraction using long wavelength MX or weak diffraction 
from microcrystals. A key aspect of improving these weak signals is to reduce the 
background scatter and absorbance during data collection. Here a method to remove the 
solvent surrounding protein crystals with a view to aid S-SAD or P-SAD phasing using long 
wavelength X-rays, where achieving a low background absorption is critical has been 
outlined, tested and validated. Although designed for future long wavelength MX 
experiments (for example, using I23 at Diamond), the Crystal transfer method described 
here may also find applications in the rapidly developing field of X-ray free electron laser 
crystallography (Boutet et al., 2012). Techniques such as serial crystallography are gaining 
momentum (Gati et al., 2014), and could greatly benefit from the tailored mounting of 
macromolecular crystals onto specially designed supports. Here I have demonstrated that 
diffraction quality from macromolecular crystals can be preserved, and in some cases 
enhanced, at short (‘standard’) wavelengths by manipulation in a humid air stream and 
removal of excess solvent by wicking. Slight changes in mosaicity and unit cell parameters in 
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some protein crystals suggests the technique may benefit from a more accurate means of 
determining relative humidity, but overall protein crystals appear unaffected by exposure to 
the humid air stream. Comparison of statistics from refined models was considered, 
however, it was not performed due to time constraints and the lack of a systematic method 
for model building to minimise random errors. The next step of this process, described in 
the following chapters, is to apply this method and the robust statistical analysis to more 
challenging macromolecular targets and to long wavelength data collection.    
2.6. Appendix  
2.6.1. Example Scripts  
2.6.1.1. XSCALE.INP 
!MAXIMUM_NUMBER_OF_PROCESSORS=16 
!RESOLUTION_SHELLS= 10 6 4 3 2.5 2.0 1.8 1.7 1.6 
!SPACE_GROUP_NUMBER=19 
!UNIT_CELL_CONSTANTS=65.46 108.41 113.15   90.000  90.000  90.000 
!REIDX=-1 0 0 0    0 -1 0 0    0 0 -1 0 
!REFERENCE_DATA_SET= fae-rm.ahkl 
 
!MINIMUM_I/SIGMA=3.0 
!REFLECTIONS/CORRECTION_FACTOR=50   !minimum #reflections/correction_factor 
!0-DOSE_SIGNIFICANCE_LEVEL=0.10 
!WFAC1=1.5 ! factor applied to e.s.d.'s before testing equivalent reflections 
!SAVE_CORRECTION_IMAGES= FALSE ! TRUE is default 
 
  OUTPUT_FILE=datasetX_Y.HKL                      !at minimum of f' 
  FRIEDEL'S_LAW=FALSE !TRUE 
  MERGE=FALSE !TRUE 
  STRICT_ABSORPTION_CORRECTION=TRUE  !FALSE is default 
  INPUT_FILE= .../datasetX_Y/XDS_ASCII.HKL 
!    INCLUDE_RESOLUTION_RANGE= 20 1.6 
!    CORRECTIONS= DECAY MODULATION ABSORPTION 
!    CRYSTAL_NAME=Seleno1 !Remove first "!" to switch on 0-dose extrapolation 
!    STARTING_DOSE=0.0  DOSE_RATE=1.0  !Use defaults for 0-dose extrapolation 
 
 
 74 
 
2.6.1.2. XSCALE and Pointless  
module load ccp4  
module load XDS 
module load global/cluster 
 
cd Dataset1_1 
xscale 
pointless -copy xdsin dataset1_1.HKL hklout pointless.mtz  
echo "done" 
cd .. 
cd dataset1_2 
xscale 
pointless -copy xdsin dataset1_2.HKL hklout pointless.mtz  
echo "done" 
cd .. 
 
2.6.1.3. Aimless  
module load ccp4  
module load XDS 
module load global/cluster 
 
cd dataset1_1 
aimless hklin pointless.mtz hklout aimless.mtz << eof > aimless.log 
run 1 all 
scales constant 
ANALYSIS isigminimum 2 
resolution 60.0 0.00 
anomalous on 
eof 
cd .. 
cd dataset1_2 
aimless hklin pointless.mtz hklout aimless.mtz << eof > aimless.log 
run 1 all 
scales constant 
ANALYSIS isigminimum 2 
resolution 60.0 0.00 
anomalous on 
eof 
cd .. 
 
 
 
 75 
 
2.6.1.4. Data Extraction  
echo dataset1_1 hc1 > Protein_Wavelength_Results  
grep "                                           Overall  InnerShell  OuterShell" dataset1_1/ aimless.log 
>>Protein_Wavelength_Results  
grep "Low resolution limit" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "High resolution limit" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Rmerge  (within I+/I-)" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Rmerge  (all I+ and I-)" dataset1_1/ aimless.log >> 1A_EAL_results 
grep "Rmeas (within I+/I-)" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Rmeas (all I+ & I-)" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Rpim (within I+/I-)" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Rpim (all I+ & I-)" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Rmerge in top intensity bin" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Total number of observations" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Total number unique" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Mean((I)/sd(I))" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Mn(I) half-set correlation CC(1/2)" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Completeness                          " dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Multiplicity                             " dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Anomalous completeness                   " dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Anomalous multiplicity                    " dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "DelAnom correlation between half-sets" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "Mid-Slope of Anom Normal Probability" dataset1_1/ aimless.log >> Protein_Wavelength_Results  
grep "REFLECTING_RANGE_E.S.D.=" dataset1_1/XDS_ASCII.HKL >> Protein_Wavelength_Results  
grep "UNIT_CELL_CONSTANTS=" dataset1_1/XSCALE.INP >> Protein_Wavelength_Results  
echo >> Protein_Wavelength_Results  
echo >> Protein_Wavelength_Results  
 
2.6.2. Statistical Tests  
2.6.2.1. Mann-Whitney U-test 
All data from both populations were ranked in ascending order and assigned a rank of one 
to n, where n represents the total number of crystals from combined populations. Adding up the 
ranks for a population gives the ranked sum R1, which was used to calculate U1 using equation (1), 
 
𝑈1 =  𝑛1𝑛2 +  
𝑛1(𝑛1 + 1)
2
− 𝑅1  
(2.1) 
where 𝑛1 and 𝑛2 represent the number of samples in population one and two respectively. U1 
represents the number of times a data point from population one is smaller than a data point from 
population two, when comparing all possible pairs of samples, where one sample is taken from each 
population. U1 was used to calculate U2 using equation (2), 
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𝑈2 =  𝑛1𝑛2 − 𝑈1   
(2.2) 
where U2 represents the equivalent of U1 for population two. In larger sample sizes (n1 and n2 > 10) 
ranked data from the Mann-Whitney U-test become near normally distributed. Using equation (3), 
𝑍 =  
2𝑈 −  𝑛1𝑛2
√𝑛1𝑛2(𝑛1 + 𝑛2 + 1)
3
  
(2.3) 
we can transform the U statistic (the higher value of U1 and U2) to give a sampling distribution 
comparable to the standard normal (Z) distribution. Observed Z-values were compared to the critical 
Z-value, representing data ±1.96 standard deviations from the calculated mean (95% of the sample 
population). The null hypothesis was rejected if calculated Z-values exceeded the critical Z-value in 
either direction.   
2.6.2.2. Student’s t-test 
The t-values were calculated using equation (1.4), 
𝑡 =
𝑋1̅̅ ̅ − 𝑋2̅̅ ̅
√𝑆𝑝
2 (
1
𝑛1
+
1
𝑛2
)
 
 (2.4) 
where 𝑋1̅̅ ̅ is the mean of population one, 𝑋2̅̅ ̅ is the mean of population two and 𝑛1 and 𝑛2 are the 
number of samples in population one and two, respectively. 𝑆𝑝
2 represents the pooled sample 
variance, as defined by equation (5),  
 
𝑆𝑝
2 =  
𝑑𝑓1𝑆1
2 + 𝑑𝑓2𝑆2
2
𝑑𝑓1 + 𝑑𝑓2
 
  (2.5) 
where 𝑑𝑓1 and 𝑑𝑓2 represent the degrees of freedom of populations one and two (equations (6) and 
(7), respectively) and 𝑆1
2and 𝑆2
2 represent the sample variances of populations one and two, 
respectively. Calculated t-values were analysed against critical t-values from Student's t-distribution 
tables for α(2) = 0.05 (Student, 1908) with degrees of freedom calculated using equation (8),   
𝑑𝑓1 = 𝑛1 −  1 
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(2.6) 
𝑑𝑓2 = 𝑛2 − 1  
 (2.7) 
𝐷𝐹 = 𝑑𝑓1 + 𝑑𝑓2  
(2.8) 
If observed t-values were found to be greater than the critical t-value, the null hypothesis is rejected. 
In addition to t-values, P-values were calculated using standard statistical analysis software. The P-
value quantifies the uncertainty of obtaining the observed data if the null hypothesis were true. A 
critical P-value of 0.05 was used to judge significance, with the null hypothesis rejected if the 
observed p-values were less than or equal to the critical P-value. 
2.6.3. Correlation Coefficients  
Table 2.A1: Correlation coefficients of overall data quality indicators in relation to mosaicity.  
Protein  Lysozyme 1 Lysozyme 2 Insulin Thaumatin Ferritin 1 Ferritin 2 
Treatment  Ctrl HC Ctrl HC Ctrl HC Ctrl HC Ctrl HC Ctrl HC 
Rmerge (%) Vs 
Mosaicity (°) 
0.29 0.14 0.32 0.11 0.17 0.44 0.42 -0.36 0.33 0.86 0.60 0.67 
Rp.i.m. (%) Vs 
Mosaicity (°) 
0.32 0.15 0.30 -0.16 0.21 0.47 0.37 -0.39 0.36 0.86 0.68 0.34 
I/σ(I) Vs 
Mosaicity (°) 
-0.65 -0.58 -0.41 -0.56 -0.60 -0.29 0.51 0.17 -0.27 -0.84 -0.67 0.54 
High 
Resolution 
Limit (Å) Vs 
Mosaicity (°) 
0.85 0.82 0.58 0.77 0.95 0.78 0.15 -0.08 0.51 0.88 0.80 0.77 
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Chapter 3 – Excess Solvent and Data 
quality at Long Wavelength 
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3.1. Introduction  
Data collection for phasing using long wavelengths (>2Å), including S-SAD, requires very 
accurate measurement of weak signals that can easily be swamped by more prominent signals and 
background absorption/scattering (Chapter 1). The weak anomalous signals of native sulphur atoms 
can be greatly enhanced by using X-ray wavelengths approaching the absorption edge energy of 
sulphur, ~ 5 Å. However, at longer wavelengths absorption of X-rays by air, the crystal, surrounding 
solvent and the sample mount increase along with background scatter. This makes accurate 
measurement of anomalous signals difficult. In an effort to reduce absorption by air, helium paths 
have been used (Biou et al., 2005) and in-vacuum crystallography is currently under development at 
the Diamond Light Source for beamline I23 (Wagner et al., 2015). As discussed in Chapter 2, a wide 
variety of sample or crystal handling techniques may be exploited (e.g. to remove excess 
surrounding solvent) to minimise the effects of  absorption and background scatter, and this special 
handling is particularly applicable for long wavelength or S-SAD phasing experiments.  
The ‘optimum’ wavelength for data collection has been a lively topic of discussion within 
the X-ray crystallography community for several years. It was thought that use of short (λ = 0.5 Å) 
and ultra-short (λ = 0.3 Å) wavelength X-rays could be used to reduce background scatter and 
absorption errors (Arndt, 1984). This idea was abandoned after it became apparent that there was 
no significant improvement in the signal-to-noise ratio compared to synchrotron collection at λ = 0.9 
Å (Polikarpov et al., 1997). Although collection at ultra-short wavelengths was not attempted here, 
the results presented in Chapter 2 suggest that absorption and background scatter are not a limiting 
factor in data quality at 1 Å, even in the presence of excess surrounding solvent. Another 
consideration in the ‘optimum’ wavelength for data collection is crystal size. Recent work suggests 
that smaller crystals (≤ 10 μm) collected with micro-focus beams at high energies (40 keV) allow 
photoelectric escape due to increased photoelectron path length, thereby reducing energy 
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deposition within the crystal and minimising radiation damage (Cowan and Nave, 2008, Nave and 
Hill, 2005, Schneider, 2008, Holton and Frankel, 2010).   
The possible significance of surrounding solvent on data quality has been discussed in 
previous studies using one of two single crystals (Cipriani et al., 2012, Kiefersauer et al., 2000, Kitago 
et al., 2010b, Kitatani et al., 2009, Wierman et al., 2013) but the true effects on data quality have 
never been systematically tested or quantified. Following the successful use of the HC1 to preserve 
crystals for removal of mother liquor (Chapter 2), this study investigates the effects of excess solvent 
on data quality for long wavelength data collection. To achieve this, the same sample handling 
techniques and statistical analyses described in Chapter 2 were applied to three different types of 
soluble protein crystals: bacteriocin syringacin M (BSM), PA3825-EAL and bacteriocin pectocin M2 
(BPM2).  
BSM is a colicin M-like bacteriocin from Pseudomonas syringae pv. Tomato DC3000 which 
kills susceptible cells by targeting lipid II phosphoester bonds for cleavage to inhibit peptidoglycan 
synthesis (Grinter et al., 2012, El Ghachi et al., 2006, Harkness and Braun, 1989). These colicin-like 
bacteriocins have potential for use as protein based antibiotics that target close relatives to the 
bacteriocin producing strain (Riley, 1998). The specificity of receptor binding in colicins is regulated 
through the central domain, which is flanked by an unstructured translocation domain at the N-
terminus (Fig. 3.1A, Orange) and a cytotoxic domain at the C-terminal end (Fig 3.1A, Red). BSM has a 
compact mixed β-sheet/helix structure with an unstructured translocation domain typical of colicin-
like bacteriocins (Grinter et al., 2012). The cytotoxic domain is comprised of a half β-barrel fold 
(Fig.3.1B, Red) unique to colicin M type bacteriocins (Zeth et al., 2008) which coordinates the active 
site metals.  
Much like BSM, BPM2 is a colicin M-like bacteriocin with the half β-barrel fold (Fig. 3.2, 
Blue). However, BPM2 lacks the unstructured translocation domain seen in BSM and has a 
ferrodoxin domain (Fig. 3.2, Red) connected to the C-terminal cytotoxic domain (Fig. 3.2, Blue) by a 
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helical linker (Fig. 3.2, Green) (Grinter et al., 2014). Pectobacterium releases pectinases and 
cellulases to breakdown plant cell tissues and cause cell lysis; releasing intracellular nutrients which 
are taken up by the bacteria, of which ferrodoxin is the major iron containing protein (Grinter et al., 
2012). Bacteriocin pectocin M2 allows pecterobacterium to obtain iron directly from plant 
ferrodoxins through interactions with TonB-dependent receptors (Grinter et al., 2014). Both BSM 
and BPM2 represent good examples of a biologically interesting targets for protein 
crystallographers, as well as a challenge for sample handling due to the high solvent content of both 
protein crystals, ~ 80% and ~ 70% respectively for BSM and BPM2 (Fig. 3.3). BPM2 presents a 
particular challenge for long wavelength MX due to the presence of a highly absorbing 2Fe-2S 
cluster.  
PA3825-EAL is an EAL domain containing protein involved in the cleavage of cyclic-di-GMP, a 
ubiquitous signalling molecule in bacteria involved in regulation of biofilm formation. PA3825-EAL 
will be discussed in greater depth in Chapter 6.  
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3.2. Methods 
3.2.1. Protein Purification 
Purified Bacteriocin Syringacin M (BMS) and Bacteriocin Pectocin M2 (BPM2) proteins were 
provided by Dr Rhys Grinter from the University of Glasgow and stored at -80°C (Grinter et al., 2014, 
Grinter et al., 2012). Details of PA3825-EAL expression and purification can be found in Chapter 6.  
3.2.2. Crystallisation and Cryoprotection 
All protein crystals were produced via the vapour diffusion method as either sitting or 
hanging drops. BSM protein was equilibrated against 8% w/v PEG 8000, 30% v/v ethylene glycol, 
0.13 M CaCl2, 0.03 M MgCl2 and 0.1 M bicine/tris base pH 8.5 at a ratio of 2:3 in 5 μl hanging drops at 
19°C. BSM crystals are grown in 30% ethylene glycol so required no additional cryo protection. BPM2 
crystals were produced by equilibrating BPM2 proteins against 1.8 M ammonium sulphate, 3% MPD 
and 0.1 M Mes pH 6.5 at a 1:1 ratio in 5 μl sitting drops at 19°C. BPM2 crystals grew as large clusters 
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which were separated into single crystals with an acupuncture needle. Crystals were cryoprotected 
by transferring to a drop of reservoir solution with 25% (v/v) glycerol before flash cooling. PA3825-
EAL crystal trays were set up using a Mosquito LCP liquid handling robot (TTP Labtech, Hertfordshire, 
England, UK). 15-20 mg/ml PA3825-EAL was equilibrated against 0.8 M sodium phosphate 
monobasic, 1.2 M potassium phosphate dibasic and 0.1 M sodium acetate pH 4.5 (final pH measured 
as pH 7.1) at a 1:1 ratio in 5 μl sitting drops at 4°C. PA3825-EAL crystals were cryoprotected by 
transferring crystals into 0.1 M sodium acetate pH 4.5 and 2.4 M zinc chloride before flash cooling in 
liquid nitrogen.  
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3.2.3. Sample Preparation, Data Collection, Data Processing and Statistical 
Analysis  
BSM, PA3825-EAL and BPM2 samples were prepared by the same protocol detailed in 
Chapter 2. Examples of control and HC-transferred samples for all proteins are presented in Figure 
3.4. As PA3825-EAL and BMP2 crystals were not grown in their cryoprotectant, the relative humidity 
used for their transfer was determined from their cryoprotectant solutions not reservoir solutions. 
Crystals were thus transferred to their cryoprotectant solution before placing them in the humid air 
stream. 
 
Data collection was performed as before, at 1 Å wavelength and with additional control 
and HC-transferred datasets collected at longer wavelengths (up to 2 Å). PA3825-EAL and BPM2 data 
were collected using the standard rotation/oscillation mode. BSM data were collected using the 
standard rotation data collection mode (‘BSM-one’) and also by the inverse beam method (‘BSM-
two’), to maximise the potential anomalous signal from the native sulphur atoms. The long 
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wavelength limit was determined from the maximum high resolution limit of the crystals and the 
shortest available distance between the crystal and the detector. To achieve this, three test images 
were taken at phi values 0°, 45° and 90° to give an indexing solution and a high resolution limit. Data 
collection parameters for all test crystals are summarised in table 3.1. All data were processed using 
the pipeline and bash scripts previously described, to determine the maximum high resolution limit 
and obtain data quality indicators (see Chapter 2). Control and HC-transferred populations at 
standard (λ = 1 Å) and longer wavelengths (λ ~ 2 Å) were compared to judge the effects of excess 
surrounding solvent on data quality at these wavelengths. In the case of BPM2, λ = 1 Å and λ = 2 Å 
controls and λ = 1 Å and λ = 2 Å HC-transferred populations were analysed for significant differences 
using a two tailed Student’s t-test as described in Chapter 2.  
Table 3.1: Data collection parameters for all crystals 
All crystals were collected on a Pilatus 6M detector with a 0.1° step and 0.1 s exposure times. *Maximum 
resolution as defined by the detector edge at wavelengths and detector distances stated above.  
 
 
 
Crystal BSM-1 BSM-2 PA3825-EAL BPM2 
Wavelength (Å) 0.9795 2.0 1.0 1.8 0.9795 1.8 1.0 2.0 
Beamline I02 I04 I04 I03 
Beam Size (μm) 82 x 21 90 x 45 90 x 45 80 x 20 
Detector 
Distance (mm) 
444.11 156.46 398.80 169.49 405.61 169.81 455.08 173.88 
Maximum 
Resolution* (Å) 
2.22 2.09 2.10 2.35 
Total Angular 
Range (°) 
120 120 120 180 
Inverse Beam No Yes No No 
Space Group P6322 P6322 P43212 P3121 
Transmission 
(%) 
20 30 1 10 
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3.2.4. RADDOSE-3D Analysis  
All protein crystal types were analysed with RADDOSE-3D (Zeldin et al., 2013) between λ = 
1.0 Å and   λ = 2.4 Å to provide the elastic yield (photons), diffraction efficiency (photons/MGy), 
diffraction weighted dose (MGy) and the max dose (MGy). The flux for each wavelength at the 
appropriate transmission was calculated from the measured flux at Diamond Light Source I04 with 
the 100 μm aperture, 300 mA ring current and 100% transmission (Fig. 3.5) 
(www.diamond.ac.uk/Beamlines/Mx/i04). Theoretical values were calculated for crystals and buffer 
using the input parameters presented in Table 3.A2. Values for the buffer alone were calculated by 
changing the number of molecules in the asymmetric unit to 0 and increasing the solvent content to 
100%. BPM2 RADDOSE-3D calculations were performed on two crystal shapes, with a long x-axis in 
crystal 1 (Fig. 3.6a) and a long z-axis in crystal 2 (Fig. 3.6b) as BPM2 crystals were rectangular in 
shape as opposed to more cubic for BSM and PA3825-EAL. 
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3.3. Results  
As described in Chapter 2, diffraction data obtained from the crystals were assessed for 
crystal integrity based on the unit cell parameters and mosaicity; and estimates of diffraction data 
quality were based on Rmerge, Rp.i.m., I/σ(I) and maximum high resolution limit, with statistical 
treatment using Student’s t-test. All data were found to be normally or weakly normally distributed 
(Table 3.A3) so the Mann-Whitney U-test was not performed.  
3.3.1. Crystal Integrity 
BSM-one HC-transferred populations showed a consistent improvement in mosaicity 
compared to control populations (Table 3.6) at both wavelengths used. This difference is evident in 
the increased spread in mosaicity of control samples in figure 3.7. Unit cell parameters are also 
variable, with the c-axis significantly increasing in HC-transferred samples compared to control 
(Table 3.6). However, the a and b unit cell parameters remain constant between treatments (Table 
3.6).  
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BSM-two control and HC-transferred populations at λ = 1 Å and λ = 1.8 Å both showed 
consistent a and b unit cell parameters. However, a statistically significant shrinkage in the c-axis was 
observed in the λ = 1 Å control population that was not observed in the λ = 1.8 Å control or HC-
transferred populations (Table 3.6). The same pattern was observed for mosaicity, with the control 
population collected at λ = 1 Å exhibiting significantly higher mosaicity than all other populations. 
This can be seen in figure 3.8 where individual λ = 1 Å control and HC-transferred populations 
showed a very different distribution from each other, with the HC-transferred population having 
much lower mosaicity (0.04-0.15°) and shorter spread. On the other hand both treatments collected 
at λ = 1.8 Å showed a very similar distribution and spread of values for mosaicity (Fig. 3.8).   
PA3825-EAL showed a statistically significant increase in average unit cell parameters (a 
and b) in HC-transferred populations, with an average increase of 0.20 Å and 0.14 Å for λ = 1 Å and λ 
= 1.8 Å populations, respectively. A significant increase in the c axis was also observed in the control 
population at λ = 1 Å, while no significant differences were seen between λ = 1.8 Å populations 
(Table 3.6). Mosaicity remained constant between all treatments collected at λ = 1 Å and λ = 1.8 Å, 
as seen in figure 3.10. Both treatments at λ = 1 Å showed some significant outliers, as identified by 
the Grubb’s test (Grubbs, 1950). These datasets have been circled in red in figure 3.10 and were 
excluded from calculations of averages, standard deviations and the statistical analysis.    
BPM2 crystals also showed a statistically significant reduction in unit cell parameters (a and 
b) in the HC-transferred populations at λ = 1 Å and λ =2 Å (Table 3.6), while unit cell parameters in 
the c-axis remain constant, as judged by Student’s t-test (Table 3.6). A statistically significant 
decrease in mosaicity was observed in control populations at both wavelengths (Table 3.6). This is 
evident in Figure 3.12, particularly in control datasets collected at λ = 1 Å where all data points are 
clustered around 0.07°. One outlier was identified in the λ = 1 Å control population by the Grubb’s 
test and is circled in red in figure 3.12. Again, this data point was excluded from averages, standard 
deviations and statistical tests.        
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3.3.2. Data Quality Indicators 
3.3.2.1. Bacteriocin syringacin M-one  
Individual BSM-one data quality indicators for λ = 1 Å and λ = 2 Å are plotted against 
mosaicity in figure 3.7a-h. In data collections at λ = 1 Å and λ = 2 Å, HC-transferred samples show 
more consistent Rmerge, Rp.i.m. and I/σ(I) while control samples show a much greater spread; with 
higher R-factors (Fig. 3.7a-d), lower I/σ(I) (Fig. 3.7e-f) and lower high resolution limit (Fig. 3.7g-h).  
Average data quality indicators were calculated for 7/7 and 7/8 control/HC-transferred 
crystals for λ = 1 Å and λ = 2 Å, respectively, and are presented in Table 3.2. The λ = 1 Å populations 
show no difference in overall Rmerge, Rp.i.m. or I/σ(I), however, high resolution statistics are 
significantly improved in HC-treated samples in all cases, including the high resolution limit (Table 
3.6). This is evident in figure 3.14 where average control data (grey circles) and HC-transferred data 
(grey diamonds) are within one standard deviation in the y axis in overall plots (Fig. 3.14a and c), and 
well over one standard deviation apart in the y axis in high resolution plots (Fig. 3.14b and d). Data 
collected at λ = 2 Å show a significant improvement in all data quality indicators following HC-
transfer with the exception of average high resolution I/σ(I) (Table 3.6). Again, this is evident in 
figure 3.14 where only average high resolution I/σ(I) treatment populations are within one standard 
deviation of the other.   
3.3.2.2. Bacteriocin Syringacin M-two  
Individual BSM-two data quality indicators for λ = 1 Å and λ = 1.8 Å are plotted against 
mosaicity in figure 3.8a-h. All λ = 1A data show a clear trend of lower overall Rmerge, Rpim and 
mosaicity, higher I/σ(I) and high resolution limit following exposure to the humid air stream. 
However, both populations show a similar trend of increasing Rmerge and Rpim and decreasing I/σ(I) 
and high resolution limit with increasing mosaicity (Fig. 3.8a, c, e and g). Datasets collected at λ = 1.8 
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Å have a much more consistent spread in mosaicity between control and HC-populations, but HC-
transferred populations still show an improvement in all data quality indicators (Fig. 3.8b, d, f and h).  
The differences mentioned above are reflected in the Student’s t-test results (Table 3.6), 
where λ = 1 Å HC-transferred Rmerge, Rp.i.m., I/σ(I) and high resolution limit are significantly better than 
controls. λ = 1.8 Å HC-transferred populations show similar significant improvements with the 
exception of high resolution limit, which remains constant between treatments. Average data 
quality indicators were calculated from 8/10 and 10/10 control/HC-transferred crystals for λ = 1 Å 
and λ = 1.8 Å, respectively, and are presented in Table 3.3. Average data quality indicators plotted 
against average high resolution limit in Figure 3.14 clearly show the difference between treatments; 
with all data quality indicators (except λ = 1.8 Å high resolution limit) over one standard deviation 
apart.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 91 
 
Table 3.2: Average data-collection statistics for bacteriocin syringacin M-one crystals at λ = 1 Å and λ 
= 1.8 Å. Values in parentheses show one standard deviation. Values for multiplicity, completeness, 
Rmerge, Rp.i.m., mean I /σ(I) and CC(1/2) are shown as overall statistics followed by the highest 
resolution bin below. 
 
‡Maximum high resolution limit defined by AIMLESS using an I/σ(I) > 2 in the highest resolution shell. ▼Highest resolution 
bin based on I/σ(I) > 2. +Rmerge = ∑ ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/ ∑ ∑ (ℎ𝑘𝑙)𝑖ℎ𝑘𝑙𝑖ℎ𝑘𝑙  and *Rp.i.m. = ∑ √
1
𝑛−1
∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/𝑖ℎ𝑘𝑙
∑ ∑ (ℎ𝑘𝑙)𝑖ℎ𝑘𝑙 , where 𝐼𝑖(ℎ𝑘𝑙) represents observed intensity of the ith measurement of the reflection hkl and 〈𝐼(ℎ𝑘𝑙)〉 
represent the mean intensity of reflection hkl after scaling. •CC(1/2) is calculated by 𝑟 =
𝑛(∑ 𝑥𝑦)−(∑ 𝑥)(∑ 𝑦)
√[𝑛 ∑ 𝑥2−(∑ 𝑥)
2
][𝑛 ∑ 𝑦2−(∑ 𝑦)
2
]
 where 
x and y represent random half sets of reflection and n is the sample size.  
Crystal Bacteriocin Syringacin M  
One λ = 1 Å 
Bacteriocin Syringacin M  
One λ = 2.0 Å 
Method Control HC-
Transferred 
Control HC-Transferred 
No. Crystals  7 7 7 8 
Crystal Size (mm)     
Relative Humidity (%) N/A 89.0 N/A 89.0 
Space Group P6322 P6322 P6322 P6322 
Unit-cell      
Parameters (Å) 
a = b = 161.09 
(0.50) c = 
99.26 (0.35) 
a = b = 160.76 
(0.47) c = 
99.73 (0.01) 
a = b = 161.1 
(0.20) c = 
99.37 (0.11) 
a = b = 161.00 
(0.31) c = 99.76 
(0.26) 
Mosaicity (°) 0.137 (0.065) 0.064 (0.017) 0.194 (0.039) 0.151 (0.033) 
Maximum High 
Resolution Limit (Å)‡  
3.02 (0.05) 2.88 (0.07) 3.05 (0.13) 2.94 (0.05) 
High Resolution        
Bin Range (Å) ▼ 
3.26-3.05 3.26-3.05 3.26-3.05 3.26-3.05 
Multiplicity  12.2 (1.8) 12.1 (2.6) 11.5 (1.8) 12.5 (0.2)  
 12.3 (1.8) 12.2 (2.7) 11.6 (1.8) 12.3 (0.1) 
Completeness (%) 99.7 (0.3) 98.6 (1.8) 99.5 (0.2) 98.9 (1.4) 
 100.0 (0.0) 99.2 (1.4) 99.9 (0.2) 99.7 (0.6) 
Rmerge+ (%) 8.8 (2.9) 6.9 (1.1) 8.7 (2.7) 6.1 (1.0) 
 101.4 (48.0) 41.2 (5.7) 91.0 (47.0) 52.9 (14.3) 
Rp.i.m.* (%) 2.5 (0.9) 2.0 (0.3) 2.6 (0.9) 1.8 (0.3)  
 28.8 (13.9) 11.6 (1.5) 26.8 (13.7) 15.5 (4.2) 
〈𝐈/𝛔(𝐈)〉 22.9 (6.9) 26.5 (4.3) 21.6 (7.2) 29.3 (5.0) 
 2.9 (1.1) 6.0 (1.4) 3.2 (1.7) 4.9 (1.4) 
CC(1/2)• 
0.9784 
(0.0538) 
0.9783 
(0.0495) 
0.9621 
(0.0964) 
0.9993  
(0.0004) 
 
0.7930 
(0.1432) 
0.9163 
(0.0828) 
0.8143 
(0.1321) 
0.9434  
(0.0251) 
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Table 3.3: Average data-collection statistics for bacteriocin syringacin M-two crystals at λ = 1 Å and λ 
= 1.8 Å. Values in parentheses show one standard deviation. Values for multiplicity, completeness, 
Rmerge, Rp.i.m., mean I /σ(I) and CC(1/2) are shown as overall statistics followed by the highest 
resolution bin below 
 
•See Table 3.2 footnote for definitions. 
Crystal Bacteriocin Syringacin M  
Two λ = 1 Å 
Bacteriocin Syringacin M  
Two λ = 1.8 Å 
Method Control HC-
Transferred 
Control HC-
Transferred 
No. Crystals  8 10 10 10 
Crystal Size (mm) 
0.19 (0.02) x 
0.17 (0.02) x 
0.12 (0.01)  
0.19 (0.02) x 
0.17 (0.03) x 
0.13 (0.01)  
0.21 (0.04) x 
0.18 (0.03) x 
0.14 (0.02) 
0.18 (0.02) x 
0.17 (0.02) x 
0.14 (0.02) 
Relative Humidity (%) N/A 89.5 N/A 89.5 
Space Group P6322 P6322 P6322 P6322 
Unit-cell      
Parameters (Å) 
a = b = 160.24 
(0.32) c = 
99.27 (0.29) 
a = b = 160.36 
(0.12) c = 
99.76 (0.08) 
a = b = 160.76 
(0.59) c = 
99.71 (0.28) 
a = b = 160.56 
(0.11) c = 
99.75 (0.22) 
Mosaicity (°) 0.19 (0.06) 0.10 (0.03) 0.14 (0.02) 0.13 (0.04) 
Maximum High 
Resolution Limit (Å)•  
3.37 (0.15) 3.11 (0.14) 3.17 3.06 
High Resolution        
Bin Range (Å) • 
3.41-3.74 3.41-3.74 3.17-3.39 3.17-3.39 
Multiplicity  12.5 (0.4) 13.0 (0.3) 12.5 (0.5) 12.5 (1.8) 
 13.2 (0.1) 13.4 (0.3) 12.4 (0.5) 12.3 (1.9) 
Completeness (%) 99.3 (0.5) 98.8 (2.0) 93.8 (9.3) 93.9 (4.0) 
 99.9 (0.2) 99.4 (1.5) 95.4 (8.1) 96.1 (2.9) 
Rmerge (%)• 11.7 (3.6) 6.6 (1.5) 7.5 (1.9) 5.7 (1.0) 
 86.4 (23.2) 38.0 (18.6) 104.1 (53.9) 61.6 (18.8) 
Rp.i.m. (%)• 3.4 (1.2) 1.9 (0.4) 2.2 (0.6) 1.6 (0.1)  
 23.2 (6.3) 10.5 (5.1) 30.2 (16.3) 17.9 (5.8) 
〈𝐈/𝛔(𝐈)〉 18.5 (5.4) 32.0 (5.3) 24.8 (7.3) 31.4 (4.8) 
 3.0 (1.1) 8.8 (4.4) 2.4 (1.0) 4.4 (1.9) 
CC(1/2)• 
0.9993 
(0.0007) 
0.9998 
(0.0004) 
0.9996 
(0.0005) 
0.9998 
(0.0004) 
 
0.8741 
(0.0587) 
0.9618 
(0.0316) 
0.8256 
(0.1232) 
0.9212 
(0.0481) 
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3.3.2.3. Bacteriocin syringacin M RADDOSE-3D Analysis 
RADDOSE-3D analysis for bacteriocin syringacin M experiments predicts a slight increase in 
the elastic yield from 12.4 keV to 10.3 keV with a steady decrease thereafter with decreasing energy 
for both crystal and buffer (Fig. 3.9a). The diffraction efficiency shows a steady decrease with 
decreasing energy towards a plateau around 5.2 keV at 4.95E+11 photons/MGy. Buffer alone shows 
a marginal increase in diffraction efficiency over a crystal at higher energies, which gradually 
decreases with energy (Fig. 3.9b). Diffraction weighted dose increases to a peak around 0.06 MGy 
between 7.8 keV and 8.9 keV before decreasing back to 0.03 MGy at 5.2 keV (Fig. 3.9c). Diffraction 
weighted dose for buffer alone differs from the crystal at 10.3 keV, 7.8 keV and 6.2 keV with all 0.01 
MGy lower (Fig. 3.9c). Maximum dose shows a similar trend to diffraction weighted dose, with an 
 96 
 
initial increase to around 0.35 MGy between 6.9-8.9 keV which decreases at lower energies. Protein 
and buffer show little difference at higher energies but max dose decreases slightly for buffer alone 
at 8.9 keV and lower.  
3.3.2.4. PA3825-EAL 
Overall individual data quality indicators for control and HC-transferred PA3825-EAL 
datasets collected at λ = 1 Å and λ = 1.8 Å are presented in Figure 3.10, with outliers determined by 
the Grubb’s test circled in red. Mosaicity and overall data quality indicators show near identical 
spread and correlation between treatments at λ = 1.0 Å and λ = 1.8 Å, although data collected at λ = 
1.8 Å show a much larger distribution in mosaicity compared to λ = 1.0 Å data (Fig. 3.10). Both 
treatments at λ = 1.0 Å show outliers in mosaicity and/or data quality indicators, which were omitted 
from averages, standard deviations and statistical analysis.  
Average values and standard deviations for PA3825-EAL for both treatments at λ = 1.0 Å 
and λ = 1.8 Å were calculated from 11 crystals from each population and are presented in Table 3.4. 
All average values show significant overlap between treatments and data points are well within one 
standard deviation (Fig. 3.14). This is reflected in the Student’s t-test results where all data quality 
indicators, except λ = 1 Å overall I/σ(I), show no significant differences between treatments at λ = 1 
Å or λ = 1.8 Å.  
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Table 3.4: Average data-collection statistics for PA3825-EAL at λ = 1 Å and λ = 1.8 Å. Values in 
parentheses show one standard deviation. Values for multiplicity, completeness, Rmerge, Rp.i.m., mean I 
/σ(I) and CC(1/2) are shown as overall statistics followed by the highest resolution bin below. 
 
•See Table 3.2 footnote for definitions. 
 
Test Crystal PA3825-EAL λ = 1 Å PA3825-EAL λ = 1.8 Å 
Method Control HC-
Transferred 
Control HC-
Transferred 
No. Crystals  11 11 11 11 
Crystal Size (mm) 0.23 (0.07) x 
0.18 (0.06) x 
0.16 (0.05)  
0.22 ( 0.05) x 
0.17 (0.04) x 
0.16 (0.03)  
0.18 (0.03) x 
0.15 (0.03) x 
0.13 (0.02)  
0.17 (0.03) x 
0.14 (0.02) x 
0.12 (0.03) 
Relative Humidity (%) N/A 95 N/A 95 
Space Group P43212 P43212 P43212 P43212 
Unit-cell      
Parameters (Å) 
a = b = 63.83 
(0.21)   c = 
135.40 (0.42) 
a = b = 64.03 
(0.07)   c = 
135.70 (0.20) 
a = b = 63.90 
(0.15)    c = 
135.32 (0.49) 
a = b = 64.04 
(0.09)   c = 
135.64 (0.18) 
Mosaicity (°) 0.08 (0.07) 0.076 (0.013) 0.12 (0.05) 0.15 (0.08) 
Maximum High 
Resolution Limit (Å)•  
1.86 (0.09) 1.87 (0.13) 1.86 (0.04) 1.85 (0.05) 
High Resolution        
Bin Range (Å) • 
1.88-1.92 1.88-1.92 1.86-1.90 1.86-1.90 
Multiplicity  8.0 (0.1) 8.0 (0.2) 7.0 (0.2) 6.9 (0.1) 
 5.1 (0.5) 5.1 (1.5) 2.7 (0.4) 2.3 (0.2) 
Completeness (%) 99.1 (1.1) 99.6 (0.7) 95.5 (1.9)  97.7 (1.1) 
 96.0 (6.7) 96.8 (6.5) 69.2 (8.5) 80.6 (6.1) 
Rmerge•  (%) 6.9 (1.8) 5.5 (1.4) 4.9 (0.8) 4.24 (1.0) 
 56.8 (17.9) 50.3 (24.1) 40.6 (9.1) 32.5 (11.1) 
Rp.i.m.•  (%) 2.5 (0.7) 2.0 (0.5) 1.9 (0.3) 1.6 (0.4) 
 27.2 (8.8) 25.8 (14.9) 27.2 (6.2) 24.2 (8.6) 
〈𝐈/𝛔(𝐈)〉 20.4 (7.2) 21.0 (3.3) 24.3 (4.2) 26.5 (7.7) 
 3.0 (2.6) 2.5 (1.1) 2.3 (0.5) 2.7 (1.4) 
CC(1/2) • 0.9990 
(0.0000) 
0.9991 
(0.0013) 
0.9994 
(0.0005) 
0.9997 
(0.0004) 
 0.8207 
(0.1048) 
0.8038 
(0.2453) 
0.6036 
(0.1802) 
0.6232 
(0.3073) 
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3.3.2.5. PA3825-EAL RADDOSE-3D Analysis  
Analysis with RADDOSE-3D shows an initial dip in the elastic yield and diffraction efficiency 
from 12.4 keV to 10.3 keV, followed by a significant increase at 8.9 Kev and a gradual decrease 
below 8.9 keV (Fig. 3.11). Values for the buffer show no variation from the crystal in elastic yield (Fig. 
3.11a) but an increased diffraction efficiency over all energies (Fig. 3.11b). Diffraction weighted dose 
and maximum dose increase between 12.4 keV and 10.3 keV, followed by a gradual decrease at 
lower energies. Buffer alone has a consistently lower diffraction weighted dose and maximum dose 
compare to the crystal at all energies (Fig. 3.11c-d), accounting for the higher diffraction efficiency 
observed in Fig. 3.11b. RADDOSE-3D calculations suggest there is a slight increase in the elastic yield 
and diffraction efficiency of crystals collected at λ = 1.8 Å compared to λ = 1.0 Å, with a 1.3 and 1.9 
times increase, respectively (Fig. 3.11a-b). Diffraction weighted dose and maximum dose both 
 100 
 
decrease at λ = 1.8 Å compared to λ = 1.0 Å with a 1.5 times decrease in both dose calculations (Fig. 
3.11c-d).   
3.3.2.6. Bacteriocin Pectocin M2  
Individual data quality indicators plotted against mosaicity for BMP2 present a clear trend 
between treatments collected at both wavelengths. Control datasets show a pronounced skew 
towards improvement in mosaicity, Rmerge, Rp.i.m., I/σ(I) and high resolution limit when compared to 
HC-transferred samples (Fig. 3.12). This is particularly evident in λ = 1 Å datasets where control 
mosaicity is clustered between 0.048° and 0.082° (excluding Grubb’s test outliers circled in red in 
figure 3.12) and HC-transferred datasets spread between 0.054° and 0.592° (Fig. 3.12a,c, e and g). 
The difference between data quality indicators and mosaicity between treatments is less 
pronounced in λ = 2 Å datasets, but still suggest an improvement over HC-transferred samples (Fig. 
8.11b, d, f and h).  
Average data quality indicators and standard deviations for control/HC-transferred 
populations were calculated from 16/11 and 12/10 crystals for λ = 1 Å and λ = 2 Å, respectively, and 
are presented in Table 3.5. Statistical analysis shows a significant improvement in data quality 
indicators of control samples at λ = 1 Å and λ = 2 Å, with the exception of overall Rmerge and Rp.i.m. at λ 
= 2 Å which show no significant difference. These differences are evident in average data quality 
indicators plotted in figure 3.14, where data points are over or close to one standard deviation apart 
in the vertical direction, with the exception of overall Rp.i.m. collected at λ = 2 Å (Fig. 3.14a). High 
resolution limits for BPM2 at λ = 2 Å are within one standard deviation (Fig. 3.14), but are still 
significantly different (Table 3.6). 
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Table 3.5. HC1 Vs Control: Average data-collection statistics for bacteriocin pectocin M2 crystals at λ 
= 1 Å and λ = 1.8 Å. Values in parentheses show one standard deviation. Values for multiplicity, 
completeness, Rmerge, Rp.i.m., mean I /σ(I) and CC(1/2) are shown as overall statistics followed by the 
highest resolution bin below.  
 
•See Table 3.2 footnote for definitions.  
Crystal Bacteriocin Pectocin M2 
 λ = 1.0 Å 
Bacteriocin Pectocin M2 
 λ = 2.0 Å 
Method Control 
HC-
Transferred 
Control 
HC-
Transferred 
No. Crystals  16 11 12 10 
Crystal Size (mm) 
0.15 (0.02) x 
0.10 (0.02) x 
0.09 (0.01) 
0.13 (0.03) x 
0.08 (0.02) x 
0.09 (0.02) 
0.16 (0.02) x 
0.11 (0.02) x 
0.09 (0.02)  
0.15 (0.03) x 
0.10 (0.02) x 
0.09 (0.01) 
Relative Humidity (%) N/A 80.5 N/A 80.5 
Space Group P3121 P3121 P3121 P3121 
Unit-cell      
Parameters (Å) 
a = b = 117.30 
(0.39)   c = 
128.42 (0.31) 
a = b = 116.39 
(0.64)   c = 
128.12 (0.34) 
a = b = 117.49 
(0.09)    c = 
128.39 (0.15) 
a = b = 117.02 
(0.53)   c = 
128.59 (0.41) 
Mosaicity (°) 0.062 (0.010) 0.227 (0.147) 0.121 (0.029) 0.184 (0.040) 
Maximum High  
Resolution Limit (Å)•   
2.16 (0.17) 2.64 (0.4) 2.28 (0.05) 2.46 (0.1) 
High Resolution        
Bin Range (Å) • 
2.63-2.76 2.63-2.76 2.61-2.73 2.61-2.73 
Multiplicity  10.0 (0.1) 9.5 (0.6) 9.6 (0.2) 9.4 (0.1) 
 10.0 (0.1) 9.2 (1.1) 9.6 (0.4) 9.5 (0.2) 
Completeness (%) 99.8 (0.0) 94.6 (8.5) 99.0 (1.4) 99.2 (1.2) 
 100.0 (0.0) 90.0 (16.0) 98.4 (2.7) 98.5 (2.5) 
Rmerge•  (%) 5.7 (3.4)  8.3 (2.8) 9.0 (2.0) 9.7 (1.5) 
 24.6 (25.9) 77.2 (57.4) 39.9 (13.7) 66.4 (18.7) 
Rp.i.m.•  (%) 1.9 (1.1) 2.9 (1.0) 3.1 (0.7) 3.3 (0.5) 
 8.2 (8.6) 27.7 (22.0) 13.5 (4.7) 22.6 (6.3) 
〈𝐈/𝛔(𝐈)〉 34.0 (9.0) 21.0 (7.9) 21.1 (3.9) 17.2 (2.5) 
 12.7 (4.6) 5.2 (4.4) 7.9 (2.0) 4.6 (1.5) 
CC(1/2)• 
0.9993 
(0.0006) 
0.9991  
(0.0005) 
0.9976 
(0.0009) 
0.9985 
(0.0005) 
 
0.9799 
(0.0423) 
0.8155  
(0.2309) 
0.9741 
(0.0227) 
0.9311 
(0.0426) 
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3.3.2.7. Bacteriocin Pectocin M2 RADDOSE-3D Analysis  
As with the BSM crystal, BPM2 sees a slight increase in elastic yield at 10.3 keV followed by 
a steady decrease with decreasing energy (Fig. 3.13a); as well as a steady decrease in diffraction 
efficiency with decreasing energy (Fig. 3.13b). Diffraction weighted dose and maximum dose also 
repeat the pattern seen in BSM with an increase to a maximum around 6.9-7.8 keV and decreasing 
thereafter (Fig. 3.13c-d).  Elastic yield shows no difference between crystal orientations or the buffer 
alone (Fig. 3.13a). Crystal orientation two, with the beam passing through the long z-axis of the 
crystal, shows a 1.4 times increase in diffraction efficiency at 12.4 keV compared to crystal 
orientation one. This gradually decreases with the energy until there is little to no difference around 
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7.8 keV (Fig. 3.13c). Buffer using the same dimensions as crystal orientation one shows a very similar 
curve to that of crystal orientation one. A Similar pattern is seen in diffraction weighted dose and 
maximum dose, with crystal orientation two presenting with a lower diffraction weighted dose and 
maximum dose at higher energies compared to crystal orientation one and buffer, until they become 
equal around 7.8 keV (Fig. 3.13c-d).  
BPM2 crystals show a higher elastic yield and diffraction efficiency at higher energies, with 
a 5.3 and 7.8 times reduction, respectively, between λ = 1.0 Å and λ = 2.0 Å (Fig. 3.13a-b). Data 
collections at λ = 1.0 Å and λ = 2.0 Å are above and below the absorption edge of iron (λ = 1.74 Å), 
respectively, so absorption is not as severe as data collection at the iron edge. However, diffraction 
weighted dose and maximum dose is still increased by 0.020 MGy and 0.182 MGy, respectively, at λ 
= 2.0 Å compared to data collection at λ = 1.0 Å (Fig. 3.11c-d).  
Table 3.6: Student’s t-test results comparing control and HC-transferred populations for all data 
quality indicators. + represents populations that are statistically the same and - represents 
populations that are statistically different. Symbols in parentheses are for data in the highest 
resolution bin ranges defined in Table 3.2, 3.3, 3.4 and 3.5.  
Crystal Bacteriocin 
Syringacin M One 
Bacteriocin 
Syringacin M Two 
PA3825-EAL Bacteriocin 
Pectocin M2  
Wavelength (Å)  1.0 2.0 1.0 1.8 1.0 1.8 1.0 2.0 
Unit Cell Parameter 
(a=b=) (Å) 
+ + + + - - - - 
Unit Cell Parameter 
(c=) (Å) 
- - - + - + + + 
Mosaicity (°) - - - + + + - - 
Rmerge• (%) +(-) -(-) -(-) -(-) + (+) + (+) -(-) + (-) 
Rp.i.m. • (%) +(-) -(-) -(-) -(-) + (+) + (+) -(-) + (-) 
I/σ(I) +(-) -(+) -(-) -(-) - (+) + (+) -(-) -(-) 
Maximum High 
Resolution Limit (Å) • 
- - - + + + - - 
 
• See Table 3.2 footnote for definitions  
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Like Vs Like Treatments at Different Wavelengths 
Bacteriocin Syringacin M-one  
BSM-one populations showed a significant improvement in data quality indicators 
following exposure to the humid air stream with a decrease in the mosaicity of HC-transferred 
samples and some differences in unit cell parameters. To further investigate this, control samples 
collected at λ = 1 Å and λ = 2 Å and HC-transferred samples collected at λ = 1 Å and λ = 2 Å were 
compared using the same statistical tests described previously. Average data quality indicators were 
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calculated from 7/7 and 7/8 λ = 1 Å/ λ = 2 Å crystals for control and HC-transferred populations, 
respectively, and are presented in Table 3. 7. 
Comparison of the control crystals at different wavelengths showed consistent unit cell 
parameters and mosaicity (Table 3.10), this is evident from the similar spread of data points along 
the x-axis between control samples collected at λ = 1.0 Å (orange circles) and λ = 2.0 Å (blue circles) 
in figure 3.15a, c, e and g. HC-transferred samples collected at λ = 1.0 Å and λ = 2.0 Å also show 
consistent unit cell parameters, however, mosaicity is significantly improved in HC-transferred 
populations collected at λ = 1 Å. A clear divide in mosaicity is seen between λ = 1 Å and λ = 2 Å HC-
transferred populations in figure 3.15b, d, f and h, with all λ = 1 Å data points (orange circles) being 
lower than the lowest λ = 2 Å data point (blue circles).  
Comparison of average data quality indicators for BSM-1 control populations collected at λ 
= 1 Å and λ = 2 Å and for the HC-transferred populations at λ = 1 Å and λ = 2 Å showed no significant 
differences (Table 3.10). The similarity in data quality indicators is evident in figure 3.18, where 
control populations at both wavelengths (grey circles) are within one standard deviation, as are HC-
transferred populations (yellow diamonds).  
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Table 3.7: Control vs Control and HC1 vs HC1 average data-collection statistics for bacteriocin 
syringacin M-one at λ = 1 Å and λ = 2.0 Å. Values in parentheses show one standard deviation. 
Values for multiplicity, completeness, Rmerge, Rp.i.m., mean I /σ(I) and CC(1/2) are shown as overall 
statistics followed by the highest resolution bin below.  
 
• See Table 3.2 footnote for definitions.  
Crystal 
Bacteriocin Syringacin  
M-1 Control 
Bacteriocin Syringacin  
M-1 HC-transferred 
Wavelength (Å) 1.0 2.0 1.0 2.0 
No. Crystals  7 7 7 8 
Crystal Size (mm)     
Relative Humidity (%) N/A N/A 89.0 89.0 
Space Group P6322 P6322 P6322 P6322 
Unit-cell      
Parameters (Å) 
a = b = 161.09 
(0.50) c = 
99.26 (0.35) 
a = b = 161.1 
(0.20) c = 
99.37 (0.11) 
a = b = 160.76 
(0.47) c = 
99.73 (0.01) 
a = b = 161.00 
(0.31) c = 
99.76 (0.26) 
Mosaicity (°) 0.137 (0.065) 0.194 (0.039) 0.064 (0.017) 0.151 (0.033) 
Maximum High 
Resolution Limit (Å)•   
3.02 (0.05) 3.05 (0.13) 2.88 (0.07) 2.94 (0.05) 
High Resolution        
Bin Range (Å) • 
3.26-3.05 3.26-3.05 3.26-3.05 3.26-3.05 
Multiplicity  12.2 (1.8) 11.5 (1.8) 12.1 (2.6) 12.5 (0.2)  
 12.3 (1.8) 11.6 (1.8) 12.2 (2.7) 12.3 (0.1) 
Completeness (%) 99.7 (0.3) 99.5 (0.2) 98.6 (1.8) 98.9 (1.4) 
 100.0 (0.0) 99.9 (0.2) 99.2 (1.4) 99.7 (0.6) 
Rmerge•  (%) 8.8 (2.9) 8.7 (2.7) 6.9 (1.1) 6.1 (1.0) 
 101.4 (48.0) 91.0 (47.0) 41.2 (5.7) 52.9 (14.3) 
Rp.i.m.•  (%) 2.5 (0.9) 2.6 (0.9) 2.0 (0.3) 1.8 (0.3)  
 28.8 (13.9) 26.8 (13.7) 11.6 (1.5) 15.5 (4.2) 
〈𝐈/𝛔(𝐈)〉 22.9 (6.9) 21.6 (7.2) 26.5 (4.3) 29.3 (5.0) 
 2.9 (1.1) 3.2 (1.7) 6.0 (1.4) 4.9 (1.4) 
CC(1/2)• 
0.9784 
(0.0538) 
0.9621 
(0.0964) 
0.9783 
(0.0495) 
0.9993 
(0.0004) 
 
0.7930 
(0.1432) 
0.8143 
(0.1321) 
0.9163 
(0.0828) 
0.9434 
(0.0251) 
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Bacteriocin Syringacin M-two  
As with BSM-one, BSM-two crystals showed a significant improvement in data quality 
following transfer in the humid air stream with reproducible increases in high resolution limit and 
other data quality indicators. Average data quality indicators and standard deviations were 
calculated from λ = 1 Å/λ = 1.8 Å data collections from 8/10 and 10/10 crystals, respectively, for 
control and HC-transferred populations; and are presented in Table 3.8.  
Control populations collected at λ = 1 Å show a much larger variance in mosaicity 
compared to the control population collected at λ =1.8 Å, with no outliers flagged by the Grubbs test 
(Fig. 3.16a, c, e and g). This is reflected in the average values, with a statistically significant increase 
in mosaicity of 0.05° in λ = 1 Å controls (Table 3.8). λ =1.8 Å controls show much smaller variation in 
mosaicity, with data points laying between a minimum of 0.11° and maximum of 0.17°. In addition to 
the increase in mosaicity, λ = 1 Å controls show a significant decrease in all unit cell parameters 
(Table 3.10). HC-transferred BSM-two crystals are much more stable in the humid air stream, with 
both populations collected at λ = 1 Å and λ = 1.8 Å showing a similar spread in mosaicity (Fig. 3.16b, 
d, f and h) and no significant differences by the t-test (Table 3.10). Unit cell parameters show a 
similar significant increase in a and b unit cell parameters in the λ = 1.8 Å population but the c axis 
remains unchanged between populations (Table 3.10).  
Control populations show a consistent improvement in overall and high resolution Rmerge, 
Rp.i.m. and I/σ(I) at λ = 1.8 Å (Table 3.10) while HC-transferred populations only see an improvement 
in overall Rmerge, Rp.i.m. and I/σ(I) at  λ = 1.8 Å (Table 3.10). This is clearly observed in figure 3.18, 
where control BSM two data at λ = 1.8 Å (filled blue circles) have much lower average Rp.i.m. and 
higher I/σ(I) compared to data at λ = 1.0 Å (open blue circles). A similar trend is observed in high 
resolution limit, with λ = 1.8 Å control data showing a significant improvement over λ = 1.0 Å control 
data. The HC-transferred populations show no significant differences in the high resolution limit at 
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the two wavelengths, and their average high resolution Rp.i.m. and I/σ(I) show no significant 
differences (Table 3.10).  
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Table 3.8: Control vs Control and HC1 vs HC1 average data-collection statistics for bacteriocin 
syringacin M-two at λ = 1 Å and λ = 1.8 Å. Values in parentheses show one standard deviation. 
Values for multiplicity, completeness, Rmerge, Rp.i.m., mean I /σ(I) and CC(1/2) are shown as overall 
statistics followed by the highest resolution bin below.  
 
• See Table 3.2 footnote for definitions  
 
 
Crystal Bacteriocin Syringacin  
M-2 Control 
Bacteriocin Syringacin  
M-2 HC-transferred 
Wavelength (Å) 1.0 1.8 1.0 1.8 
No. Crystals  8 10 10 10 
Crystal Size (mm)     
Relative Humidity (%) N/A N/A 89.5 89.5 
Space Group P6322 P6322 P6322 P6322 
Unit-cell      
Parameters (Å) 
a = b = 160.24 
(0.32) c = 
99.27 (0.29) 
a = b = 160.76 
(0.59) c = 
99.71 (0.28) 
a = b = 160.36 
(0.12) c = 
99.76 (0.08) 
a = b = 160.56 
(0.11) c = 
99.75 (0.22) 
Mosaicity (°) 0.19 (0.06) 0.14 (0.02) 0.10 (0.03) 0.13 (0.04) 
Maximum High 
Resolution Limit (Å)•   
3.37 (0.15) 3.17 (0.14) 3.11 (0.14) 3.06 
High Resolution        
Bin Range (Å) • 
3.64-3.37 3.64-3.37 3.39-3.17 3.39-3.17 
Multiplicity  12.4 (0.5) 12.7 (0.5) 13.1 (0.3) 12.7 (1.8) 
 13.0 (0.1) 13.2  (0.5) 13.4 (0.3) 12.4 (1.9) 
Completeness (%) 99.3 (0.4) 93.8 (9.6) 98.9 (1.9) 94.0 (4.1) 
 99.9 (0.2) 95.4 (8.4) 99.5 (1.6) 96.0 (3.0) 
Rmerge•  (%) 12.1 (3.8) 6.6 (1.6) 7.8 (2.0)  5.7 (0.9) 
 100.6 (26.6) 43.5 (20.5) 94.5 (53.4) 61.6 (18.74) 
Rp.i.m.•  (%) 3.6 (1.3) 1.9 (0.5) 2.3 (0.5)  1.6 (0.2) 
 28.3 (7.6) 12.3 (6.1) 26.2 (14.6) 17.8 (5.8) 
〈𝐈/𝛔(𝐈)〉 18.0 (5.3) 29.7 (8.4)  26.7 (4.7) 31.8 (4.8) 
 2.4 (0.9) 7.4 (4.2) 4.0 (2.3) 4.6 (1.9) 
CC(1/2)• 
0.9992 
(0.0009) 
0.9996 
(0.0005) 
0.9998 
(0.0004) 
0.9999 
(0.0003) 
 
0.7887 
(0.1345) 
0.9536 
(0.0351)  
0.8550 
(0.1134) 
0.9227 
(0.0493) 
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3.3.3.3. Bacteriocin Pectocin M2 
Although exposure of BPM2 crystals to the humid air stream shows a detrimental effect on 
data quality, particularly in the high resolution limit. The effect is reproducible and the HC-
transferred and control populations at λ = 1 Å and λ = 2 Å can be analysed for differences in data 
quality as above. Average data quality indicators and standard deviations were calculated from λ = 1 
Å/λ = 2 Å data collections from 16/11 and 12/10 crystals, respectively, for control and HC-transferred 
populations; and are presented in Table 3.9.  
Individual data quality indicators are plotted against mosaicity in figure 3.17 for control 
populations and for HC-transferred populations at both wavelengths with Grubb’s test outliers 
circled in red. Control populations collected at λ = 1 Å show lower mosaicity and improved data 
quality indicators compared to control data collected at λ = 2 Å (Fig. 3.17a, c, e and g). However, the 
same trend is not observed for HC-transferred data, which show comparable spreads in mosaicity 
and all data quality indicators at both wavelengths (Fig. 3.17 b, d, f and h).  
Control populations show a significant improvement in data quality at λ = 1 Å (Table 3.10). 
Overall and high resolution Rmerge, Rp.i.m., I/σ(I) and high resolution limit all show significant 
improvements over average data collected at λ = 2 Å. This is evident in figure 3.18 where control 
populations (blue) are well over one standard deviation apart. The same effect is not observed 
between HC-transferred crystals, with all overall and high resolution data quality indicators all within 
one standard deviation of one another (Fig. 3.18) and showing no significant difference between 
wavelengths (Table 3.10).  
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Table 3.9: Control vs Control and HC1 vs HC1 average data-collection statistics for bacteriocin 
Pectocin M2 at λ = 1 Å and λ = 1.8 Å. Values in parentheses show one standard deviation. Values for 
multiplicity, completeness, Rmerge, Rp.i.m., mean I/σ(I) and CC(1/2) are shown as overall statistics 
followed by the highest resolution bin below.  
 
• See Table 3.2 footnote for definitions  
 
 
Crystal Bacteriocin Pectocin M2 
Control 
Bacteriocin Pectocin M2 HC-
transferred 
Wavelength (Å) 1.0 2.0 1.0 2.0 
No. Crystals  15 12 14 12 
Crystal Size (mm)     
Relative Humidity (%)     
Space Group P3121 P3121 P3121 P3121 
Unit-cell      
Parameters (Å) 
a = b = 117.30 
(0.39)   c = 
128.42 (0.31) 
a = b = 117.49 
(0.09)    c = 
128.39 (0.15) 
a = b = 116.39 
(0.64)   c = 
128.12 (0.34) 
a = b = 117.02 
(0.53)   c = 
128.59 (0.41) 
Mosaicity (°) 0.07 (0.04) 0.121 (0.029) 0.227 (0.147) 0.184 (0.040) 
Maximum High 
Resolution Limit (Å)•  
2.16 (0.17) 2.28 (0.05) 2.64 (0.4) 2.46 (0.1) 
High Resolution        
Bin Range (Å) • 
2.29-2.37 2.29-2.37 2.63-2.76 2.63-2.76 
Multiplicity  10.0 (0.1) 9.2 (0.3) 9.5 (0.6) 9.4 (0.1) 
 9.5 (0.1) 7.5 (0.2) 9.2 (1.1) 9.5 (0.2) 
Completeness (%) 99.8 (0.0) 98.4 (2.3) 94.6 (8.5) 99.2 (1.1) 
 100.0 (0.0)  96.6 (5.0) 90.0 (16.0) 98.7 (2.3) 
Rmerge• (%) 6.0 (1.9) 10.5 (2.4) 8.3 (2.8) 10.0 (2.0) 
 46.6 (35.7) 97.1 (36.5) 77.2 (57.4) 61.1 (17.2) 
Rp.i.m.• (%) 2.0 (0.6) 3.6 (0.8) 2.9 (1.0) 3.5 (0.7) 
 16.0 (12.4) 37.6 (14.3) 27.7 (22.0) 20.8 (5.7) 
〈𝐈/𝛔(𝐈)〉 26.3 (5.2) 15.6 (3.1) 21.0 (7.9) 15.9 (4.5) 
 5.7 (1.9) 2.7 (0.9) 5.2 (4.4) 4.3 (2.2) 
CC(1/2)• 
0.9995 
(0.0005) 
0.9976 
(0.0009) 
0.9991 
(0.0005) 
0.9983 
(0.0006) 
 
0.9463 
(0.1072) 
0.7498 
(0.1497) 
0.8155 
(0.2309) 
0.9403 
(0.0408) 
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Table 3.10: Student’s t-test results for all data quality indicators. + represents populations that are 
statistically the same and - represents populations that are statistically different. Symbols in 
parentheses are for data in the highest resolution bin ranges defined in Table 3.7, 3.8, 3.9. C = 
control and H = HC-transferred.  
Test Crystal Bacteriocin Syringacin 
M-1 
Bacteriocin Syringacin 
M-2 
Bacteriocin Pectocin 
M2 
Treatment  C H C H C H 
Analysis  1.0 Vs 2.0 1.0 Vs 2.0 1.0 Vs 1.8 1.0 Vs 1.8 1.0 Vs 2.0 1.0 Vs 2.0 
Unit Cell Parameter 
(a=b=) (Å) 
+ + - - + + 
Unit Cell Parameter 
(c=) (Å) 
+ + - + + - 
Mosaicity (°) + - - + - + 
Rmerge• (%) +(+) +(+) -(-) -(+) -(-) +(+) 
Rp.i.m. • (%) +(+) +(+) -(-) -(+) -(-) +(+) 
I/σ(I) +(+) +(+) -(-) -(+) -(-) +(+) 
Maximum High 
Resolution Limit (Å) • 
+ + - + - + 
 
• See Table 3.2 footnote for definitions  
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3.4. Discussion  
Previous work (see Chapter 2) demonstrated that it is possible to manipulate protein 
crystals in a humid stream with minimal effects on crystal integrity and data quality. However, 
lysozyme, thaumatin, insulin and ferritin are well characterised model samples and not 
representative of modern protein targets under investigation using X-ray crystallography. The 
samples used in Chapter 2 also diffracted close to or beyond the geometrical limits of the detector at 
λ ~ 1 Å, so measurement of high resolution data at longer wavelengths would be impossible. BSM, 
PA3825-EAL and BPM2 crystals diffracted to a much lower resolution and required cryo-protection 
prior to flash cooling, but still crystallised in a reproducible manner to allow large populations of 
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crystals to be examined for statistically significant differences. BSM and BPM2 crystals both have a 
very high solvent content, 70% and 80% respectively, and are particularly susceptible to 
dehydration, making them a potentially serious challenge for manipulation in the humid air stream. 
With PA3825-EAL cryoprotected in 2.4 M ZnSO4 and BPM2 containing two 2Fe-2S clusters, they are 
both expected to have a high absorbance at longer wavelengths, making them both a good test for 
absorption effects with and without excess surrounding solvent.  
3.4.1. Control Vs HC-transferred Samples at λ = 1.0 Å and λ ~ 2.0 Å 
3.4.1.1. Bacteriocin Syringacin M  
The mosaicity and unit cell parameters underwent significant changes in BSM-one and -
two, with HC-transferred crystals showing an increase in size along the c-axis and a reduction in 
mosaicity compared to control crystals. One exception was BSM-two crystals collected at λ = 1.8 Å. 
These showed no significant differences in either parameter but had a higher mosaicity (0.15°) 
uncharacteristic of the other HC-transferred BSM samples. This suggests that BSM samples are 
particularly susceptible to changes induced by exposure to the humid air stream. With such a high 
solvent content of (~70%) it is likely that the crystal packing is being affected. This is reflected in the 
observed improvement in data quality indicators for HC-transferred samples in high and low 
resolution bins for the majority of cases taken over four different populations. Based on the pattern 
of reduced average mosaicity, significant or not, observed in HC-transferred samples it stands to 
reason that the humid air stream is having an effect on the crystals. Alternatively, the highly variable 
nature of the control populations may also point to an intrinsic variability in BSM crystals which 
makes systematic study of their data quality difficult. In either case, this makes comparing the 
effects of long wavelength data collection between control and HC transferred samples problematic.  
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3.4.1.2. PA3825-EAL 
PA3825-EAL crystals show significant shrinkage in a, b and c axis unit cell parameters at λ = 
1.0 Å and a and b axis unit cell parameters only at λ = 1.8 Å in control samples. The reasons behind 
this increase in unit cell parameters in HC-transferred samples is unknown, possibly an effect of the 
humid air stream or expansion of solvent or protein upon cooling/ data collection (Burmeister, 
2000). However, the mosaicity of crystals and the data quality remains unaffected suggesting these 
changes are inconsequential.  
All data quality indicators, except overall I/σ(I) show no significant difference between 
treatment at standard or longer wavelengths. RADDOSE-3D calculations show that the diffraction 
efficiency of the crystals at λ = 1.0 Å and λ = 1.8 Å is relatively unchanged, with crystals at longer 
wavelength diffracting more efficiently by 1.52E+11 photons/MGy. Data were collected 0.52 Å above 
and 0.28 Å below the zinc K edge and well below the sulphur K edge so absorption effects should be 
minimal at both wavelengths. Although we would expect sulphur absorption to be increased in λ = 
1.8 Å, particularly controls with excess ZnSO4 buffer, the effects on data quality appear to be 
negligible. All datasets, at both wavelengths, were subjected to the same absorption correction 
during scaling, namely the strict absorption correction = true and Friedel’s law = false settings in 
XDS/XSCALE (Kabsch, 2010a, Kabsch, 2010b); with Friedel pairs treated as separate reflections when 
calculating absorption correction factors.   
3.4.1.3. Bacteriocin Pectocin M2 
BPM2 crystals reacted very poorly to manipulation in the humid air stream, showing a 
consistent shrinkage in the a and b unit cell parameters and an increase in mosaicity. This has a clear 
knock on effect, significantly reducing the high resolution limit and negatively affecting the quality of 
diffraction data from the crystals. As a result, comparison of control and HC transferred samples at 
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different wavelengths yielded no useful information on the effects of data quality when collecting at 
long wavelengths with or without excess solvent.  
3.4.2. Like Vs Like Treatments at λ = 1.0 Å and λ ~ 2.0 Å 
3.4.2.1. Bacteriocin Syringacin M 
Comparison of data from like treatments (i.e. control vs control, etc.) collected at different 
wavelengths is somewhat more reliable in BSM-one compared to BSM-two. BSM-one control data at 
λ = 1.0 Å or λ = 2.0 Å show no significant difference in unit cell parameters, mosaicity or other data 
quality indicators except mosaicity in the HC-transferred crystals, which is increased in the λ = 2.0 Å 
populations. BSM-two data on the other hand are much more variable, with control crystals 
demonstrating a shrinkage in all unit cell parameters and an increase in mosaicity in the λ = 1.0 Å 
data. BSM-two HC-transferred crystals also see a shrinkage in the a and b axis of λ = 1.0 Å crystals.  
The stability of BSM-one’s unit cell and mosaicity is reflected in data quality indicators 
which show no differences when comparing like with like treatments at different wavelengths. The 
same cannot be said for BSM-two data, with control crystals showing a significant improvement in 
data quality at λ = 1.8 Å. The similarity in BSM-one populations and the improvements in BSM-two 
data when going to longer wavelengths were unexpected based on predictions by RADDOSE, which 
suggests a 8.5 fold drop in diffraction efficiency with increasing wavelengths from λ = 1.0 Å to λ = 2.0 
Å  (Fig. 3.9b). Based on the wide range of differences observed in crystal integrity measures in 
control and HC-treated crystals BSM appears to be an inappropriate crystal for used in these 
systematic studies based on the intrinsic variability of the crystals themselves. This variability 
emphasises the need for robust statistical analysis in method development for X-ray crystallography. 
Experimentation on a single BSM crystal from control and HC-transferred crystals, from either BSM-1 
or BSM-2, could have resulted in any number of conclusions on the effects of excess surrounding 
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solvent on data quality at long wavelengths depending on the particular crystal data were collected 
from.  
3.4.2.2. Bacteriocin Pectocin M2 
Although control samples of BMP2 show a significant improvement over HC-transferred 
samples, the changes caused by the humid air stream are reproducible; allowing comparison of like 
with like treatments, i.e. HC-transferred vs HC-transferred, at λ = 1.0 Å and λ = 2.0 Å. Control 
populations processed to the same high resolution limit show a significant improvement in data 
quality indicators when collected at λ = 1.0 Å. No such differences in data quality indicators are 
observed between HC-transferred populations at λ = 1.0 Å and λ = 2.0 Å; suggesting these effects 
stem from the presence of excess surrounding solvent. The HC-transferred populations collected at λ 
= 1.0 Å show a large standard deviation which could skew calculations of p-values, however, the 
three datasets causing this have not been identified as outliers by the Grubb’s test and removing the 
datasets has no effect on the final result of the t-test.  
BPM2 contains a 2Fe-2S cluster (Grinter et al., 2014) which will greatly increase the 
absorption of X-rays at λ = 2.0 Å, however, these effects appear insignificant in populations where 
excess surrounding solvent has been removed. RADDOSE-3D calculations suggest the diffraction 
efficiency of crystals in the optimum orientation should dramatically decrease from 5.78E+12 
photons/MGy at λ = 1.0 Å to 6.25E+11 photons/MGy at λ = 2.0 Å, a 8.2 times increase in efficiency. 
However, RADDOSE-3D does not take excess surrounding solvent into account so we would expect 
the same decrease in photons/MGy in both control and HC-transferred samples. Calculations with 
buffer alone show the cryo buffer would receive a smaller maximum dose than the crystal in 180° 
collections suggesting the absorption by excess surrounding buffer is not sufficient to cause the 
significant differences observed in control data quality at λ = 2.0 Å.   
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These differences in data quality may also be the result of radiation damage experienced 
through increased absorption of X-rays at λ = 2.0 Å. Primary radiation damage occurs by direct 
interaction of the X-ray beam with electrons to generate photoelectrons and ejection of energetic 
electrons from atoms (Teng and Moffat, 2000), with the first port of call for site specific radiation 
damage being reduction of metallic centres (Garman and Weik, 2015, Hough et al., 2008a, Ellis et al., 
2008, Yano et al., 2005b). This makes BMP2’s 2Fe-2S centre a likely target as an electron sink for the 
free electrons (Ellis et al., 2002, Nishino and Okamoto, 2000). However, this damage should occur 
regardless of the presence of excess surrounding solvent once the appropriate dose limit has been 
reached (Owen et al., 2006a, Murray et al., 2005, Henderson, 1990). A change in colour of BPM2 
crystals is clearly seen in both control and HC-transferred samples (Fig. 3.19), signifying the 2Fe-2S 
cluster has been reduced. Despite this, no reduction in data quality is observed in HC-transferred 
populations while control populations collected at λ = 2.0 Å do show a significant decrease in data 
quality, suggesting that primary radiation damage is not the cause.  
Secondary damage results from the generation of free radicals which will vary by the 
nature of the solvent (Murray et al., 2004, Shimizu et al., 2007), temperature (Burmeister, 2000, 
Owen et al., 2006a, Ravelli and McSweeney, 2000) and presence of scavengers (Allan et al., 2013, 
Murray and Garman, 2002). Radiation damamge presents as either global or specific damage, with 
global radiation damage causing a loss of high resolution reflections and an increase in unit cell 
volume, Rmerge/meas/p.i.m , B-factors and mosaicity (Garman, 2010). Specific damage occurs between 
covalent bonds in a specific reproducible order in cryo-crystallography; with disulphide bridges 
breaking first, followed by decarboxyation of glutamates and aspartates, loss of hydroxyl groups 
from tyrosines and finally the cleavage of carbon sulphur bonds in methionines (Garman, 2010).  
All populations were collected at the same temperature and no free radical scavengers 
were present in the buffers so solvent presents the only variable left to investigate. The process of 
secondary damage requires thermal diffusion of these reactive atomic and molecular radicals, which 
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is greatly reduced at cryo temperatures (Ravelli and McSweeney, 2000, Garman, 2003b). However, 
mobile hydroxyl radicals and electrons have been reported at 77K (Lange et al., 1995, Whalley, 1973, 
Eiben and Taub, 1967), along with other accounts of secondary radiation damage at cryogenic 
temperatures (Sevilla and D'Arcy, 1978, Sevilla et al., 1979, Box and Budzinski, 1971). BPM2 has a 
high solvent content of ~ 80% and the presence of excess surrounding solvent will greatly increase 
the number of solvent and water molecules available to form hydroxyl radicals, hydrated electrons, 
protons, hydrogen radicals and hydrogen gas (Faraggi et al., 1995, Alexander and Lett, 1967, Weik et 
al., 2000, Burmeister, 2000, von Sonntag and Schuchmann, 1994). The radiolysis of water molecules 
is depicted in figure 3.20. Ionisation produces a free electron and a water cation leading to 
production of hydroxyl radicals (Hiroki et al., 2002). The damage caused by these highly reactive free 
radical species may account for the detrimental effects on data quality observed in λ = 2.0 Å control 
populations. 
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3.5. Conclusions  
This work has built on the previous study presented in Chapter 2, in which a humidity 
controlled device and micromanipulators were employed to allow precise removal of surrounding 
solvent from protein crystals, in preparation for either transfer to a different mount, for in-vacuum 
experiments, or for crystallographic study. Following those findings - that robust ‘model’ protein 
crystals can be manipulated routinely without causing deterioration of their diffraction quality - the 
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next step was to conduct experiments on more “true to life” protein crystals (weaker diffracting, 
limited diffraction limit, high solvent content, physically more fragile, etc) and statistically assess the 
effects of crystal manipulation and excess solvent on their data quality, including at longer 
wavelengths.  
As expected, protein samples with higher solvent content showed some variability when 
exposed to the humid air stream. BSM crystals proved highly variable, with four populations of 
control and HC-transferred crystals tested, giving different results on the state of mosaicity and unit 
cell parameters both between treatments and when comparing like treatments. The knock on effect 
of these changes in crystal integrity on data quality were evident for HC-transferred crystals which, 
in the majority of cases, showed an improvement in high resolution limit and other data quality 
indicators. While an improvement in data quality in the humid air stream can be considered a 
favourable result, both the HC-transferred and control crystals demonstrated too much variability to 
give a clear impression of the effects of longer wavelengths and excess solvent on data quality. 
Changes to the BSM crystals in the humid air stream suggests that the optimum humidity may not 
have been determined, despite repeated experiments producing a relative humidity within 0.5%. It 
may be that a more accurate means of determining the relative humidity of BSM crystals than the 
‘loop method’ is required to optimise conditions for BSM to become a more reliable sample for 
systematic studies.  
PA3825-EAL protein crystals proved much more stable in the humid air stream. Although 
significant differences were observed in some unit cell axis upon exposure to the humid air stream, 
up to 0.3 Å the mosaicity remained unaffected. With a solvent content of approximately 50%, 
PA3825-EAL is expected to be less susceptible to the changes seen in the more highly hydrated BSM 
crystals. The changes in unit cell parameters between treatments appears to have had no knock on 
effects on the quality of diffraction data obtained. The presence of excess solvent also appears to 
have no significant effects on data quality at λ = 1.8 Å. This may be explained by the predicted 
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diffraction efficiency from RADDOSE which suggests little difference between crystals collected at λ = 
1.0 Å and λ = 1.8 Å. RADDOSE predicts a peak in diffraction efficiency for PA3825-EAL around λ = 1.4 
Å, however, this is likely the result of the zinc absorption edge due to the 2.4 M zinc sulphate 
present as a cryo-protectant. 
BPM2 presents an interesting case of crystals undergoing a negative change in data quality 
following exposure to the humid air stream in a highly reproducible manner that allows further 
study. At its best, BPM2 crystals diffracted to an average maximum resolution of 2.16 Å (λ = 1.0 Å 
control crystals); following exposure to the humid air stream this dropped considerably to an 
average of 2.64 Å (λ = 1.0 Å HC-transferred crystals). Despite this drop in high resolution limit, data 
quality in HC-transferred samples remains high with reasonable merging statistics. The more 
interesting conclusions appear when comparing populations handled in the same manner (i.e. 
control vs control) at different wavelengths. For HC-transferred naked protein crystals at λ = 1.0 Å 
and λ = 2.0 Å there is no observable difference in data quality indicators from a total population of 
26 protein crystals. Based on the 9.2-fold drop in diffraction efficiency from data collection at λ = 1.0 
Å to λ = 2.0 Å, as calculated by RADDOSE, this should be reflected in average data quality indicators. 
Although this is not observed in HC-transferred populations it is seen in control populations, where λ 
= 1.0 Å samples show significantly superior data quality indicators than at λ = 2.0 Å. If this decrease 
in data quality was caused solely by using long wavelength X-rays we would expect HC-transferred 
samples to show a similar decrease in data quality. As this is not observed, the only other variable is 
the presence of excess solvent which, when paired with long wavelength X-rays, leads to an increase 
in absorption, background scatter and the production of high energy radicals which have detrimental 
effects on data quality.  
Although BSM proved incompatible with the systematic study of data quality in relation to 
data quality it does provide insight into the use of the HC1 in sample handling. Treatment with the 
HC1 is highly dependent on the behaviour of protein crystals when removed from the stable 
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environment of the mother liquor, namely the degree of variability in crystal packing. Of all the 
protein crystals tested in Chapters 2 and 3, BSM has the highest solvent content at ~ 80%. Initial 
crystals studied (Chapter 2) had solvent contents between 26% and 60%, with the two higher of the 
four, thaumatin (57%) and ferritin (60%), demonstrating statistically significant variability in unit cell 
parameters and mosaicity. However, the data quality indicators remained unaffected (Table 2.7). 
This chapter looked to investigate more “true to life” protein crystals, with BSM, PA3825-EAL and 
BPM2 having solvent contents of 80%, 50% and 70%, respectively. PA3825-EAL interacted with the 
humid air stream in a similar manner to thaumatin and ferritin, with statistically significant changes 
in unit cell parameters while data quality remained unaffected (Table 3.6). BSM and BPM on the 
other hand demonstrated significant changes in unit cell parameters and mosaicity which had a 
knock on effect on data quality between control and HC-transferred samples as discussed above in 
detail. Based on the observations of crystal variability, both crystal integrity and data quality, and its 
relation to solvent content a scale of difficulty guideline for use of the HC1 for manipulation of 
protein crystals can be proposed; with solvent contents up to 50% as relatively easy cases, 51-60% as 
potentially problematic cases and >61% as complicated/difficult cases.  
Based on this study, which has used statistical analysis based on multiple crystal 
experiments (and crystal types),  it is not possible to produce a more specific predictive model for 
the effects on data quality of excess solvent paired with long wavelength X-rays. A number of 
variables including the buffers used for cryo-protection, crystal size and orientation, solvent content 
and the presence of metal centres and other heavy atoms could have a significant effect on the final 
data from a diffraction experiment. Nevertheless, crystal manipulation and optimising conditions for 
data collection will become a more important issues for expermintalists as we approach much longer 
wavelengths – for example, 3-4 Å proposed for I23 at Diamond -  with a view to perform S-SAD 
phasing experiments. For this study, investigations using these long wavelengths was not yet 
technically possible and must remain for the future.  
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3.6. Appendix  
3.6.1. Dose Calculations   
Table 3.A1: Calculated fluxes at different energies from Diamond Light Source beamline I04 from 
data measured at 100% transmission at 300 mA ring current (Fig. 3.5).  
 
 
 
 
 
 
 
Table 3.A2: RADDOSE-3D input parameters for bacteriocin syringacin M, PA3825-EAL and 
bacteriocin pectocin M2 at different X-ray energies. Energies and fluxes are listed in Table A3.1. 
Numbers in brackets represent simulations for bacteriocin pectocin M2 crystal orientation two (Fig. 
3.6b).  
Protein Bacteriocin syringacin M PA3825-EAL Bacteriocin Pectocin M2 
Crystal/Buffer Crystal Buffer Crystal Buffer Crystal 1 (2) Buffer 
Beam Parameters    
Full Width Half Max. 
(μm) 
90 x 45 90 x 45 90 x 45 90 x 45 90 x 45 90 x 45 
Crystal Parameters    
Xtal Dimensions (μm) 185 x 160 x 
140 
185 x 160 x 
140 
100 x 100 x 
100 
100 x 100 
x 100 
150 x 250 x 
150 (250 x 
150 x 150) 
150 x 250 x 
150 (250 x 
150 x 150) 
Number of Monomers 1 0 1 0 2 0 
Number of Residues 284 284 259 259 279 279 
Solvent Heavy Atoms Ca 30, Cl 
30, Mg 30, 
Cl 30 
Ca 30, Cl 
30, Mg 30, 
Cl 30 
Zn 2400, S 
2400, Na 
100 
Zn 2400, 
S 2400, 
Na 100 
S 2000, S 100 S 2000, S 100 
Protein Heavy atoms S 7, Ca 1 N/A S 7 N/A Fe 4, S 9 N/A 
Solvent Fraction (%) 79.51 100 48.76 0 70.42 0 
Wedge Parameters    
Angular Range (°) 0-120 0-120 0-120 0-120 0-180 0-180 
Exposure Time (s) 120 120 120 120 180 180 
 
Energy (keV) Wavelength (Å) Flux Ph/s) 
12.4 1.0 2.00E+10 
10.3 1.2 3.16E+10 
8.9 1.4 3.16E+10 
7.8 1.6 2.51E+10 
6.9 1.8 2.00E+10 
6.2 2 1.26E+10 
5.6 2.2 1.26E+10 
5.2 2.4 1.00E10 
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3.6.2. Test for Normality 
Table 3.A3: Correlation coefficients to test for normality in control and HC-transferred populations 
of bacteriocin syringacin M, PA3825-EAL and bacteriocin pectocin M2 crystals collected at λ = 1Å. 
Critical values are presented for α = 0.01, (α = 0.05) and [α = 0.10]. Populations are considered highly 
normal if correlation coefficients exceed all critical values, normal if higher than α = 0.01 and α = 
(0.05) critical values and weakly normal if only higher than α = 0.01 critical values.  
Protein Bacteriocin  
syringacin M-1 
Bacteriocin 
syringacin M-2 
PA3825-EAL 
Bacteriocin  
Pectocin M2 
Control/ 
HC-trans. 
Control HC-trans. Control HC-trans. Control HC-trans. Control HC-trans. 
Overall 
Rmerge (%) 
0.92 0.96 0.95 0.94 0.92 0.95 0.97 0.98 
High Res. 
Rmerge (%) 
0.95 0.97 0.84 0.89 0.93 0.97 0.98 0.95 
Overall 
Rp.i.m. (%) 
0.91 0.96 0.95 0.94 0.93 0.95 0.87 0.97 
High Res. 
Rp.i.m. (%) 
0.95 0.97 0.84 0.88 0.93 0.94 0.97 0.95 
Overall 
I/σ(I) 
0.97 0.95 0.96 0.95 0.94 0.96 0.93 0.96 
High Res. 
I/σ(I) 
0.98 0.96 0.96 0.96 0.93 0.99 0.95 0.94 
High Res. 
Limit (Å) 
0.98 0.97 0.91 0.96 0.95 0.90 0.98 0.97 
Unit Cell 
Parameters 
(a=b=) 
0.99 0.97 0.98 0.91 0.97 0.98 0.91 0.90 
Unit Cell 
Parameters 
(c=) 
0.98 0.95 0.96 0.82 0.97 0.97 0.82 0.92 
Mosaicity 
(°) 
0.96 0.99 0.97 0.95 0.99 0.96 0.97 0.89 
Critical 
Value   
0.86 
(0.91) 
[0.92] 
0.86 
(0.91) 
[0.92] 
0.85 
(0.90) 
[0.92] 
0.84 
(0.89) 
[0.91] 
0.89 
(0.92) 
[0.94] 
0.89 
(0.92) 
[0.94] 
0.90 
(0.94) 
[0.95] 
0.91 
(0.94) 
[0.95] 
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Table 3.A4: Correlation coefficients to test for normality in control and HC-transferred populations 
of bacteriocin syringacin M, PA3825-EAL and bacteriocin pectocin M2 crystals collected at λ ~ 2Å. 
Critical values are presented for α = 0.01, (α = 0.05) and [α = 0.10]. Populations are considered highly 
normal if correlation coefficients exceed all critical values, normal if higher than α = 0.01 and α = 
(0.05) critical values and weakly normal if only higher than α = 0.01 critical values.  
Protein Bacteriocin  
syringacin M-1 
Bacteriocin 
syringacin M-2 
PA3825-EAL 
Bacteriocin  
Pectocin M2 
Control/ 
HC-trans. 
Control HC-trans. Control HC-trans. Control HC-trans. Control HC-trans. 
Overall 
Rmerge (%) 
0.94 0.96 0.97 0.97 0.94 0.96 0.97 0.95 
High Res. 
Rmerge (%) 
0.96 0.96 0.96 0.97 0.98 0.97 0.98 0.97 
Overall 
Rp.i.m. (%) 
0.95 0.91 0.96 0.97 0.96 0.97 0.96 0.95 
High Res. 
Rp.i.m. (%) 
0.96 0.97 0.96 0.97 0.94 0.96 0.97 0.97 
Overall 
I/σ(I) 
0.98 0.98 0.96 0.98 0.97 0.98 0.99 0.95 
High Res. 
I/σ(I) 
0.98 0.93 0.98 0.95 0.97 0.87 0.98 0.98 
High Res. 
Limit (Å) 
0.95 0.98 0.99 0.96 0.97 0.93 0.98 0.98 
Unit Cell 
Parameters 
(a=b=) 
0.99 0.95 0.95 0.95 0.98 0.98 0.99 0.87 
Unit Cell 
Parameters 
(c=) 
0.97 0.97 0.96 0.93 0.94 0.96 0.95 0.92 
Mosaicity 
(°) 
0.97 0.97 0.93 0.94 0.93 0.95 0.87 0.96 
Critical 
Value   
0.88 
(0.92) 
[0.93] 
0.88 
(0.92) 
[0.93] 
0.86 
(0.91) 
[0.92] 
0.86 
(0.91) 
[0.92] 
0.89 
(0.92) 
[0.94] 
0.89 
(0.92) 
[0.94] 
0.89 
(0.93) 
[0.94] 
0.89 
(0.92) 
[0.94] 
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Chapter 4 – Cancerous Inhibitor of 
Protein Phosphatase 2A, a Target for S-
SAD phasing 
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As discussed in previous chapters (1, 2 and 3), X-ray crystallography has developed 
considerably from its humble beginnings solving the structure of NaCl (Bragg and Bragg, 1913), and 
is now tackling more and more difficult targets. Thanks to improvements in data quality through 
more stable high brilliance synchrotron sources, improved phasing software and developments in 
detector technology (Rajendran et al., 2011b) there has been a resurgence in the use of S-SAD to 
solve the phase problem (Chapter 1). Cancerous Inhibitor of Protein phosphatase 2A (CIP2A) is a 
recently discovered oncoprotein prevalent in a wide number of cancers. Currently no structural data 
for CIP2A is available beyond sequence based secondary structure predictions. In the event of 
purification, crystallisation and data collection CIP2A has no homology models for phasing by 
molecular replacement, however, full length CIP2A has 37 sulphur atoms (21 Cys and 16 Met) 
making it a potential target for S-SAD phasing.  Full length CIP2A, and the N-terminal and C-terminal 
recombinant CIP2A proteins in this study have Bijvoet ratios of 0.33%, 0.38% and 0.22% at λ = 1.0 Å, 
all very difficult cases for S-SAD phasing. By increasing the wavelength to 2 Å, 3 Å or even 4 Å the 
bijvoet ratio increases by approximately 4.1, 8.0 and 12.8 fold, respectively, making successful 
phasing much more likely. This project aimed to express, purify and crystallise these recombinant 
protein fragments of CIP2A N- and C-terminal regions for use on the long wavelength X-ray 
crystallography beamline (I23) currently under development at Diamond Light Source.  
4.1. Cancer Biology 
Understanding and treating cancer remains one of the biggest challenges facing modern 
medicine. Tumourigenesis is a complex process requiring cells to be able to sustain proliferative 
signalling, evade growth suppression, resist cell death, enable replicative immortality, inducing 
angiogenesis and activate invasion and metastasis. These are usually referred to as the “hallmarks of 
cancer” (Fig. 4.1) (Hanahan and Weinberg, 2000). Since 2000 these hallmarks have been expanded 
to include the emerging ones of deregulating cellular energetics and avoiding immune destruction, 
as well as the cancer cell enabling characteristics of genome instability and mutation and tumour-
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promoting inflammation (Fig. 4.1) (Hanahan and Weinberg, 2011). The multistep process cells go 
through to acquire these hallmark capabilities, which may occur in any order each by a variety of 
mechanisms, illustrates the complexity that clinicians and health sector scientists are faced with 
when treating and researching new treatments for cancers. Examples of potential drugs to target 
individual hallmarks are shown in Figure 4.1, some of which have entered clinical trials with a select 
few approved for clinical use.  
 
Phosphoregulation of proteins is one of the most common mechanisms for regulating 
protein function and cell signalling, including cell growth, survival and differentiation (Westermarck 
and Hahn, 2008, Khanna et al., 2013, Ciccone et al., 2015). As a result, phosphorylation and 
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dephosphorylation are subject to tight controls by complementary switches in the form of kinases 
and phosphatases. Deregulation of this tightly controlled balance by upregulating protein kinases or 
down regulating protein phosphatases has been attributed to pathogenesis of a wide variety of 
human diseases, including various cancers (Westermarck and Hahn, 2008, Eifert and Powers, 2012, 
Perrotti and Neviani, 2013). Interestingly, it has been found that up regulation of kinase signalling via 
the RAS pathway cannot cause transformation without simultaneous inhibition of protein 
phosphatase 2A (PP2A) (Westermarck and Hahn, 2008, Perrotti et al., 2010). This points to PP2A 
reactivation as a potential therapy in conjunction with kinase inhibition (Westermarck and Hahn, 
2008, Perrotti and Neviani, 2013). A key factor in inhibition of PP2A is the overexpression of a 
recently discovered oncoprotein, cancerous inhibitor of protein phosphatase 2A (CIP2A).  
4.1.1. Cancerous Inhibitor of Protein Phosphatase 2A  
The protein “p90” was first discovered through association of “p90” auto-antibodies with 
p62, a  cytoplasmic RNA binding protein involved in regulation of IGF II mRNA expression (Soo Hoo et 
al., 2002), and later named CIP2A when identified as an endogenous PP2A-interacting protein 
(Junttila et al., 2007). Junttila et al also identified CIP2A as oncogenic PP2A inhibitor by its ability to 
replace small-t antigen in the transformation of p53 and Rb tumour suppressor deficient HEK cells. 
Since its discovery, CIP2A has been linked to a plethora of cancer processes including decreased cell 
viability, anchorage independent growth, progenitor cell self-renewal, protection from senescence 
induction, cell cycle regulation and mitosis (Khanna et al., 2013). More importantly, depletion of 
CIP2A with small interfering RNAs (siRNAs) in xenografted tumours has been shown to inhibit growth 
in various cancers (Junttila et al., 2007, Come et al., 2009, Xue et al., 2013) and hypomorphic CIP2A 
mice models are healthy and viable (Laine et al., 2013); although spermatogenesis is affected 
(Ventela et al., 2012).  
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CIP2A expression has been observed in a wide variety of cancers, both solid and 
haematological, including gastric, bladder, ovarian, tongue, hepatocellular, colon, non-small cell lung 
carcinoma and chronic myeloid leukaemia; with CIP2A overexpression found in 39-90% of patient 
samples (Khanna et al., 2013). In addition to being highly prevalent, CIP2A expression has been 
correlated with tumour grade (Come et al., 2009, Dong et al., 2011, Khanna et al., 2009, Xue et al., 
2013, Laine et al., 2013) and negative response to treatment (Laine et al., 2013, Bockelman et al., 
2011). CIP2A acts through several common signalling pathways including Myc, the EGFR-MEK-ETS1 
pathways, p53 inactivation and over expression of E2F1 and ATF2 (Fig. 4.4) (Khanna et al., 2013). 
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4.1.1.1. Myc, CIP2A and Cancer 
Myc is a transcription factor for the leucine zipper family that has been linked to cell cycle 
regulation, proliferation, growth, differentiation and metabolism; unsurprisingly, deregulation of 
Myc has been found to promote cell transformation and tumour progression (Junttila and 
Westermarck, 2008). Phosphorylation plays a key role in the regulation of Myc, with 
phosphorylation of Serine 62 (S62) by ERK stabilising Myc, and phosphorylation of Threonine 58 
(T58) by GSK-3β targeting Myc for degradation (Pulverer et al., 1994, Sears et al., 2000). However, 
degradation of Myc by ubiquitination is dependent on dephosphorylation of S62 by PP2A (Yeh et al., 
2004). Ergo, expression of CIP2A prevents PP2A from dephosphorylating Myc S62 leading to cell 
proliferation and transformation (Fig. 4.3) (Junttila and Westermarck, 2008). In addition to 
preventing Myc degradation, CIP2A has been found to promote expression of Myc which, in turn, 
stimulates CIP2A mRNA and protein expression to form a positive feedback loop (Kerosuo et al., 
2010, Mathiasen et al., 2012).  
4.1.1.2. E2F1, CIP2A and Cancer 
E2Fs are a family of transcription factors that can act as transcriptional activators (E2F1-3a) 
and transcriptional repressors (E2F3b/E2F4-8) (Putzer and Engelmann, 2013). E2F1 has been found 
to induce apoptosis, acting as an antitumourigenic fail-safe in a similar way to p53 (Putzer and 
Engelmann, 2013); although E2F1 can act by p53 dependent and independent mechanisms (Stanelle 
and Pützer, 2006). As a result E2F1 was championed as a predictive factor of radiosensitivity and 
chemosensitivity (Lee et al., 2008). However, it has since been found that increased E2F1 along with 
reduced retinoblastoma protein 1 can be associated with resistance to chemotherapy (Han et al., 
2003, Sharma et al., 2010). E2F1 and CIP2A act as part of an oncogenic positive feedback loop with 
E2F1 activating the CIP2A promoter and CIP2A preventing removal of a phosphate from Serine 364 
of E2F1 which may explain this (Laine et al., 2013). This leads to reduced activity of p53 and 
inhibition of senescence induction.  
 136 
 
 
4.1.1.3. Akt, CIP2A and Cancer 
Akt is a Serine/Threonine kinase from the AGC family with 3 isoforms (Akt1/PKBα, 
Akt2/PKBβ and Akt3/PKBγ). Akt recognises the motif R-X-R-X-X-S/T-B (Alessi et al., 1996), where X 
represents any amino acid and B is a bulky hydrophobic residue, to allow direct phosphorylation of 
various cellular targets involved in preventing apoptosis, promoting protein expression and 
regulating cellular metabolism (Wang et al., 2015). Cellular targets for activation and inhibition by 
Akt and the affected cellular processes are shown in Figure 4.4. Akt itself is activated through the 
PI3K pathway and is further regulated through dephophoprylation of threonine 308 and serine 473 
by PP2A to switch between being anti- and pro-apoptotic (Andrabi et al., 2007). Overexpression of 
CIP2A prevents dephosphorylation of these sites to promote cell survival.  
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4.1.2. CIP2A as a Drug Target 
Based on the evidence that transformation of cells requires the activation of kinases and 
suppression of PP2A, and the fact that PP2A itself is rarely mutated; targeting PP2A inhibitors 
presents a feasible option for cancer therapy (Khanna et al., 2013). The widespread influence of 
CIP2A on multiple pathways, as discussed above, and the evidence that mouse models with depleted 
CIP2A are healthy suggests CIP2A makes a good target for treating many cancers. How drugable 
CIP2A is remains unclear due to the lack of any structural data or evidence for enzymatic activity. 
Although the structure of CIP2A remains elusive, bioinformatics analysis has provided some insight 
into the possible structure and domain organisation. 
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4.1.3. Protein Phosphatase 2A  
The prevalence of CIP2A in cancer is thought to be the result of its interaction with PP2A 
(Junttila et al., 2007), an important regulator in a host of cellular processes. PP2A represents a family 
of heterotrimeric serine/threonine phosphatases responsible for a large proportion of 
serine/threonine phosphatase activity in eukaryotes (Millward et al., 1999). PP2A consists of a 36 
KDa catalytic subunit (PP2AC, Fig. 4.5 purple) and a 65 KDa structural subunit (PP2AA, Fig. 4.5 green), 
each of which have α and β isoforms (Aα, Aβ, Cα and Cβ), as well one of a variety of regulatory B 
subunits ranging from 50-135 KDa (Fig. 4.5 cyan) (Cohen, 1990, Cho and Xu, 2007). Figure 4.5 is 
pictured with the regulatory subunit B56γ1, a proposed tumour suppressor consisting of eight 
pseudo-HEAT repeats (Cho and Xu, 2007). The combination of different A, B and C subunit isoforms 
gives a total of 75 possible distinct PP2A holoenzymes which can affect activity as well as determine 
substrate and tissue specificity (Cegielska et al., 1994, Eichhorn et al., 2009).   
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PP2A regulates a large cohort of proteins involved in various cellular processes through 
direct or indirect interactions including β-catenin from the Wnt signalling pathway (Eichhorn et al., 
2009, Polakis, 2012), G1/S cyclins in cell cycle transition (McCourt et al., 2013), MEK and ERK of the 
MAPK/ERK pathway (Ciccone et al., 2015), AKT and GSK3β of the PI3K/AKT cascade (Andrabi et al., 
2007, Janssens et al., 2008) as well as inhibition of PIM1 and Jak2 which inhibit the pro-apoptotic 
molecule BAD (Aho et al., 2004, Samanta et al., 2009, Oaks et al., 2013). A summary of these direct 
and indirect interactions is shown in Figure 4.6. Although PP2A is involved in regulation of a wide 
variety of cellular pathways, generally a negative trait when considering drug targets due to a high 
potential for causing unwanted side effects, the subunit specificity gives scope for high tissue 
specificity PP2A-activating drugs (PADs) as viable therapeutics. Some examples include forkosil/1,9-
dideoxyforkosil (Neviani et al., 2005), Fingolimod (Kappos et al., 2010, Ingwersen et al., 2012) and 
OP449 (Agarwal et al., 2014). In addition to PADs, targeting inhibitors of PP2A also present possible 
drug targets. Of particular interest is the cancerous inhibitor of protein phosphatase 2A, which is the 
target of this study 
4.2. Methods  
Recombinant protein vectors were designed based on the initial bioinformatics work 
presented below, with two constructs produced encompassing the N-terminal residues 1-191, 
preceding the predicted transmembrane domain, and the C-terminal coiled coil domain (residues 
635-882). Vectors were transformed into E. coli cells and purification attempted with a variety of 
chromatographic techniques.  
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4.2.1. Bioinformatics 
The full length human CIP2A sequence was analysed with the basic local alignment search 
tool: protein (BLASTp) servers to find homologues and allow sequence alignment. The full length 
sequence was also with various secondary structure prediction servers including, InterProScan5 
(Jones et al., 2014), Motif scan, PSIPRED (McGuffin et al., 2000) and JPRED (Cole et al., 2008). 
Function and disorder predictions were carried out on the full length sequence with FFPRED (Buchan 
et al., 2010) and DISOPRED, respectively. Crystallisation propensity of the full length sequence, half 
of N-terminal region (residues 1-191) and the C-terminal half of the protein (residues 635-882) was 
also assessed with PPCpred (Mizianty and Kurgan, 2011) and XtalPred (Slabinski et al., 2007).  
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4.2.2. Vectors 
N and C terminal constructs for CIP2A were produced from residues 1-191 (CIP2A-N) and 
residues 635-882 (CIP2A-C). Sequences were cloned into pET-28 b (+) vectors between NdeI and 
XhoI restriction sites to produce a thrombin cleavable His6 tag at the N-terminus and a non-cleavable 
His6 tag at the C-terminus. Sequences were produced and cloned into pET-28 b (+) (Fig. 4.7) and 
Puc57 vectors by GenScript. 
4.2.3. Expression Trials  
CIP2A-N and CIP2A-C were transformed into Rosetta D2 and BL21 E. Coli cell in the 
presence of 30 μg/ml kanamycin by standard methods. Starter cultures were grown in 10 ml of LB 
broth with 30 μg/ml kanamycin at 37°C overnight. 100 ml of LB broth was inoculated with 1 ml of 
starter culture and grown at 37°C with shaking to an OD600 between 0.4-0.6; cells were then induced 
with 0.1 mM, 0.5 mM or 1.0 mM IPTG at 22°C. Pellets were harvested by centrifugation at 5000 rpm 
(Sorvall SLC6000 rotor) for 10 minutes at 4°C and resuspended in buffer A (0.1 M Tris-HCl pH 8.0, 0.5 
M NaCl, 20 mM Imidazole, 2% glycerol) plus 10 mM MgCl2, 10 μg/ml DNAse and 300 μg of lysozyme 
per gram of pellet. Cells were lysed by sonication in two cycles of 45 and 30 seconds and centrifuged 
for 15 minutes at 16,000 rpm (Sorvall SS34 rotor) at 4°C. Cells prior to induction and cleared lysate 
were loaded onto an SDS PAGE gel to assess expression levels.  
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4.2.4. Protein Purification 
Scaled up 1L LB cultures for CIP2A-N and CIP2A-C constructs were grown and harvested as 
detailed in the section above, with induction performed with 0.1 mM IPTG at 22°C. Clarified lysate 
was filtered with a 0.22 μm syringe filter and loaded onto a 5 ml Ni-NTA affinity column (GE 
Healthcare) pre-equilibrated in buffer A. Affinity chromatography was performed using an AKTA 
purifier (GE Healthcare) according to manufacturer’s instructions. The Ni-NTA column was washed 
 143 
 
with a linear gradient to 10 % buffer B (0.1 M Tris-HCl pH 8.0, 0.5 M NaCl, 1 mM TCEP, 20 mM 
Imidazole, 2% glycerol and 0.5 M imidazole) over one column volume (CV) followed by 5 CV of 10% 
buffer B. CIP2A-N and CIP2A-C were eluted with a linear gradient of increasing buffer B from 10-
100% over 6 CV. CIP2A-C fractions were pooled to a final volume of 6 ml and  3 ml was loaded onto 
either Superdex 75 16/60 or Superdex 200 10/300 gel filtration columns equilibrated in size 
exclusion chromatography (SEC) buffer (20 mM Tris-HCl, pH 8, 300 mM NaCl, 1mM TCEP).  
4.3. Results  
4.3.1. Bioinformatics  
4.3.1.1. BLASTp 
BLASTp of the full length human CIP2A sequence reveals no homologues to CIP2A other 
than CIP2A from other species and proteins of unknown function. CIP2A appears well conserved 
between species, as shown in Figure 4.A1, with the CIP2A sequence from chimpanzees, Rhesus 
macaques, white-tuffed-ear marmosets, black flying foxes, naked mole rats and mice being 99.4% 
conserved at best and 87.2% conserved at worst.  
4.3.1.2. PSIPRED, FFPred and DISOPRED  
PSIPRED analysis (McGuffin et al., 2000) predicts CIP2A to be completely helical, with 
possible disordered protein binding regions at the N and C-terminal ends of the sequence (Fig. 4.A2). 
A disordered region is also predicted between residues 551-596. FFPred corroborates the largely 
helical structure predicted by PSIPRED, but suggests the N-terminal region forms an ordered helical 
structure while the C-terminal helices are more disordered. A disordered coil is also predicted 
between residues 562-597, similar to PSIPRED (Fig. 4.A3). In addition to secondary structure 
predictions FFPRED identifies a number of potential phosphorylation sites (red boxes in Fig. 4. A3) 
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and glycosylation sites (green boxes in Fig. 4.A3). DISOPRED suggests a similar ordered N-terminal 
arrangement and disordered C-terminus.  
4.3.1.3. InterProScan5 and Motif Scan 
The secondary structure predictions reported above are in line with the domain prediction 
from InterProScan5 and Motif Scan predictions (Fig. 4.8). Domain analysis predicts armadillo 
domains in the N-terminal half of CIP2A (residues 48-309), three helix repeats which form an 
ordered right handed super helical tertiary structure (Conti and Kuriyan, 2000, Conti et al., 1998, 
Daniels et al., 2001). A leucine zipper (residues 331-352) and transmembrane region (residues 192-
212) are also predicted in and near the predicted armadillo repeats, respectively. Finally, a coiled coil 
region (residues 635 and 880) is predicted, which are regularly found to be intrinsically unstructured 
(Mason and Arndt, 2004, Chana et al., 2002) to facilitate the wide variety of protein-protein 
interactions and other functions associated with these domains (Burkhard et al., 2001). 
 
4.3.1.4. Crystallisation Prediction 
PPCpred predictions (Mizianty and Kurgan, 2011) for the full length CIP2A suggests a very 
high propensity for production, purification and crystallisation to fail, with probabilities of 62%, 52% 
and 84% respectively.  
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Predictions for two constructs of the coiled coil region of CIP2A, 636-833 and 619-890, 
both showed a lower propensity for failure in production, purification and crystallisation. However, 
the construct for residues 619-890 presented with a much higher propensity for crystallisation to fail 
(47%) compared to residues 635-882 (19%). These results were corroborated by XtalPred (Slabinski 
et al., 2007) which suggested both full length and coiled coil domain alone would be difficult cases 
based on the large regions of disorder.  
PPCpred analysis of the N-terminal sequence used to generate the model in Figure 4.9 
predicted a high probability of failure at protein production (51%), purification (55%) and 
crystallisation (42%). As with the C-terminal region, XtalPred predicted this N-terminal construct to 
be a difficult target. A shorter N-terminal construct (residues 1-191) was also tested based on 
predictions of a transmembrane domain at residues 192-212. The shorter N-terminal construct 
shows a much better propensity to protein production and crystallisation with failure predicted at 
35% and 24%, respectively. However, the chance of failure in purification was still very high at 66%. 
Again XtalPred predicted this to be a difficult target based on a high instability index. Despite a high 
prediction of failure CIP2A was pursued as a challenging target as it is a high value target which could 
be potentially very rewarding for future drug discovery. It should also be kept in mind that 
crystallisation prediction is largely based on previously solved structures and CIP2A has few 
homologues based on sequence and only a small number of secondary structure homologues for the 
N-terminal half of the protein.  
4.3.1.5. Structure and Function Prediction  
Building on earlier bioinformatics work in the Molecular Biophysics Group at the University 
of Liverpool by third year hons student Sam Pringle, new insights into the predicted structure and 
function of CIP2A have been obtained. 
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BLASTp (Altschul et al., 1990) of full length CIP2A produces various coiled coil structures 
relating to residues 500-905 of CIP2A (CIP2A-CT), the N-terminal half (1-500) however, produces no 
homologous sequences. The presence of a C-terminal coiled coil was confirmed by MultiCoil2 (Trigg 
et al., 2011)  and logiCoil (Vincent et al., 2013), with three potential dimeric coiled coil regions. As 
with many coiled coil domains CIP2A-CT was predicted to be intrinsically unstructured by IUpred 
(Dosztanyi et al., 2005), which also predicted four possible ligand binding sites. In addition to being 
intrinsically unstructured CIP2A-CT is predicted to have a high propensity for self-aggregation, as 
judged by AmylPred2 (Tsolis et al., 2013). These properties may explain the difficulties faced during 
purification, as discussed later.  
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Although the N-terminal domain showed no sequence identity to other proteins during 
BLASTp searches, analysis with HHpred (Hildebrand et al., 2009) found secondary structure 
homologues for residues 40-420. These included the importin α-1 subunit (98.3%), catenin β-1 
(98.1%) and karyopherin β2 (95.7%); despite a sequence homology of ≤ 20% at best. All secondary 
structure homologues have Armadillo (Arm) repeats, three helix repeats that form right handed 
super-helical structures (Coates, 2003, Huber et al., 1997), usually involved in protein-protein 
interactions (Conti and Kuriyan, 2000, Conti et al., 1998, Daniels et al., 2001). InterProScan5 (Jones 
et al., 2014) corroborated the presence of potential Arm repeats between residues 50-420 of CIP2A. 
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A model of N-terminal CIP2A (CIP2A-NT) was generated from secondary structure 
homologues (PDB codes: 4HXT, 4B8J, 4EV8, 4FDD, 43GA and 2OF3) using protein threading with 
HHpred modeller (Fig. 4.9) (Hildebrand et al., 2009, Söding et al., 2005) . CIP2A-NT was validated by 
VERIFY3D (Eisenberg et al., 1997), QMEAN6 (Benkert et al., 2011) and Ramachandran plots (Lovell et 
al., 2003), and assessed for conserved structural elements with ConSurf (Goldenberg et al., 2009). Six 
homologous structures were found for CIP2A-NT, four of which were bound to nuclear localisation 
sequences (NLS). Superposition of Karyopherin α bound to the c-Myc NLS peptide (Conti and 
Kuriyan, 2000) and adenomatous polyposis coli (APC) bound to the Sam68 NLS peptide (Morishita et 
al., 2011) with CIP2A-NT showed binding relative to CIP2A-NT’s highly conserved central region  (Fig. 
4.10a-b). Homology with Karyopherin α bound to the c-Myc NLS peptide is particularly interesting as 
CIP2A is known to interact directly with c-Myc (Junttila et al., 2007).  
4.3.2. Expression Trials  
Expression trials for CIP2A-N and CIP2A-C showed clear over expression in Rosetta D2 (Fig. 
4.19) and in BL21 cells (data not shown). Solubilised whole cells in lanes 2 and 7 of Figure 4.11 for 
CIP2A-C and CIP2A-N respectively, show very little leakage of the plasmid before induction, with a 
clear increase in expression following induction at ~ 22 kDa for CIP2A-N and ~ 35 kDa for CIP2A-C, in 
line with the predicted molecular weights based on sequence (21 kDa and 30.7 kDa, respectively). 
Increasing the concentration of IPTG on both constructs appears to have little effect on the overall 
levels of expression.  
 149 
 
 
4.3.3. Protein Purification  
Purification of CIP2A-N by nickel affinity chrmoatography gave a large peak of 350 mAU 
during the wash with 10% buffer B (Fig. 4.13a), which consisted largely of impurities and some 
CIP2A-N protein as seen in lane 3 of Figure 4.12. This intial larger peak is followed by two smaller 
peaks, labelled peak two and three in Figure 4.13. Peak two elutes at around 225 mM imidazole with 
a more prominent band around 22 KDa with many impurities (Fig. 4.12, lane 4). Peak three elutes 
around 300 mM imidazole with very high purity CIP2A-N (Fig. 4.12, lane 3), however the absorbance 
of 150 mAU over ~ 6 ml gives only 1 mg of almost pure protein from 6 litres of cells. Repeats of 
CIP2A-N protein production with increased IPTG concentration on induction saw the formation of 
inclusion bodies and significantly reduced yield (data not shown). 
CIP2A-C nickel affinity chromatography gave a single large peak of 1100 mAU spread over 
160-500 mM imidazole, with maximum absorbance around 300 mM imidazole (Fig. 4.13b). SDS-
PAGE of samples from the peak show a large number of impurities in the left hand side and centre of 
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the peak (Fig. 4.12, lanes 7-8) with more pure CIP2A-C on the right hand side of the peak (Fig. 4.12, 
Lane 9).  
 
Dialysis of CIP2A-N and CIP2A-C to remove excess imidazole for gel filtration caused both 
proteins to crash out of solution. Addition of 1-3 mM DTT to CIP2A-C prevented precipitation during 
dialysis as shown in Figure 4.14, where samples of CIP2A-C post dialysis (lanes 3-5) and post 
centrifugation to remove any precipitate (lane 6-8) show no difference in the SDS-PAGE profile. 
However, addition of DTT to binding buffer caused nickel to leach from the column so it was 
replaced with TCEP in the final binding buffer. Addtion of DTT and TCEP to CIP2A-N had no effect on 
precipitation during dialysis, however, buffer exchange by concentration proved more effective, but 
still presented with some loss of protein. Reduction in CIP2A-N was too severe to continue but 
enough CIP2A-C remained for gel filtration. Pooled CIP2A-C eluates ran down a Superdex 75 16/60 
and Superdex 200 10/300 gel filtration columns both eluted in the void volume (Fig. 4.16a and b, 
 151 
 
respectively), suggesting aggregation of CIP2A-C with itself and the other impurities seen in SDS-
PAGE analysis (Fig. 4.15). 
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 4.4. Discussion  
4.4.1. Bioinformatics, Expression Trails and Purification  
Expression of both CIP2A-N and CIP2A-C constructs in E. coli cells was successful, although 
initial expression of CIP2A-N was low and attempts to increase yield saw the formation of inclusion 
 154 
 
bodies and a further reduction in yield. CIP2A-C purification was more successful in terms of yield 
but purity was poor following Ni-affinity purification with a tendency for protein to aggregate in 
preparation for and during gel filtration. Recloning CIP2A-C into a vector with a single cleavable his 
tag may allow elution over a narrower imidazole concentration and improve purity, as well as 
permitting a second round of Ni-affinity purification following tag cleavage. Alternatively addition of 
a solubility tag such as small ubiquitin-related modifier (SUMO), glutathione S-transferase (GST) or 
maltose-binding protein (MBP) may help prevent aggregation during purification (Walls and 
Loughran, 2011). The large number of post translational modifications identified by FFPRED may also 
indicates a need for expression in mammalian or insect cells to allow proper folding.   
In light of more in-depth bioinformatics analysis following initial attempts at purification, a 
redesign of the N-terminal construct to encompass the entire armadillo repeat may be beneficial. 
However, the high self-aggregation propensity of the N-terminal domain predicted by AmylPred2 
suggests this domain may still prove a difficult case for expression, purification and crystallisation. As 
with CIP2A-C, the large number of phosphorylation and glycosylation sites predicted by FFPRED may 
contribute to the aggregation of the N-terminal construct. Recloning into mammalian or insect cell 
vectors may be beneficial in preventing aggregation and improving the yield of protein by allowing 
post translational modifications for more effective folding. However, all structural homologues of 
the full length N-terminal region identified via ConSurf (Goldenberg et al., 2009) were expressed and 
purified using E. Coli cells (Ishiyama et al., 2010, Chang et al., 2012, Chang et al., 2014, Conti and 
Kuriyan, 2000); so expression in insect or mammalian cells may not be necessary with the full Arm-
domain.  
4.5. Conclusions  
CIP2A was identified as both a biologically and medically important target for future drug 
discovery approaches and also as a suitable difficult and challenging candidate for eventual sulphur 
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phasing experiments on I23. However, expression and purification to the levels required for 
crystallisation proved too challenging during the time scale of this thesis. Clearly, it is necessary that 
considerable time is allocated to improving yield and purity as well as to examining alternative 
molecular biology approaches to those taken here. Work on producing and crystallising full length 
CIP2A is continuing within the Molecular Biophysics Group in partnership with Prof. Richard Clark 
from the Institute of Translational Medicine at the University of Liverpool.  
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4.6. Appendix  
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Chapter 5 – Achromobacter xylosoxidans 
Targets for S-SAD phasing 
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5.1. Introduction  
In parallel with the unsuccessful attempts to purify and crystallise fragments of CIP2A for 
phasing experiments on I23 at Diamond Light Source (Chapter 5), a set of more easily attainable and, 
according to a review of the relevant literature, more soluble bacterial proteins were selected from 
the Achromobacter xylosoxidans (Ax) genome (unpublished data from Hasnain group at Liverpool) 
for expression, purification and crystallisation. Two protein targets were finally selected from a 
group of sixteen Ax proteins, initially selected on the basis of the ease of crystallisation, as judged by 
the number of homologues present in the PDB, and by the sulphur content of the protein; the aim 
being to provde relatively simple and difficult phasing cases for experiments using I23. The proteins 
selected were UTP-glucose-1-phosphate uridyltransferase (AxUDT) and α/β hydrolase (AxABH). In 
addition to this, A. xylosoxidans is an opportunistic pathogen known to infect cyctic fibrosis sufferers 
(Cystic Fibrosis Foundation Patient Registry. Annual Data Report 2013. Cystic Fibrosis foundation, 
Bethesda, MD) and silencing of the equivalent genes encoding AxUDT and AxABH in P. eruginosa 
were found to be essential to the survival of the bacteria (Winstanley et al., 2009); making both 
proteins potential targets for structure based drug design.  
AxUDT, also known as a UDP-glucose phosphorylase or UGPase, catalyses the addition of a 
UTP molecule to glucose-1-phosphate to produce UDP-glucose, a key component in the synthesis of 
glycogen (Alonso et al., 1995) for the production of glycolipids, glycoproteins and proteoglycans 
(Thoden and Holden, 2007). UGPases play an essential role in both prokaryotic and eukaryotic 
organisms but carry out the same reaction using completely unrelated proteins in terms of sequence 
and 3D-structure (Mollerach and Garcia, 2000, Mollerach et al., 1998). Owing to their role in the 
production of various virulence factors, UGPases have become important drug targets for use 
against Gram-negative bacteria such as Escherichia coli and Streptococcus pneumoniae (Genevaux et 
al., 1999, Bonofiglio et al., 2005). AxUDT is a 276 residue 30 kDa protein with 10 sulphur atoms 
(three cysteines and seven methionines), giving a Bijvoet ratio of 0.32% at λ = 1 Å, 1.23% at λ = 2 Å, 
 161 
 
2.47% at λ = 3 Å and 3.97% at λ = 4 Å, assuming one molecule in the asymmetric unit . Based on the 
Wang limit of 0.6% (Yao et al., 2005) this should be a relatively straightforward case for sulphur 
phasing at ‘standard’ beamline wavelengths.   
AxABH is a member of one of the largest groups of structurally related enzymes which 
conveys an impressive cross-section of catalytic functions including but not limited to 
acetylcholinesterases, dienelactone hydrolases, lipases, thioesterases, serine carboxypeptidases, 
proline iminopeptidases, proline oligopeptidases, haloalkane dehalogenases, haloperoxidases, 
epoxide hydrolases, and hydroxynitrile lyases (Holmquist, 2000). α/β hydrolases have a well 
conserved fold of 8 to 11 parallel β-sheets flanked by α-helices, which houses the conserved catalytic 
triad (Nucelophile-Histidine-Acid) for hydrolysis as shown in Figure 5.1 (Marchot and Chatonnet, 
2012). Additional highly variable motifs decorate the conserved α/β fold to form the active site and 
convey the wide variety of enzymatic functions. The exact enzymatic activity of AxABH is currently 
unknown. AxABH is a 311 residue 34.5 kDa protein with three sulphur atoms (three methionines, no 
disulphide bridges), giving a Bijvoet ratio of 0.16% at 1 λ = 1 Å, 0.62% at λ = 2 Å, 1.29% at λ = 3 Å and 
2.06% at λ = 4 Å, assuming one molecule in the asymmetric unit . This is likely to be a very difficult 
case for S-SAD phasing using the wavelengths attainable at standard MX beamlines but represents a 
good test for S-SAD experiments at the long wavelengths expected for I23. 
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Both proteins were successfully expressed in E. coli, purified and crystallised. The 
crystallisation conditions were optimised in an attempt to produce high symmetry crystals, allowing 
for high redundancy anomalous data to be collected with minimal effects from radiation damage. 
This resulted in several crystal forms being available for study. However, owing to technical 
difficulties in the development of the I23 experimental end station, the anticipated long wavelength 
diffraction data for AxUDT and AxABH crystals could not be collected. As a result phasing attempts 
were performed on AxABH and AxUDT using molecular replacement and S-SAD and heavy atom 
soaking, respectively. After multiple phasing attempts involving several experiments, the structure of 
AxUDT remained unsolved. AxABH was successfully phased by molecular replacement for several 
crystal forms, which have been studied in an attempt to reveal details of the hydrolytic process it 
catalyses.  
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5.2. Methods  
5.2.1. Cloning, Expression and Purification  
The Sequences for Achromobacter xylosoxidans UTP-glucose-1-phosphate uridyltransferase 
(AxUDT) and α/β hydrolase (AxABH) were cloned into pET47b(+) (Fig. 5.2) between BamHI and 
HindIII to generate an N-terminal 3C protease cleavable His6 tagged protein. Both plasmids were 
made by Genscript. Plasmids were transformed into BL21 E. coli cells in the presence of 30 mg/ml 
kanamycin. Small scale expression trials in 100 ml of LB media were performed with whole cells and 
cleared lysate ran on an SDS PAGE to assess expression levels. Expression was then scaled up to 2 
litre cultures. Cultures were grown to an OD600 of 0.4-0.6 at 37°C and induced with 0.15 mM IPTG at 
18°C for 16 hours. Cultures were spun at 5000 RPM (Sorvall SLC6000) for 10 minutes at 4°C and 
resuspended in buffer A (0.1 M Tris-HCl pH 8, 0.5 M NaCl, 1 mM TCEP and 20 mM imidazole) plus 10 
mM MgCl2, 10 μg/ml DNAse and 300 μg of lysozyme per gram of pellet. Cells were lysed by 
sonication in two cycles of 45 and 30 seconds and clarified by centrifugation at 16,000 rpm at 4°C for 
15 minutes (Sorvall SS34 rotor). Cleared lysate was loaded onto a Ni-NTA affinity column 
prequilibrated in buffer A with protein eluted over a liner 0.05-0.5 M imidazole gradient following a 
10 ml wash with 0.05 mM imidazole on an AKTA purifier (GE Healthcare). The N-terminal His6 tag 
was cleaved overnight at 4°C with 3C protease during dialysis against 30 mM imidazole, 20 mM Tris-
HCl pH 8, 0.5 M NaCl and 1 mM TCEP. The cleaved tag and other impurities were removed by a 
second round of Ni affinity chromatography. Untagged AxUDT and AxABH containing fractions, as 
judged by absorbance at 280 nm, were pooled to a final volume of ~ 6 ml and filtered with a 0.22 µm 
syringe filter before loading onto a Superdex 200 16/60 gel filtration column prequillibrated in size 
exclusion chromatography (SEC) buffer (20 mM Tris-HCl, pH 8, 300 mM NaCl, 1mM TCEP) and eluted 
over one column volume.  
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5.2.2. Crystallisation 
Purified AxUDT and AxABH were concentrated to 15-20 mg/ml as quantified by absorbance 
at 280 nm for all crystallisation experiments. Initial crystal trials were set up using the sitting drop 
vapour diffusion method with a Cartesian crystal robot in 200 nL drops consisting of protein and 
reservoir solution from Wizard I + II, Wizard III + IV, JCSG-plus HT-96, Morpheus, PEG/ION, and Index 
HT commercial crystallisation screens at a ratio of 1:1. Trays were incubated at 4°C and 18°C.  
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5.2.2.1. UTP-glucose-1-phosphate Uridyltransferase 
Initial hits for AxUDT were found in Index HT A3/A5/G11 conditions (0.1 M BIS-Tris pH 5.5 
and 2.0 M ammonium sulphate/ 0.1 M Hepes pH 7.5 and 2.0 M Ammonium sulphate/ 0.2 m MgCl, 
0.1 M BIs-Tris pH 6.5 and 25% (w/v) PEG 3350) at 18°C, 4°C and 4°C, respectively. Index HT condition 
G11 was optimised using a Hamilton Star Lab liquid Handler to produce precipitant gradients (22-
28% w/v PEG 3350) and pH screens (0.1 M BIS-Tris pH 6-7). Crystals were grown at 4°C in 500 nL 
sitting drops with protein concentrations between 5-15 mg/ml set up using a TPP mosquito LCP 
crystallisation robot. Long rod shaped crystals appeared after several days with the best crystals 
growing in 0.2 M MgCl2, 24% (w/v) PEG 3350 and 0.1 M BIS-Tris pH 6.5 (Fig. 5.3).  
5.2.2.2. α/β Hydrolase  
 Initial hits for AxABH were found in several screen conditions with 25% PEG 3350 in the 
presence of different divalent metals including 0.2 M magnesium chloride, 0.2 M calcium acetate 
and 0.2 M calcium chloride; as well as in the presence of 0.2 M lithium sulphate. A large hexagonal 
rod also grew in 0.1 M BIS-Tris pH 6.5, 2% Tacsimate and 20% PEG 3350 which required no further 
optimisation. Crystals in PEG with divalent metals were set up as described for AxUDT with an 
increasing PEG 3350 gradient (15%-26%) in the presence of different metals (0.2 M CaCl2, 0.2 M 
LiSO4 , 0.2 M MgCl2 or 0.2 M NaCl) and buffers (0.1 M BIS-Tris pH 5.5-6.5). The best crystals were 
produced around 17% PEG 3350 with different metals giving different crystal forms. Tacsimate 
conditions were optimised to reproduce the long hexagonal crystals with an increasing PEG 3350 
gradient (10-30%) and pH screens (0.1 M BIS-Tris pH 5.5-6.5) with 2% tacsimate. An alternative 
optimisation with 20% PEG 3350 and an increasing tacsimate gradient (0-25%) and a pH screen (0.1 
M BIS-Tris pH5.5-6.5) was also conducted.  
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5.2.3. Data Collection  
5.2.3.1. UTP-glucose-1-phosphate Uridyltransferase 
Single crystal diffraction data from AxUDT crystals were collected for molecular 
replacement at 100 K on beamline I24 at Diamond Light Source, UK. S-SAD data were collected at λ = 
2 Å on beamline I03 from multiple AxUDT crystals using inverse beam data collection over 360° with 
10° wedges. Heavy atom soaks were also performed on AxUDT crystals by transferring crystals into 
crystallisation buffer in the presence of heavy atoms (10 mM Gd, PtCn, PtCl, HgT, W or Au) overnight 
at 4°C. Inverse beam data were collected over 360° with 10° sweeps at the appropriate heavy atom 
absorption edges. Multiple datasets were collected from single crystals. Data collection parameters 
for all AxUDT crystals are presented in table 5.1. All AxUDT crystals were cryoprotected by 
minimising surrounding solvent around the crystal when cooling (Pellegrini et al., 2011).  
Table 5.1: AxUDT data collection parameters.  
 
 
 
Crystal AxUDT 
MR1 
AxUDT 
MR2 
AxUDT  
S-SAD 
AxUDT 
PtCn 
AxUDT 
HgT 
AxUDT 
W 
AxUDT 
Au 
Wavelength (Å) 0.9860 0.9860 2.0 1.0703 1.0077 1.2123 1.0385 
Beamline I24 I24 I03 I04 I04 I04 I04 
Beam Size (μm) 10 x 10 10 x 10 50 x 20 20 x 20 20 x 20 20 x 20 20 x 20 
Maximum Resolution* (Å) 1.5 1.7 3.0 2.1 2.1 2.1 2.1 
Total Angular Range (°) 160 150 360 360 360 360 360 
Inverse Beam Wedge (°) N/A N/A 10 10 10 10 10 
Oscillation (°) 0.10 0.15 0.10 0.10 0.10 0.10 0.10 
Exposure time per frame (s) 0.10 0.15 0.10 0.10 0.10 0.10 0.10 
Transmission (%) 19 25 10 100 15 20 20 
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5.2.3.2. α/β Hydrolase  
Single crystal diffraction data for different crystal forms of AxABH were collected at 100 K 
over multiple visits on beamlines I02 and I04-1 at Diamond Light Source, UK. AxABH crystals grown 
in tacsimate and lithium sulphate were cryo-protected by briefly soaking crystal in crystallisation 
buffer with 25% (v/v) ethylene glycol. AxABH crystals grown in calcium chloride, calcium acetate and 
magnesium chloride were cryo-protected by minimising surrounding solvent around the crystal 
when cooling. Data collection parameters for all AxABH crystals can be found in Table 5.2.  
Table 5.2: AxABH data collection parameters. 
 
5.2.4. Structure Solution and Refinement  
5.2.4.1. UTP-glucose-1-phosphate Uridyltransferase 
Molecular replacement was performed using Phaser (McCoy et al., 2007) and Molrep 
(Vagin and Teplyakov, 2010a) with various sequence and secondary structure homologues and using 
the automated molecular replacement pipeline MrBUMP (Keegan and Winn, 2007, Keegan and 
Winn, 2008). S-SAD and heavy atom soaked data were processed using XDS (Kabsch, 2010b) with 
Crystal AxABH  
CaCl2-1 
AxABH  
CaCl2-2  
AxABH  
LiSO4 
AxABH  
MgCl2 
AxABH  
Tac 
Wavelength (Å) 0.9795 0.9200 0.9800 0.9795 0.9200 
Beamline I02 I04-1 I02 I02 I04-1 
Beam Size (μm) 82 x 21 60 x 50 20 x 20 82 x 21 60 x 50 
Maximum Resolution* (Å) 1.6 1.7 1.5 2.0 1.6 
Total Angular Range (°) 160 250 140 170 120 
Oscillation (°) 0.10 0.10 0.10 0.10 0.10 
Exposure time per frame (s) 0.10 0.10 0.10 0.10 0.10 
Transmission (%) 30 11 30 10 17 
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data scaled together using XSCALE and merged with AIMLESS (Evans and Murshudov, 2013) to assess 
the presence of anomalous signal.  
5.2.4.2. α/β Hydrolase  
Diffraction data for all crystal forms were processed with the Xia2 3daii pipeline at 
Diamond light source (Kabsch, 2010b, Winter et al., 2013). All structures were solved by molecular 
replacement with Molrep (Vagin and Teplyakov, 2010a). AxABH-Li was solved using chain A of a 
putative lipase from Acinetobacter brumannii (PDB code: 4OPM, swquence identity 25%) and the 
model built with Buccaneer (Cowtan, 2012) using the Molrep molecular replacement model as the 
PDB input. Further refinement of the structures was performed with REFMAC5 (Murshudov et al., 
2011), with model building carried out in COOT (Emsley et al., 2010). Model validation was 
performed using Molprobity (Chen et al., 2010). AxABH-Ca1, AxABH-Ca2, AxABH-Mg and AxABH-Tac 
were solved using the refined AxABH-Li structure as the search model. Figures of all structures were 
prepared with PyMol version 1.3r1 (The PyMOL Molecular Graphics System, Version 1.7.4 
Schrödinger, LLC).  
5.3. Results  
5.3.1. Expression and Purification  
Expression trials of both AxUDT and AxABH showed high levels of expression in BL21 E. coli 
at molecular weights around 34 KDa and 39 KDa, respectively (Fig. 5.3). Purification of both proteins 
was relatively straightforward. 
5.3.1.1. UTP-glucose-1-phosphate Uridyltransferase 
His tagged AxUDT was eluted from the Ni NTA column at high purity (Fig. 5.4) with the 
majority of impurities removed in the initial wash to produce a single well defined peak at 280 nm. 
Final impurities were removed to give near 100% purity after cleavage of the His tag and gel 
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filtration (Fig. 5.5) to give approximately 8 mg of protein as judged by absorbance at 280 nm. Gel 
filtration showed a single symmetrical peak suggesting AxUDT exists in solution as a monomer (Fig. 
5.6).  
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5.3.1.2. α/β Hydrolase  
Initial Ni affinity purification of AxABH showed some impurities but an overwhelming 
majority of the protein present was AxABH (Fig. 5.7, lanes 4-6). Most impurities were removed 
following the second round of Ni affinity purification (Fig. 5.7, lane 9) and near 100% pure AxABH 
after gel filtration (Fig. 5.7, lane 10) to give 25 mg of protein as judged by absorbance at 280 nm. A 
single broad symmetrical peak from gel filtration suggests AxABH exists as a monomer in solution 
(Fig. 5.8).  
 
 
 
 172 
 
 
5.3.2. Crystallisation  
5.3.2.1. UTP-glucose-1-phosphate Uridyltransferase 
Initial crystal hits for AxUDT grew primarily as thin rod shaped crystals with some frayed 
tree shaped crystals as shown in Figure 5.9. Other showers of crystals were observed but not 
optimised. Ammonium sulphate and PEG 3350 conditions (Fig. 5.9a-b and 5.9c, respectively) 
outlined earlier were optimised, with the PEG 3350 condition giving reproducible long rod shaped 
crystals around 24% PEG 3350 (Fig. 5.9c). 
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5.3.2.2. α/β Hydrolase  
Several crystal forms were produced in optimised PEG 3350 conditions with varying 
divalent metals and lithium sulphate (Fig. 5.10a-c) which proved relatively reproducible. The long 
hexagonal crystal from initial screening (Fig. 5.10d) proved more difficult to reproduce with scaled 
up drop sizes failing to reproduce the same crystal form. Other crystals similar to those observed in 
the PEG 3350/divalent/lithium conditions were observed but never another large hexagonal rod.  
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5.3.3. Structure Solution and Refinement  
5.3.3.1 UTP-glucose-1-phosphate Uridyltransferase 
Despite a high level of sequence identity (49%: 3JUJ) AxUDT could not be phased by 
molecular replacement with all homology models tried using Molrep or Phaser. Models with high 
secondary structure homology from HHpred (Soding et al., 2005) also failed to produce a sensible 
rotation and translation function. Models were trimmed manually to remove flexible loops and leave 
the conserved core based on alignment of multiple homology models, but still failed to produce any 
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contrast in the molecular replacement solutions. Molecular replacement models generated with 
CHAINSAW (Stein, 2008) and MrBUMP (Keegan and Winn, 2008) also failed to produce a sensible 
solution. Analysis of the solvent content shows AxUDT-MR1 and AxUDT-MR2 to have between 8-10 
molecules in the asymmetric unit which may explain the difficulty of finding a sensible solution by 
molecular replacement. Processing determined the spacegroup as P21 with a unit cell of a = 80.2, b = 
89.5 and c = 179.0 with α = 90 β = 100.1 and γ = 90. Closer inspection of AxUDT-MR1 also showed 
the presence of multiple crystal lattices which could account for further difficulty in finding a 
solution.  
S-SAD data were collected on nine AxUDT crystals at 2 Å wavelength. Of the nine crystals 
two showed multiple lattices in the diffraction pattern, two suffered severe radiation damage within 
a few hundred images (multiplicity ~ 0.5 and completeness ~ 21%) and one showed little to no 
diffraction. Shorter exposure times and reduced transmission should be considered to reduce 
radiation damage if the diffraction experiment is repeated. Multiple datasets were collected from 
the four remaining crystals but no discernible anomalous signal was observed in individual datasets, 
with an anomalous slope between 0.85-1.10 and anomalous completeness between 50-85%. The 
low anomalous completeness is likely to be due to the low symmetry space group (C2/P2) and the 
low anomalous multiplicity (~1.4). Scaling multiple datasets from the same crystal in all possible 
combinations with XSCALE to increase anomalous completeness showed no improvement in the 
anomalous slope and SHELX failed to identify the anomalous substructure. Combining the data from 
multiple crystals was not attempted as indexing solutions for different crystals gave significantly 
different solutions (Table 5.A1). Although AxUDT crystals were not in an optimum space group (P2, 
C2 or P1) to allow high multiplicity anomalous data to be collected the inability to generate 
significant anomalous signal when combining several datasets demonstrated the limitations of S-SAD 
phasing on standard MX beamlines (Doutch et al., 2012) and the need for a specialised beamline 
such as I23.  
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Heavy atom soaking also failed to produce a solution. Of the soaks attempted PtCn, HgT, W 
and Au soaked crystals produced diffraction, however, all but W soaked crystals showed weak 
diffraction to ≤ 4 Å and failed to process. Inverse beam datasets for each heavy atom soak were 
scaled with XSCALE (Kabsch, 2010b) but showed no detectable anomalous signal. Multiple datasets 
from the same crystal were scaled together using XSCALE in all possible combinations but data 
proved non-isomorphous and detrimental to measuring any anomalous signal. Data were 
reprocessed with XDS (Kabsch, 2010b) with fewer frames to reduce the effects of radiation damage 
but showed no improvement in anomalous signal.    
5.3.3.2. α/β Hydrolase  
High to medium resolution structures of AxABH in the presence of lithium, magnesium, 
tacsimate and two crystals forms with calcium were obtained at 1.81 Å, 2.0 Å, 1.76 Å, 2.12 Å and 
1.72 Å resolution respectively. Data processing, refinement and validation statistics for all structures 
are presented in Table 5.3. AxABH shows the typical α/β hydrolase fold with a twisted eight stranded 
β-sheet flanked by several α-helices (Fig. 5.11b, coloured blue). After β-sheet six AxABH has a five 
helix domain (α4-8) constituting an additional domain of unknown function (DUF). The DUF consist 
of a parallel helix turn helix motif made up of α4 and α5 (HTH1) followed by a second longer parallel 
helix turn helix motif from α6 and α7 (HTH2) and finally a single long α-helix (α8) spanning 28 
residues which passes behind HTH1 (Fig. 5.11b, coloured orange). This DUF forms a hydrophobic 
pocket, presumably the active site, which brings the substrate into the vicinity of the catalytic 
Nucleophile-His-Acid triad formed by the conserved α/β hydrolase fold (Marchot and Chatonnet, 
2012). The active site was determined based on the presence of a bound ligand which appears to be 
2,2-Bis(hydroxymethyl)-2,2’,2”- nitrilotriethanol (BIS-tris) from the crystallisation condition based on 
the shape of the difference density (Fig. 5.12a-b). LigPlot+ generated an active site consisting of 
Tyr59, Asp127, Tyr128, Gly162, Pro165, Phe184, Leu229, Tyr232, Phe263 and Phe264 (Fig. 5.12c). 
However, AxABH doesn’t conform to the conserved catalytic triad with a phenylalanine (Phe264) in 
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the acid position and an aspartate (Asp127) in the nucleophilic position (Fig. 5.12a-b, coloured cyan 
and green, respectively). The highly conserved histidine residue is present (Fig. 5.12a-b, coloured 
red). This suggests AxABH may be an inactive hydrolase.  
Table 5.3: Crystallization, crystallographic data collection and structure refinement statistics for AxABH. 
Values in parentheses refer to the highest resolution bin. 
Structure  AxABH-Li AxABH-Ca1 AxABH-Ca2 AxABH-Mg AxABH-Tac 
Data Collection      
Space Group  C2 P21 P21 P21 P212121 
Cell Axes (Å) 99.06 x 78.42 
x 46.27 
46.13 x 81.74 
x 157.50 
91.09 x 83.22 x 
134.20 
58.43 x 168.49 
x 69.62 
81.13 x 94.75 
x 170.00 
Angles (°) 90.00 x 106.64 
x 90.00 
90.00 x 96.11 
x 90.00 
90.00 x 106.94 
x 90.00 
90.00 x 102.19 
x 90.00  
90 x 90 x 90 
Wavelength (Å) 0.9795 0.9795 0.9200 0.9795 0.9200 
Resolution (Å) 39.33-1.81 56.54-2.12 60.83-1.72 68.05-2.00 58.69-1.76 
Unique Reflections (#) 28570    
(2091) 
60340   
(3691) 
194851  
(14750) 
87387     
(6402) 
129182 
(9384) 
Redundancy 2.7 (2.6) 2.5 (2.8) 4.8 (4.7) 3.4 (3.3) 3.9 (4.5) 
Rpim (%) 5.9 (47.8) 4.3 (39.5) 4.2 (34.6) 5.8 (32.4) 3.6 (38.7) 
I/σ(I)  10.2 (1.9) 13.1 (2.1) 13.6 (2.3)  8.7 (2.4) 16.5 (2.0) 
Completeness (%) 97.3 (96.0) 91.1 (75.4) 98.7 (95.9) 98.4 (98.8) 98.4 (99.3) 
CC1/2 0.995 (0.691) 0.997 (0.768) 0.997 (0.730) 0.998 (0.853) 0.999 (0.734) 
Refinement       
Molecules/AU 1 4 6 4 4 
Rwork/Rfree (%) 19.7/24.0 21.6/27.4 22.2/25.3 20.2/25.0 20.6/24.7 
Rmsd Bond Length (Å) 0.017 0.015 0.020 0.015 0.018 
Rmsd Bond Angles (°) 1.772 1.719 1.963 1.712 1.833 
Average  B factor (Å2)  30.8 41.2 19.4  34.4 29.4 
Solvent Content (%) 51.5 43.4 48.5 50.1 48.8 
Ramachandran 
Statistics (%) 
     
Favoured Regions  97.26 95.49 98.20 96.35 96.90 
Allowed Regions  2.40 4.42 0.74 3.65 2.93 
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5.4. Discussion  
5.4.1. AxABH Crystal Forms  
Crystals from optimisation of AxABH with different divalent metals produced four different crystal 
forms, (1) space group C2 with one molecule in the asymmetric unit in the presence of lithium (Fig. 
5.13a); (2) space group P21 with 4 molecules in the asymmetric unit in the presence of calcium (Fig. 
5.13b); (3) space group P21 with 4 molecules in the asymmetric unit in the presence of magnesium 
(Fig. 5.13c) and (4) space group P21 with 6 molecules in the asymmetric unit in the presence of 
calcium (Fig. 5.13e). A fifth crystal form was produced from initial screening in the presence of 
tacsimate in space group P212121 with 4 molecules in the asymmetric unit (Fig. 5.13d). Of these 
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crystal forms the tacsimate condition would likely have been the most effective crystal for sulphur 
phasing on I23 with 90 degrees of data needed for a complete dataset (compared with 180 degrees 
for all other crystal forms) and a Bijvoet ratio of 0.32%, 1.37%, 2.58% and 4.06% at 1 Å, 2 Å, 3 Å and 
4 Å, respectively.  
 
Superposition of the A chains of all crystal forms with the single molecule AxABH-Li structure 
showed little change in the overall fold of the protein with both the conserved α/β fold and DUF 
showing little deviation. The only observable conformational change is in HTH1 where AxABH-Li 
(green) and AxABH-Ca2 (cyan) structures show a displacement of approximately 3.6 Å from AxABH-
Ca1 (purple), AxABH-Tac (blue) and AxABH-Mg (orange) (Fig. 5.14). Closer inspection of the active 
site shows Gly162 in this region has moved in relation to the position of the BIS-Tris ligand in the 
active site. AxABH-Li and AxABH-Ca2’s A chain show a vertical orientation of BIS-Tris relative to 
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Asp127 (Fig. 5.15, coloured green and cyan, respectively) while AxABH-Ca1, AxABH-Tac and AxABH-
Mg have a horizontal orientation (Fig. 5.15 coloured purple, blue and orange, respectively). The 
orientation of BIS-Tris in the active site also varies between chains within the same structures so 
may be the result of crystal packing or BIS-tris being a poor fit for the active site. Ligand 2Fo-Fc 
density at σ = 1 for each crystal form is presented in Figure 5.16.  
 
5.4.2. AxABH Structure and Function 
Sequence alignment with BLASTp (Altschul et al., 1990) generated several high percentage 
homologues, up to 87% sequence homolgy at best, all of which were esterases/lipases which act on 
carboxylic esters and have a conserved ser-his-glu/asp as their nucleophile-his-acid catalytic triad. 
However, AxABH lacks both nucleophile and acid residues and shows poor structural alignment with 
carboxylaesterase structures deposited in the PDB.  
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Secondary structure alignment with PDBe (Krissinel and Henrick, 2004) produced 
homologous models with secondary structure similarity up to 78% and an RMSD of 1.74. Structures 
included a CIB like hydrolase (PDB code: 3BDI), C-C hydrolase (PDB code: 4LYD and 4LXH), serine 
hydrolase (PDB code: 1J1I), carboxylesterase (PDB code: 4CCY) and haloalkane dehydrogenase (PDB 
code: 3A2N) but alignment corresponded to the conserved α/β hydrolase fold with none of the 
identified structures showing a similar fold to AxABH’s DUF. Comparison of Protein Active Site 
Structures Server (Powers et al., 2011) was used to identify similar functional epitopes and active 
sites based on the residues binding the ligand. The strongest match was a phenylethylamine oxidase 
(PDB code: 2CFW) with a 36.6% similarity but alignment of the structures showed little agreement 
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between the protein folds. Analysis of the crystal formed showed a common dimer form between 
some crystal forms (Fig. 5.13c-e). The Proteins, Interfaces, structures and Assemblies (PISA) server 
(Krissinel and Henrick, 2007) identified a stable dimeric assembly with a dissociation constant of 4.5 
kcal/mol in AxABH between chains E and F of the Mg-ABH structure. However, analysis of the C and 
D chains showed a dissociation constant of -1.2 kcal/mol. Overall PISA found no strong indication 
that AxABH forms a dimer in solution, in agreement with the monomeric state observed in gel 
filtration purification (Fig. 5.8).  
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5.5. Conclusions  
Diffracting protein crystals were successfully produced for both AxUDT and AxABH for long 
wavelength phasing experiments on I23 but could not be tested due to technical difficulties with the 
beamline. AxUDT makes a good case for S-SAD on I23 with the failure to produce a solution by 
molecular replacement due to large numbers of molecules in the asymmetric unit and non-
isomorphism making combinations of datasets for SAD phasing impossible. With between 80-100 
sulphur atoms in the asymmetric unit AxUDT should produce a very strong anomalous signal. AxABH 
was successfully solved by molecular replacement but could still prove a valuable test subject for the 
limits of S-SAD with its low sulphur content. The function of AxABH remains unknown with the novel 
DUF domain showing little similarity to sequence, secondary structure and liganding residue 
homologues. 
5.6. Appendix  
Table 5.A1: AxUDT crystal forms from S-SAD data collection.  
Crystal 
form 
Space 
Group 
a (Å) b (Å) c (Å) α (°) β (°) γ (°) 
1 C2 80.5 90.3 137.3 90.0 105.8 90.0 
2 P1 63.0 63.8 120.5 89.1 83.8 77.3 
3 P2 80.5 90.9 179.9 90.0 99.9 90.0 
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Chapter 6 – Structural Insight into the 
Mechanism of EAL Domains 
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6.1. Introduction  
6.1.1 Pseudomonas aeruginosa  
Pseudomonas aeruginosa is a gram negative rod bacteria with a polar flagella from the 
family Pseudomonadaceae. It is oxidase positive, based on the presence of cytochrome c oxidase 
(Gaby and Hadley, 1957), and largely aerobic and non-fermentative; but has been found to be able 
to ferment nitrate and arginine (Vander Wauven et al., 1984, Palmer et al., 2007). P. aeruginosa 
presents in various colours depending on secretion of different pigments including blue-green, 
yellow- green and red-brown from pyocycanin, pyoverdine and pyorubin, respectively. P. aeruginosa 
strains are widespread throughout the world (Römling et al., 2005) and can inhabit soil, water, 
plants and animals (including humans) (Tolker-Nielsen, 2014).  
6.1.1.1. Pseudomonas aeruginosa Infection 
P. aeruginosa is an opportunistic pathogen, rarely causing disease without prior damage to 
a protective layer such as the skin or mucus membrane. Infection is also prevalent in 
immunodeficient individuals such as HIV/AIDS patients, immunosuppressed patients, post-transplant 
or following chemotherapy and in cystic fibrosis sufferers. According to the Centre for Disease 
Control (CDC) an estimated 51,000 healthcare-associated P. aeruginosa infections occur per year in 
the USA with over 13% being multidrug-resistant strains and approximately 400 deaths per year 
resulting from infections (CDC, 2014). Owing to P. aeruginosa’s prevalence in the natural world 
prevention presents a considerable challenge to hospital care. All P. aeruginosa infections are 
considered treatable and potentially curable, however, acute fulminant infections such as 
bacteremic pneumonia, sepsis and meningitis have extremely high mortality rates.  
Respiratory tract infection by P. aeruginosa is one of the most common infections in cystic 
fibrosis sufferers, although the latest data suggest a decrease in the prevalence in patients from a 
high of ~ 60% of sufferers in 1988 to ~ 50% in 2013 (Fig. 6.1) (Cystic Fibrosis Foundation Patient 
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Registry. Annual Data Report 2013. Cystic Fibrosis foundation, Bethesda, MD). Studies suggest that 
this decrease is the result of early intervention with antibiotics to reduced chronic colonisation 
(Davidson et al., 2012) and a general improvement in understanding the clinical impact, diagonosis 
and treatment of cyctic fibrosis sufferers with P. aeruginosa infections. Infection is thought to occur 
through natural contact with lakes, streams, moist soils, vegetables (Römling et al., 2005, Burns et 
al., 2001) and other CF patients (Hoiby and Pedersen, 1989, Armstrong et al., 2002); with certain 
epidemic strains more widespread within the cystic fibrosis community (Cheng et al., 1996, 
Frederiksen et al., 1999, Aaron et al., 2010). Although prevalence of P. aeruginosa is decreasing (Fig. 
6.1), prolonged chronic infection in cystic fibrosis sufferers along with regular antibiotic treatments 
gives rise to antibiotic resistant strains (Pitt et al., 2003, Smith et al., 2006), phagocytosis resistant 
strains (Mahenthiralingam and Speert, 1995) and decreased immune system recognition (Zhang et 
al., 2005).  
 
P. aeruginosa infection is also prevalent in chronic wounds such as diabetic foot ulcers and 
burn wounds. A chronic wound is trapped in a persistent inflammatory stage with excess neutrophil 
proteases causing further injury and preventing proliferation of skin cells and remodelling to 
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properly heal wounds (Yager and Nwomeh, 1999, Diegelmann, 2003). These chronic wounds present 
a favourable entry environment for bacteria to colonise and proliferate; with bacteria primarily 
originating from the skin and environment to form polymicrobial colonies. Of these bacteria, P. 
aeruginosa are frequently isolated (Davies et al., 2004, Gjodsbol et al., 2006, Dowd et al., 2008), with 
wounds found to be larger and presents delayed healing compared to P. aeruginosa free wounds 
(Gjodsbol et al., 2006, Fazli et al., 2011, Madsen et al., 1996).  
P. aeruginosa is also a major factor in ear infections leading to Otitis media, a common 
childhood infection presenting with inflammation of the middle ear; which can lead to conductive 
hearing loss, impeded speech and social skill development (Verhoeff et al., 2006). It is thought that 
biofilm formation plays a key role in the development of Otitis media, with a recent study identifying 
mucosal biofilms in 92% of samples tested using confocal laser scanning microscopy (Hall-Stoodley 
et al., 2006). The prevalence of P. aeruginosa in hospitals and its propensity to form biofilms means 
P. aeruginosa infection via medical devices have a significant clinical impact on morbidity and 
mortality as well as monetary cost (Tolker-Nielsen, 2014). Hospital acquired infections are estimated 
to occur in around 1.75 million patients (175,000 deaths) in Europe and 2 million infections (90,000 
deaths) in the US per year (Guggenbichler et al., 2011). Of these infections, P. aeruginosa accounts 
for 10-20% of nosocomial infections (Ramos et al., 2013) and, by extension, 17,500-35,000 deaths in 
Europe and 9000-18,000 deaths in the US per year. Following insertion, medical devices become 
coated with platelets, tissue and plasma proteins; these provide a surface for microbial colonisation 
and biofilm formation (Francois et al., 2000). Following inoculation a thick biofilm can form within 24 
hours (Chambless et al., 2006). The widespread use of medical devices means P. aeruginosa 
infection is seen in intravascular (Raad, 1998) and urinary catheters (Stickler et al., 1998), prosthetic 
prostheses (Martínez-Pastor et al., 2009) and  breast, penile and cochlear implants (Weichman et al., 
2013, Vaidyanathan et al., 2009, Germiller et al., 2005). Although the above P. aeruginosa infections 
are varied, with infection occurring in a wide range of tissues, all share a common virulence factor; 
the formation of biofilms.  
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6.1.2. Biofilms  
The majority of bacteria are able to exist as either single planktonic cells or surface-
anchored aggregates called biofilms. These heterogeneous bacterial communities allow bacteria to 
form protective microenvironments to protect against limited nutrients, dessication, toxic chemicals 
and fluctuations in pH and temperature (Hall-Stoodley and Stoodley, 2005). Biofilms present a 
significant stumbling block in treatment of many bacterial infections, providing protection against 
antimicrobials and the host immune system to allow persistent and chronic bacterial infections 
(Costerton et al., 1999). As a result, various anti-biofilm strategies have been developed to allow 
more effective treatment (Sommer et al., 2013, Caly et al., 2014), but many infections remain 
difficult to treat. Biofilm formation occurs over various stages, including attachment (reversible and 
irreversible), where bacteria adhere first to a surface and then to one another; followed by 
formation of the biofilm (maturation-1 and -2), by producing an extracellular matrix, and finally 
biofilm dispersal where the extracellular matrix is broken down and bacterial adhesion is reduced to 
facilitate emigration to new infection sites (Tolker-Nielsen, 2014, Sauer et al., 2002). Each stage 
involves the complex interplay between various genes and proteins to regulate biofilm progression.  
6.1.2.1. Initiation of Biofilm Formation  
Attachment and aggregation of bacterial cells to form a biofilm under different conditions 
requires a combination of several key components including the flagellum, type IV pili (twitching 
motility), Chaperone/usher protein (Cup) fimbria, extracellular DNA and Ps1 polysaccharide (Tolker-
Nielsen, 2014). Mutant strains of P. aeruginosa deficient in flagellar-mediated motility were unable 
to form a monolayer on abiotic surfaces (O'Toole and Kolter, 1998, Sauer et al., 2002), while type IV 
pili mutant strains were able to form a monolayer but not microcolonies observed in wild type 
strains (O'Toole and Kolter, 1998, Chiang and Burrows, 2003). In a similar vein to the type IV pili, Cup 
fimbria adhesins mediate attachment under different environmental conditions (Vallet et al., 2001) 
and have been found to be essential in upper respiratory tract infection by Bordetella pertussis 
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(Kimura et al., 1990). Initially extracellular DNA was assumed to be the product of lysed cells as 
opposed to a deliberate mechanism to aid biofilm formation, however, addition of DNase to cultures 
has been found to strongly inhibit biofilm formation in P. aeruginosa at the early stages of 
development (Whitchurch et al., 2002). Ps1, a mannose rich polysaccharide, also plays a key role in 
adhesion in P. aeruginosa strains, with ps1A and ps1B compromised strains demonstrating impaired 
biofilm initiation. Generation of an arabinose induced ps1 P. aeruginosa strain showed a 
deterioration in biofilm thickness with down regulation of ps1 after initial attachment under 
arabinose conditions, suggesting the ps1 polysaccharide plays a role in maintaining biofilm structure 
(Ma et al., 2006). Other polysaccharides, including the glucose-rich Pel and alginate (guluronic and 
mannuronic acid), are involved in adhesion and biofilm formation (Friedman and Kolter, 2004, Govan 
and Deretic, 1996).  
6.1.2.2. Biofilm Formation and Growth 
Following initial surface-attachment, biofilm formation in P. aeruginosa consists of non-
motile cells proliferating in a fixed position to form mushroom stalks while motile cells produce the 
mushroom caps using type IV pili (Klausen et al., 2003). Development following initial colonisation is 
more dependent on environmental conditions. Citrate-grown P. aeruginosa in flow-chambers form a 
flat biofilm, with cells in initial colonies migrating when colonies reach a certain size until maturation 
of the biofilm; where migration stops (Klausen et al., 2003). Glucose grown biofilms on the other 
hand show mushroom shaped microcolonies with mushroom caps formed by motile cell populations 
in a flagella and type IV pili dependent manner (Barken et al., 2008, Tolker-Nielsen, 2014).  
6.1.2.3. The Extracellular Matrix 
Extracellular matrix components provide an essential cell-to-cell scaffold for biofilms to 
allow attachment, cell-to-cell interactions and protection from antimicrobials (Ma et al., 2006, Yang 
et al., 2009, Friedman and Kolter, 2004). P. aeruginosa’s biofilm consists of a mix of polysaccharides 
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(Pel, Ps1 and alginate), proteins (type IV pili, Cup, CrdA, LecB and functional amyloids in 
Pseudomonas (Fap)) and extracellular DNA. In addition to their twitching motility role, type IV pili are 
also thought to act as cross linkers with extracellular DNA. As eluded to earlier, the Cup fimbria 
(CupA-D) are involved in attachment and formation of biofilms. CrdA, a large surface protein, and 
CdrB, a putative outer membrane transporter, work in combination with Ps1 to cause auto-
aggregation and crosslinking of Ps1 polymers; as well as tethering Ps1 to the cell wall of P. 
aeruginosa (Borlee et al., 2010). The 6 gene fapA-F operon expresses functional amyloids, self-
assembling protein monomers that form amyloid fibrils (Tycko, 2004). The exact function of Fap 
remains unknown but it appears to play a role in biofilm formation, with over expression producing 
“extraordinarily huge microcolonies” (Dueholm et al., 2013). The importance of extracellular DNA 
and polysaccharides was expanded on earlier and doesn’t bear repeating.  
6.1.2.4. Quorum Sensing  
A key feature of biofilms is the ability for single cells to work together through cell-to-cell 
signalling, also referred to as quorum-sensing. Individual cell expression of quorum-sensing signalling 
molecules allows the colony to regulate gene expression relative to cell density, including virulence 
factors and regulation of the biofilm itself (Passador et al., 1993). P. aeruginosa quorum-sensing is 
coordinated through three related systems, the Las, Rhl and Pqs systems which employ N-(3-
oxodoecanoyl)-L-homonoserine lactone, N-butanoyl homoserine lactone and 2-heptyl-3-hydroxy-4-
quinone, respectively as signalling molecules (Juhas et al., 2005). These three pathways work in a 
hierarchical manner with the Las system affecting expression of Rhl system mediated expression 
while the Pqs system operates between the Las and Rhl systems (Tolker-Nielsen, 2014). Quorum 
sensing has been found to regulate several hundred genes in P. aeruginosa for biofilms not 
expressed in planktonic cells (Hentzer et al., 2005). Mutation or inhibition of any one of these 
systems has been found to inhibit cap formation in flow-chamber experiments (Tolker-Nielsen, 
2014); in addition to this, the nutritional environment has been found to affect quorum-sensing 
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mutant strains with varying carbon sources causing either defects in biofilm formation or a wild-type 
phenotype (Shrout et al., 2006). Quorum-sensing has also been found to regulate extracellular DNA 
expression, pel, Cup, LecA and LecB expression and nitric oxide removal in nitrate respiration 
(Tolker-Nielsen, 2014).  
6.1.2.5. Biofilm Dispersal   
Dispersal of biofilms is equally important to allow bacteria to migrate and infect new areas. 
Emigration can be triggered by a variety of external factors such as carbon or oxygen starvation 
(Gjermansen et al., 2005, Thormann et al., 2006). A key component in the regulation of biofilm 
dispersal is the widely conserved secondary messenger, Bis-(3’-5’) cyclic di-guanylate (CdG). 
Depletion of carbon has been found to activate the biofilm dispersion locus (bdlA) in P. aeruginosa, 
which produces BdlA; a chemotaxis regulator which reduces the intracellular levels of CdG via a 
signalling cascade (Morgan et al., 2006). Other proteins involved in biofilm dispersal include RbdA, a 
GGDEF and EAL domain phosphodiesterase (PDE) with a PAS low-oxygen sensing domain, which 
negatively regulates the extracellular matrix polysaccharides Pel and Psl and upregulates bacterial 
motility (An et al., 2010). EAL domains are PDEs which degrade CdG to regulate a variety of cellular 
processes. Another CdG level altering protein involved in biofilm dispersal is DipA, an EAL domain 
containing protein found to prevent nutrient-induced dispersion by glutamate, nitric oxide, 
ammonium chloride and mercury chloride when inactivated (Roy et al., 2012). In addition to CdG, 
cis-2-deconoic acid has been found to play a key role in biofilm dispersion. Cis-2-deconoic is 
produced continuously by P. aeruginosa, but when the rate of production exceeds the rate of 
diffusion of cis-2-deconoic acid away from the microcolonies biofilm dispersal is activated (Davies 
and Marques, 2009).  
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6.1.3. Bis-(3’-5’) cyclic di-guanylate  
Bis-(3’-5’) cyclic di-guanylate (CdG) is an evolutionarily conserved universal second 
messenger in eubacteria involved in regulation of a wide variety of functions including 
developmental transitions, adhesion, motility synthesis of virulence factors and the formation of 
biofilms (Schirmer and Jenal, 2009, Boyd and O'Toole, 2012, Caly et al., 2014, Romling et al., 2013). 
CdG was first discovered 25 years ago in Acetobacter xylinium as an allosteric regulator of cellulose 
synthase (Ross et al., 1987, Romling et al., 2013). Intracellular levels of CdG are regulated by 
synthesis and degradation through diguanylate cyclases (DGCs) and phosphodiesterases (PDEs), 
respectively (Fig. 6.2). CdG specific DGCs are identified by their conserved GGDEF sequence and are 
responsible for conversion of two GTP molecules to CdG. In a similar manner, PDEs responsible for 
degradation of CdG to 5’-phosphoguanylyl-(3’-5’)-guanosine (pGpG) are identified by their conserved 
EAL sequence (Ryan et al., 2006a, Hengge, 2009); a type II CdG-specific PDE known as a HD-GYP has 
also been shown to possess PDE activity (Bellini et al., 2014). GGDEF, HD-GYP and EAL domain 
proteins will be discussed in more detail in the following section.   
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The exact mechanisms by which the changing levels in the intracellular pool of CdG affects 
changes in bacteria are still poorly understood. It has been suggested that environmental cues may 
be interpreted by differing affinity constants between CdG receptors/effectors to determine 
activation or repression of functions (Ryan et al., 2006b). This has been demonstrated in Salmonella 
typherium where YcgR and BcsA, two CdG sensing PilZ domain proteins, have a 43-fold difference in 
CdG affinity; with slight increases in CdG activating YcgR to inhibit motility and higher intracellular 
levels required to activate cellulose production through BcsA (Pultz et al., 2012). The 8 PilZ 
containing proteins in P. aeruginosa (PA3353, PA2989, PA0012, PA4324, PA2799, PA4608, PA3542 
and PA2960) showed an even larger difference between maximum and minimum affinities with a 
145-fold difference (Christen et al., 2010, Pultz et al., 2012). An alternative, but not mutually 
exclusive theory, is that CdG signalling consists of different systems related to specific tasks based on 
discrete pools of CdG; as demonstrated by regulation of entry into the S phase of the cell cycle 
through PopA following up regulation of CdG levels by DgcB and PdeA in Caulobacter crescentus 
(Abel et al., 2011).  
Despite the controversy surrounding CdGs mechanism of regulation it is evident that CdG is 
able to interact with a large number of cellular targets. To date CdG has been found to interact with 
PilZ domains (a 100 amino acid repeat found in various proteins) (Amikam and Galperin, 2006), 
transcription factors including FleQ in P. aeruginosa, VpsT in Vibrio cholera, Clp in Xanthomonas 
species, Bcam1349 in Burkholderia cenocepacia and LtmA in Mycobacterium smegmatis (Caly et al., 
2014). CdG also interacts with riboswitches, part of the 5’ untranslated region (UTR) of mRNAs, via 
GEMM elements found in the UTR of PDE and DGC genes; as demonstrated by activation of the tfoX 
gene in V. cholera through CdG binding (Sudarsan et al., 2008). Although GGDEF domains and HD-
GYP/EAL domains main function involves the formation and degradation of CdG, respectively; there 
are a certain population of enzymatically inactive variants of these proteins that are thought to act 
as sensory domains (Caly et al., 2014).  
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6.1.4. CdG Synthesis by Diguanylate Cyslases  
CdG specific DGC domain (GGDEF) activity was first identified via PleD of C. crescentus, a 
multidomain protein consisting of N-terminal CheY-like receiver domains and a C-terminal domain 
later identified as a GGDEF domain (Paul et al., 2004, Chan et al., 2004). Activation of PleD by 
phosphorylation correlated with DGC activity and the conversion of two GTP molecules to CdG (Paul 
et al., 2004). Following on from this, six more GGDEF domain proteins from Thermatoga, 
Deinococcus-Thermus, Cynobacteria, Spirochetes and Proterobacteria (α and γ) were identified and 
confirmed to possess DGC activity for CdG in the presence of Mg2+ (Ryjenkov et al., 2005). GGDEF 
domains adopt a conserved five stranded antiparallel β-sheet surrounded by helices (Fig. 6.3), similar 
to the catalytic core of adenylate cyclase (Tesmer et al., 1999, Chan et al., 2004). The GG(D/E)EF 
motif is located in the connecting loop between β2 and β3 (Fig 6.3b). This GGDEF motif forms the 
active “A site” where a single molecule of GTP binds per  monomer (Caly et al., 2014). A second 
conserved sequence (RxxD) (Chan et al., 2004), later identified as an inhibitory site through 
structural analysis of CdG-bound PleD and WspR, was found to be involved in feedback inhibition of 
GGDEF domains by preventing formation of the enzymatically active DGC domain dimer (Wassmann 
et al., 2007, Schneider, 2008).  
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Studies of GGDEF domains in solution and through crystal structures suggest DGC activity is 
mediated by formation of a dimer.  Both PleD and WspR demonstrate dynamic quaternary structure 
changes to facilitate inhibition of DGC activity in the presence of CdG. PleD consists of a receiver 
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domain, adaptor domain and DCG domain depicted in red, yellow and green, respectively in figure 
6.4; all connected by flexible linker domains. Following phosphorylation of the receiver domain (Fig. 
6.4(2)) the PleD receiver and adaptor domains dimerise (Fig. 6.4(3)), facilitating DGC domain 
dimerisation and formation of CdG from two bound GTP molecules in the “A site” of each monomer 
(Fig. 6.4(4)) (Wassmann et al., 2007). Inhibition of PleD can occur by two distinct interactions 
between CdG and inhibitory sites on the DGC and adaptor domains; i) dimeric CdG molecules bind 
the primary “I site” of the DGC domain (IP) and the inhibitory site on the adaptor domain (Fig. 
6.4(5)). ii) Following phosphorylation of the receiver domain, dimeric CdG binds the primary and 
secondary “I sites” of the DGC domain to produce a non-productive dimer (Fig. 6.4(6)) (Wassmann et 
al., 2007). WspR undergoes an equally sophisticated mode of regulation by dimerisation, elegantly 
demonstrated by crystal structures of each oligomeric state (Fig 6.5). Active WspR forms a compact 
parallel coiled coil dimer mediated by the CheY-homology domains to facilitate DCG domain 
dimerisation (Fig. 6.5.a). Inhibited WspR first takes the form of an antiparallel tetrameric coiled coil, 
facilitated by a dimeric CdG clamp which binds the DCG domain “I site” to stabilise the conformation 
of inactive dimers and prevent dimerisation of the DGC domains (Fig. 6.5b). Once stabilised, 
inhibited dimers can detach from the tetramer (Fig. 6.5c) (Schneider, 2008). Reactivation of WspR is 
achieved by PDE mediated removal of CdG to form the active parallel dimer structure in Figure 6.5a. 
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6.1.5. CdG Degradation by Phosphodiesterases  
6.1.5.1. HD-GYP Phosphodiesterases 
Degradation of CdG is undertaken by two unrelated PDEs, HD-GYPs and EAL domain 
containing proteins (Fig. 6.2). HD-GYP domains are a variant of HD-type phosphohydrolases, defined 
by a C-terminal sub domain with additional conserved residues; widely distributed but less abundant 
than EAL PDEs  (Galperin, 2005).  HD-GYP domains were first identified as a metal-dependant (Mg2+ 
or Mn2+) CdG specific PDE capable of hydrolysing CdG to two GTP molecules with pGpG as an 
intermediate (Ryan et al., 2006a). The role of HD-GYPs in regulation of biofilms was further 
investigated though four HD-GYP domain proteins in V. cholera (Hammer and Bassler, 2009), 
BB0374/PdeB from Borrelia burgdorferi (Sultan et al., 2011) and PA4108 and PA4781 from P. 
aeruginosa (Ryan et al., 2009); all of which agreed that mutation of these HD-GYP domains led to a 
decrease in CdG levels and reduced biofilm formation. Alanine substitution of individual residues 
from the GYP motif affected the degree of interaction with CdG and total alanine substitution (HD-
AAA) caused almost complete inhibition. Alanine substitution of the HD motif had no effect on 
catalytic activity (Ryan et al., 2010). The first structure of a HD-GYP domain was the inactive Bd1817, 
which lacks the catalytic tyrosine from the HD-GYP motif (Lovering et al., 2011). Bd1817 contained 
an unidentified N-terminal domain and a C-terminal HD-GYP domain separated by a 3 helix linker. 
The HD-GYP domain is completely alpha helical with a binuclear metal centre with two Fe2+ ions 
octahedrally coordinated by conserved residues and bidentately coordinated by a water molecule 
and phosphate ion (Fig. 6.6a-b). The extended HD-GYP motif, or HEExxNGxG-P in the case of Bd1817, 
is located at the solvent exposed active site pocket and forms a novel double U-shaped turn, shown 
in orange in figure 6.6c-d (Lovering et al., 2011). The first structure of a catalytically active HD-GYP 
domain was that of PmGH from Persephonella marina, solved in the presence of the substrate (CdG)  
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and final reaction product (GMP) (Bellini et al., 2014). PmGH consists of an N-terminal GAF domain, 
42 residue linker helix and a C-terminal HD-GYP domain, crystallised as a parallel dimer with binding 
mediated by the GAF domain (Fig 6.7).  The structure of the overall fold of the HD-GYP domain is 
well conserved between PmGH and Bd1817, as shown in figure 6.8a. A clear shift is observed in α6 
and α10 to accommodate the trinuclear metal site of PmGH (Fig. 6.8a). α1 and α5 of the HD domain 
also show a conformational change, shifting from an open conformation in PmGH (red loops in 
figure 6.8b) to a closed conformation in Bd1817 mediated by hydrogen bonds (green helices in figure 
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6.8b). The tri and binuclear metal sites in PmGH and Bd1817, respectively, show similar liganding 
residues between metal centres with most differences arising only in response to the new third 
metal observed in PmGH (Fig. 6.8c). CdG-bound PmGH suggests the trinuclear metal centre interacts 
directly with the scissile phosphodiester of CdG to act as a Lewis acid catalyst to activate a bridging 
water for nucleophilic attack (Bellini et al., 2014). Interestingly, the cis binding conformation of CdG 
observed in this HD-GYP (Fig. 6.9a) domain differs greatly from the extended conformations in EAL 
domains (Fig. 6.9b) which carry out the same hydrolysis reaction. 
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6.1.5.2. EAL Phosphodiesterases 
EAL domain proteins have been extensively studied, in general, and are structurally and 
functionally related with a highly conserved triosephosphate isomerase (TIM)-barrel fold with the 
active site at the C-terminal end of the barrel. The lion’s share of EAL domains possess PDE activity, 
with some  degenerated EAL domains able to bind CdG  but lack the metal coordinating residues 
required for hydrolysis. A large cohort of published data shows active EAL domains hydrolyse CdG in 
the presence of Mg2+ and Mn2+, with peak reaction rates occurring at alkaline pH (Sundriyal et al., 
2014). Of these two metals manganese-loaded EAL domains have been shown to be at least one 
order of magnitude faster than magnesium-loaded EALs, while calcium causes complete inhibition of 
PDE activity (Tchigvintsev et al., 2010, Schmidt et al., 2005, Tamayo et al., 2005, Rao et al., 2008). 
The first reaction mechanism proposed involved a single divalent metal bound to the active site 
based on the structure of tdEAL and YkuL with CdG bound in combination with mutagenesis and pH 
dependent studies on RocR (Rao et al., 2008, Minasov et al., 2009). Mutagenesis studies of RocR 
probed the catalytic importance of fourteen conserved polar residues (Fig. 6.10) including eight 
acidic residues (E175, E265, D295, D298, D318, E352 and E355), two basic residues (R179 and K316) 
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and four neutral residues (Q161, Q372, N233 and T267) (Rao et al., 2008). Of these fourteen 
residues mutation of three residues showed a negligle to 33.5 fold reduction in the Kcat (R179A, 
T267A, D296A and E355A), suggesting minor roles in catalysis. Alanine substitution of a further three 
residues (Q161A, R179A and D296A) demonstrated a two- threefold increase in Km values compared 
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to wild type RocR, suggesting potential roles in substrate binding (Rao et al., 2008). Mutation of the 
remaining seven residues (E175A, N233A, E265A, E268A, D295A, K316A and E352A) reduced activity 
to undetectable levels, suggesting an essential role in forming the active site. Of 
 
these seven, activity could be completely restored for N233A in the presence of excess Mg2+ (0.5 M) 
and partially recovered for E175A, E265A, D295A, E268A, and K316A. Only E352A showed negligible 
recovery in the face of excess Mg2+, suggesting an essential role in catalysis later eluded to as a 
potential general base catalyst for deprotonation of the catalytic water for hydrolysis (Rao et al., 
2008). The two metal structure of Thiobascillus denitrificans EAL suggested a two-metal-ion 
mechanism akin to polymerases and nucleases (Rao et al., 2008), however, this was dismissed based 
on large inter-metal distances and mutation of the second metal coordinating residues (D296 and 
D318) proving non-essential to function (Rao et al., 2008). 
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Following this intital work, the two-metal-ion catalytic mechanism was rekindled with the 
structure of Blrp1 from Klebsiella pnuemoniae, consisting of an N-terminal sensor of blue-light using 
FAD (BLUF) domain and C-terminal EAL domain with PDE activity (Barends et al., 2009). Blrp1 
structures were solved in the presence of Mn2+ and CdG at a range of pH and presented with a 
binuclear active site of Mn2+ ions coordianted by conserved Asp residues (Asp302-303) on loop 6 at 
the C-terminal end of the TIM-barrel (Fig. 6.11) (Barends et al., 2009). Based on this structural 
information Barends et al suggest a “tight” bimetallic centre, in which two metals can activate the in-
line attacking water to cleave the phosphodiester bond in CdG when they reach critical proximity. 
This model was based on a decreasing inter-metal distance with increasing pH in crystal structures in 
conjunction with in vitro kinetic observations in solution where reaction rates are greatly increased 
between pH 6 and pH 9. Structures  at pH 6 and pH 9 were determined at 2.05 Å (3GFZ) and 2.55 Å 
(3GGO), respectively and showed a decrease in inter-metal distance of 0.4 Å and 0.6 Å in molecules 
A and B, respectively, with increasing pH (Fig. 6.12). However, the manganese-loaded bimetallic 
structure reported at an activating pH shows an intact CdG molecule in the catalytic pocket instead 
of the expected product, pGpG, if the protein is truly active (Barends et al., 2009). To further 
examine the catalytic redulation of EAL domains, two previously structurally uncharacterised EAL 
domains from the core genome of P. aeruginosa, MucR-EAL and PA3825-EAL, have been examined 
in solution and by X-ray crystallography.  
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PA1727 (MucR) is a putative membrane associated protein comprised of an active DGC 
domain (GGDEF), inactive PDE domain (EAL) and a proposed oxygen, CO or NO sensing MHYT 
domain (Galperin et al., 2001), involved in alginate biosynthesis and biofilm formation (Hay et al., 
2009). Knockout studies of MucR in PDO300 P. aeruginosa generated a non-mucoid phenotype, 
increased swarming motility and a 38-fold reduction in alginate production; while upregulation of 
MucR results in a 7-fold increase in alginate production, wrinkly colony morphology, increased 
pellicle formation, auto-aggregation, and generation of structured biofilms (Hay et al., 2009). MucR 
regulation of alginate synthesis and biofilm formation is linked to activation of Alg44 by increasing 
localised CdG concentration through PDE activity. Despite biochemical evidence that MucR is an 
inactive PDE, MucR posesses all the necessary conserved residues for catalysis; making the 
mechanism by which MucR PDE activity is inhibitied a mystery. PA3825-EAL is a two domain 
cytoplasmic protein consisting of an N-terminal CSS domain and an active C-terminal EAL domain.  
CSS domains are a poorly understood receptors predicted to have a simialr fold to extracellular 
receptors of bacterial dimeric histidine kinases. To date they remain uncharacterised by both 
biochemcial and structural techniques.  
In this chapter, to further elucidate the metal-centred mechanism of the EAL domain, the 
molecular biology, crystallisation and crystal structures of PA3825-EAL in its metal-free state and 
loaded with either Ca2+, Mg2+ or Mn2+ ions, with and without CdG as well as complexed with the 
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reaction product pGpG are presented. The latter structure reveals a novel third metal binding site 
coordinated to the free oxygen atoms formed by hydrolysis of the scissile phosphodiester bond of 
CdG. The position of this new metal site suggests a possible catalytic role in activation of the 
transition state for hydrolysis. Furthermore, a combination of kinetic studies and solution state 
oligomerisation analyses have also been performed on PA3825-EAL and MucR-EAL recombinant 
proteins that, together with the crystal structures, including that of CdG-bound MucR_EAL, shown 
here for the first time, suggests a specific type of dimerisation in which a long helix (helix 8) may play 
a role in the inhbition of the EAL Domains. 
6.2. Methods  
6.2.1. Cloning, Expression and Purification  
Six DNA fragments of varying lengths encoding the EAL domain of PA3825 (residues 255-
517) were amplified by PCR from the Pseudomonas aeruginosa strain PAO1 genome before 
subcloning into pOPINF vectors using In-FusionTM cloning with a cleavable N-terminal His6-tag. 
Plasmids were transformed into Lemo21 (DE3) E. coli cells in the presence of 50 µg/ml ampicillin. 
Cultures were grown to an OD600 of 0.4-0.6 and induced with 0.15 mM IPTG at 18°C for 16 hours. 
Cultures were spun at 5000 rpm (Sorvall SLC6000 rotor) for 10 minutes at 4°C and resuspended in 
buffer A (0.1 M Tris-HCl pH 8.0, 0.5 M NaCl, 1 mM TCEP, 20 mM imidazole and 2% glycerol) plus 10 
mM MgCl2, 10 μg/ml DNAse and 300 μg of lysozyme per gram of pellet. Cells were lysed by 
sonication in two cycles of 45 and 30 seconds and clarified by centrifugation at 16,000 rpm at 4°C for 
15 minutes (Sorvall SS34 rotor). Cleared lysate was loaded onto a Ni-NTA affinity column 
prequilibrated in buffer A with affinity chromatography performed on an AKTA purifier (GE 
Healthcare). The N-terminal His6-tag was cleaved overnight at 4°C and the cleaved tag and other 
impurities removed by a second round of Ni affinity chromatography. Untagged PA3825-EAL 
containing fractions, as judged by absorbance at 280 nm, were pooled to a final volume of 6 ml and 
 209 
 
filtered with a 0.22 µm syringe filter before loading onto a Superdex 200 16/60 gel filtration column 
prequillibrated in size exclusion chromatography (SEC) buffer (20 mM Tris-HCl, pH 8, 300 mM NaCl, 
1mM TCEP) and eluted over one column volume. Purified MucR protein was provided by the Tews 
group in Southampton in 50 mM HEPES pH 7, 300 mM NaCl, 2mM MgCl2 and 2 mM β-
mercaptoethanol.  
6.2.2. Crystallisation  
Purified PA3825-EAL was concentrated to 15-20 mg/ml as quantified by absorbance at 280 
nm for all crystallisation experiments. Initial crystal trials were set up using the sitting drop vapour 
diffusion method with a Cartesian crystal robot in 200 nL drops consisting of protein and reservoir 
solution from Wizard I + II, Wizard III + IV, JCSG-plus HT-96, Morpheus, PEG/ION, and Index 
commercial crystallisation screens at a ratio of 1:1. Trays were incubated at 4°C and 18°C. 
Optimisable crystal hits were found in 3 conditions from the Wizard I + II screen as shown in figure 
6.13.  Small rhombus shaped crystals were found in condition D4 (10% isopropanol, 0.1 M Mes pH 
6.0 and 0.2 M calcium acetate) and large bipyramidal crystals in condition E4 (2.0 M ammonium 
sulphate, 0.1 M sodium cacodylate trihydrate pH 6.5 and 0.2 M sodium chloride) and G11 (0.8 M 
Sodium phosphate monobasic, 1.2 M potassium phosphate dibasic and 0.1 M sodium acetate pH 
4.5) as shown in figure 6.13a, b and c, respectively. G11 and E4 screens were optimised using a 
Hamilton Star Lab liquid Handler to produce precipitant gradients and pH screens with crystals 
grown in 500 nL sitting drops set up using a TPP mosquito LCP crystallisation robot. The best 
primitive tetragonal crystals (G11) grew at 4°C in 0.8 M sodium phosphate monobasic, 1.2 M 
potassium phosphate dibasic and 0.1 M sodium acetate pH 4.5 (final pH measured as pH 7.1), 
whereas the best centred monoclinic crystals (E4) were grown at 4°C in 6-11% iso-propanol, 0.1 M 
Mes pH 6.5, 0.1 M sodium acetate pH 4.5 and 0.2 M calcium acetate (final pH measured as pH 5.2).  
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Co-crystallisation of tetragonal PA3825-EAL crystals with magnesium or manganese was 
performed by adding 0.2 M MgCl2 or MnCl2 to optimised reservoir solution prior to dispensing. Co-
crystallisation of tetragonal PA3825-EAL crystals with CdG was achieved by adding 10 mM CdG 
directly to the protein sample. Soaking experiments for tetragonal PA3825-EAL crystals were 
performed over several days at 4°C with 10 mM CdG in optimised reservoir solution. Similar soaking 
experiments were performed with monoclinic PA3825-EAL crystals over one hour at 20°C. 
Cryoprotection was achieved by minimising surrounding solvent for primitive tetragonal crystals and 
adding 25% ethylene glycol to the crystallization buffer for monoclinic crystals.  
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6.2.3. Data Collection 
Single crystal diffraction datasets for different metal and ligand co-crystallised/ soaked 
crystals were collected at 100 K over multiple visits on beamlines I02, I04 and I04-1 at Diamond Light 
Source, UK. Manganese-apo and manganese-CdG complex crystals were collected at the manganese 
edge on I02 at Diamond. Data collection parameters are summarised in table 6.1.  
Table 6.1: Data collection parameters for PA3825-EAL protein crystals in the presence of bound 
metals (Ca2+, Mg2+, Mn2+ and Na+) and ligands (apo, CdG and pGpG).  
 
6.2.4. Structure Solution and Refinement  
Diffraction datasets were processed with the Xia2 3daii pipeline at Diamond with 5% of 
reflections removed for cross-validation (Kabsch, 2010b, Winter et al., 2013). All structures were 
solved by molecular replacement using either Molrep (Vagin and Teplyakov, 2010a) or MrBump 
(Keegan and Winn, 2008). The apo structure of PA3825-EAL was solved using residues 493-743 of a 
putative EAL domain homology model from Thiobacillus denitrificans (PDB code 2R6O) (Tchigvintsev 
et al., 2010). Metal-apo, metal-CdG and metal-pGpG complexes were solved using the refined apo 
structure as the search model. Further refinement of structures was performed with REFMAC5 
(Murshudov et al., 2011), with model building carried out in COOT (Emsley et al., 2010). Model 
Crystal Apo-Apo Ca-Apo Ca-CdG Mg-CdG Mn-CdG Mn-pGpG 
Wavelength (Å) 0.9763 0.9795 0.9200 0.9795 0.9795 1.8785 
Beamline I03 I04 I04-1 I02 I04 I02 
Beam Size (μm) 50 x 20 90 x 45 60 x 50 82 x 21 63 x 50 20 x 20 
Maximum Resolution* (Å) 1.61 1.60 1.97 1.50 2.0 2.11 
Total Angular Range (°) 130 105 240 90 180 70 
Oscillation (°) 0.10 0.15 0.10 0.10 0.50 0.10 
Exposure time per frame (s) 0.10 0.15 0.10 0.10 0.50 0.10 
Transmission (%) 5 15 47 20 10  
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validation was performed using Molprobity (Chen et al., 2010). Figures of all structures were 
prepared with PyMol version 1.3r1 (The PyMOL Molecular Graphics System, Version 1.7.4 
Schrödinger, LLC). 
6.2.5. Size Exclusion Chromatography Coupled With Multi-angle Light 
Scattering  
A SEC-MALS setup with a Superdex 200 10/300 GL SEC column on an AKTA Purifier (GE 
Healthcare) connected to DAWN HELEOS-II MALS and Optilab T-rEX refractive index detectors 
(Wyatt) was used to determine PA3825-EAL’s oligomeric state under different conditions in solution. 
The column was equilibrated overnight in SEC buffer to give stable baseline signals from all 
detectors. Detectors were calibrated using Ribonuclease A according to standard Wyatt protocols.      
SEC-MALS experiments consisted of 50 μl injections of either PA3825-EAL or MucR-EAL 
(Provided by Andy Hutchin, University of Sheffield) at varying concentrations to assess the effects of 
concentration on the oligomeric state. PA3825-EAL and MucR-EAL were also tested in the presence 
of excess substrate (5 mM CdG) and/or different divalent cations (2 mM CaCl2, MgCl2 or MnCl2). All 
experiments were performed at 4°C at a flow rate of 0.3 ml/min. Substrate and divalent metals were 
added directly to the protein solution prior to loading samples onto the column. Molecular masses 
were calculated with a dn/dc value of 0.1825.  
6.2.6. Enzymatic Assay  
Enzymatic assays were carried out by assessing PA3825-EAL conversion of CdG to pGpG by 
ion exchange chromatography with a 1 ml Resource-Q column packed with 15 μm 
polyetheretherketone (PEEK) beads (GE-Healthcare). PA3825-EAL protein was stripped of all metals 
by adding 50 mM EDTA, which was later removed by dialysis to leave protein in 50 mM tris pH 9.3 
and 50 mM NaCl. Enzymatic reactions were carried out in the presence of excess CdG (40 μM) and 
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various divalent metals (2 mM CaCl2, MgCl2, MnCl2 or both MgCl2 and MnCl2), with reactions started 
by adding 1 μM PA3825-EAL to substrate at a final reaction volume of 600 μl. 100 μL fractions were 
removed after 0, 2.5, 5 and 20 minutes and reactions stopped by addition of 10 μl of 100 mM CaCl2. 
Inhibited samples were made up to 1 ml with 890 μL of 5 mM ammonium bicarbonate (NH4CO3) and 
100 μl loaded onto a 1 ml Resource-Q column pre-equilibrated in 5 mM ammonium bicarbonate. 
GdG and pGpG were eluted with a linear gradient of 5 mM to 1 M ammonium bicarbonate over 18 
column volumes; elution was monitored by absorption at 254 nm. Optimum pH for PA3825-EAL in 
the presence of manganese was measured by the same protocol described above, with reactions 
between pH 4 and pH 8 stopped after 20 minutes.  
Michaelis-Menten kinetics were assessed in the presence of manganese by assessing 
conversion rates of CdG to pGpG between 20 μM and 200 μM CdG by 0.2 μM PA3825-EAL over forty 
minutes. Reactions were initiated as detailed above with aliquots of all three CdG concentration 
fractions stopped at certain time points with CaCl2. Samples were prepared and run down the Q-
column as described above and the peak area for the pGpG peak calculated to be plotted against the 
Michaelis-Menten equation in order to determine the Kcat. 
6.3. Results and Discussion  
6.3.1. PA3825-EAL and MucR-EAL Enzymatic Activity  
Both PA3825-EAL and MucR-EAL’s ability to hydrolyse CdG to pGpG were assessed in the 
presence of magnesium, manganese and calcium. PA3825-EAL hydrolysed CdG in the presence of 
magnesium and manganese, with Mn2+-loaded PA3825-EAL showing a much faster conversion rate 
compared to Mg2+ loaded. As expected, Ca2+-loaded PA3825-EAL was completely inhibited. The 
catalytic rates of EAL domains has been found to be highly dependent on pH, with activity 
significantly increasing towards more alkaline pHs to a peak at around pH 9.3 (Schmidt et al., 2005). 
Analysis of the optimum pH for Mn2+-loaded PA3825-EAL activity over 20 minutes shows conversion 
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rates are significantly reduced below neutral pH, with activity all but inhibited at pH 5 and below 
over a reasonable experimental timeframe (Fig. 6.14). PA3825-EAL shows a significant jump in 
activity from pH 6 (red) to pH 7 (light blue), with a further increase in activity in more alkaline 
conditions (orange). Measurements at pH 9 and above over the same time period showed no 
difference to measurements at pH 8.   
 
PA3825-EAL at pH 9.35 in the presence of Mn2+ turns over substrate with a Kcat of ~ 0.85 s-1 
(Fig. 6.15), a rate comparable with that of  other EAL domains in the literature  (Christen et al., 2005, 
Barends et al., 2009, Rao et al., 2008, Schmidt et al., 2005, Sundriyal et al., 2014). Mg2+-loaded 
PA3825-EAL on the other hand showed a 30-40 times slower reaction rate compared to Mn2+-loaded 
PA3825-EAL. Variation in the initial catalytic rate of PA3825-EAL at different substrate 
concentrations could not be  observed, as seen in figure 6.15b, even at the lowest substrate 
concentration detectable by the experimental setup (5 μM) (Fig. 6.16). Based on these observations 
the Km value must lie below 4 μM, in agreement with other recently published EAL domain activity 
(Sundriyal et al., 2014).  
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Unlike PA3825-EAL, MucR-EAL showed no activity in the presence of magnesium, 
manganese of calcium, in agreement with the observation that his-tag purified MucR-EAL contained 
high amounts of bound nucleotide, as judged by absorption at 270 nm (private communication from 
the Tews group, University of Southampton). Bound nucleotide was later revealed as CdG by the 
high resolution crystal structures. Based on sequence alone the PDE inactivity of MucR in solution is 
surprising as all necessary catalytic residues are conserved, as seen in other PDE active EAL domains 
(Fig. 6.17). The only significant difference observed between PA3825-EAL and MucR-EAL that may 
account for MucR’s inactivity, is that while PA3825-EAL is almost completely monomeric in solution 
while MucR is exclusively dimeric.   
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6.3.2. PA3825-EAL and MucR-EAL Dimerisation and Activity  
The oligomeric states of various EAL domains in crystal structures and/or in solution have 
been variously reported as monomers (Schmidt et al., 2005), dimers (Barends et al., 2009, 
Tchigvintsev et al., 2010, Minasov et al., 2009, Rao et al., 2008) and tetramers (Rao et al., 2008, Chen 
et al., 2012). SEC-MALS data were collected to establish the oligomeric states of PA3825-EAL and 
MucR in solution. PA3825-EAL samples at 3 mg/ml and 6 mg/ml show a mixture of monomers and 
dimers with monomer becoming even more prevalent with increasing concentration (Fig. 6.18a). 
This finding is counter intuitive and may warrant further investigation. Addition of both activating 
and inhibiting metals (Mg2+ and Ca2+), with or without CdG, saw a slight shift towards the monomeric 
state (Fig. 6.18b). Both conditions lead to formation of the catalytic ternary complex, suggesting that 
catalytic reactions in PA3825-EAL favour the formation of monomers. Despite this prevalence as a 
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monomer in solution, analysis of macromolecular interfaces using the PISA server (Krissinel and 
Henrick, 2007) suggest a dimer as the biological assembly for the tetragonal form of PA3825-EAL, 
while the monoclinic crystals showed no stable quaternary complex structures were likely. PISA’s 
putative though unstable interface predicted for the monoclinic form, varies considerably from the 
predicted stable interface for the tetragonal crystal (Fig. 6.19). Figure 6.19 shows the different 
predicted interfaces of the tetragonal (Fig. 6.19a) and monoclinic (Fig. 6.19b) crystal structures. 
These differences, along with the SEC-MALS data suggest PA3825-EAL does not form tight 
interacting dimers, strongly suggesting that stable tetragonal dimer is most likely a product of the 
crystal packing arrangement as opposed to a functional dimerisation.  
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In stark contrast to PA3825-EAL, MucR elutes from the gel filtration column as a single peak 
with a molecular weight comparable to dimeric MucR, as estimated by MALS. PISA calculations gave 
a stable quaternary structure with a dissociation constant of 7.0 kcal/mol, similar to the 11.2 
kcal/mol predicted for tetragonal PA3825-EAL. However, the solvation free energy on formation of 
MucR is five times more negative than that of PA3825-EAL and the MucR dimer has twice the buried 
surface area. The dimerisation interfaces between MucR monomers and PA3825-EAL monomers are 
completely different from one another in sequence (Fig. 6.19c). Based on these observations and 
SEC-MALS data it is reasonable to conclude that the dimerisation domain of MucR is real and not an 
artefact of crystal packing. Despite this, MucR is still found to be inactive in solution and with CdG in 
the active site of the crystal structures. Based on these observations there is evidence to suggest a 
general role of dimerisation inhibition in EAL domains. Further evidence of dimerisation based 
inhibition of EAL domains is presented in later sections with the structure of MucR-EAL.  
 219 
 
 
6.3.3. PA3825-EAL Apo and CdG-bound Structures 
High resolution structures of metal-free-apo, calcium apo, calcium CdG, magnesium CdG 
and manganese CdG PA3825-EAL complex were obtained; along with pGpG bound PA3825-EAL 
which will be presented separately in the next section. Data processing, refinement and validation 
statistics for all structures are presented in Table 6.2. The triosephosphate isomerase (TIM)-barrel 
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fold (αβ(βα)7) of PA3825-EAL is conserved, along with the binding of CdG in the typical extended 
conformation at the C-terminal end of the β-barrel (Fig. 6.20a and 20b, respectively). Moreover, 
PA3825-EAL structures and substrate binding are consistent with previously published CdG-EAL 
domain complexes, including BlrP1 (Barends et al., 2009), YahA (Sundriyal et al., 2014), FimX 
(Robert-Paganin et al., 2012) and RocR (Chen et al., 2012). The overall fold of PA3825-EAL remains 
unchanged between structures with metal ions and no substrate and structures with metal ions and 
CdG. The only observable differences occur between metal-free-apo structures and metal-
apo/metal-CdG structures. β-strands 1 and 2 (residues 22-30 and 37-44, respectively) are presented 
as disordered loops in metal-free-apo structures, becoming ordered in the presence of metal ions to 
complete the TIM-barrel-fold (Fig. 6.21). Without metal and/or substrate bound Leu27, Glu39, Leu41 
and Arg43 all present with double conformations (green in Fig. 6.21), which stabilise upon metal 
binding (purple in Fig. 6.21). The second difference arises in loop 6 (residues 160-170) which shows a 
significant shift in position upon metal binding, moving into the active site to coordinate the catalytic 
metal ions with two highly conserved Asp residues (Asp160-161) (Fig. 6.22).  
Mg2+ and Ca2+ CdG-bound PA3825-EAL (Fig. 6.23a and 6.23b respectively) present with two 
metals in the catalytic centre, labelled M1 and M2, as observed in similar EAL domain structures in 
the PDB (Fig. 6.24). Although Mg2+ is an activating metal in EAL domains, Mg2+-loaded PA3825-EAL 
PDB (Fig. 6.24). Although Mg2+ is an activating metal in EAL domains, Mg2+-loaded PA3825-EAL co-
crystallisation with CdG presented with an intact CdG molecule in the binding pocket (Fig. 6.23a); 
which is unsurprising considering Mg2+-loaded PA3825-EAL is highly inefficient catalytically at the
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Table 6.2: Crystallization, crystallographic data collection and structure refinement statistics. Values in parentheses refer to the highest resolution bin. 
Structure  PA3825-EAL 
Apo-Apo 
PA3825-EAL Ca-
Apo 
PA3825-EAL Ca-
CdG 
PA3825-EAL 
Mg-CdG 
PA3825-EAL-
Mn-CdG 
PA3825-EAL 
Na-pGpG 
Data Collection       
Space Group  P43212 C2 C2 P43212 P61 P43212 
Cell Axes (Å) a = 64.34, 
b = 64.34,  
c = 134.00 
a = 112.4,  
b = 59.8,  
c = 96.7 
a = 112.2,  
b = 59.4,  
c = 92.8  
a = 64.6, 
b = 64.6,  
c = 135.7  
a = 107.9, 
b = 107.9,  
c = 93.5 
a = 64.8,  
b = 64.8,  
c = 135.8 
Angles (°) α = β = γ = 90 β = 115.0 β = 115.0  α = β = λ = 90 γ = 120 α = β = γ = 90 
Beamline  I03 I04 I04-1 I02 I04 I02 
Wavelength (Å) 0.9763 0.9795 0.9200 0.9795 0.9795 1.8785 
Resolution (Å) 64.34-1.60 
(1.64-1.60) 
43.10-1.61 (1.65-
1.61) 
51.29-2.44 (2.50-
2.44) 
29.16-1.77 
(1.81-1.77) 
33.06-2.59 
(2.66-2.59) 
27.16-2.15 
(2.21-2.15) 
Unique Reflections (#) 36008 (2598) 71975 (5229) 20405 (1494) 28763 (2072) 26152 (1919) 16288 (1689) 
Redundancy 9.3 (9.2) 3.0 (3.1) 4.5 (4.8) 6.2 (6.7) 10.3 (10.5) 3.8 (3.8) 
Rpim (%) 3.1 (30.2) 2.4 (38.9) 2.6 (42.2) 2.2 (26.7) 5.4 (94.2) 7.2 (40.5) 
I/σ(I) 18.0 (3.2) 18.3 (2.3) 17.3 (2.0) 18.8 (2.6) 17.5 (1.3) 6.6 (2.4) 
Completeness (%) 100.0 (99.5) 97.4 (96.4) 98.1 (98.9) 99.5 (99.8) 99.9 (99.7) 98.8 (99.2) 
CC1/2 0.999 (0.900) 0.999 (0.761) 0.999 (0.774) 0.999 (0.851) 0.999 (0.756) 0.988 (0.725) 
Refinement        
Molecules/AU 1 2 2 1 2 1 
Rwork/Rfree (%) 18.3/23.2 18.7/22.3 21.3/27.2 19.1/23.7 18.7/25.3 20.0/26.1 
Rmsd       
Bond Length (Å) 0.022 0.022 0.012 0.020 0.012 0.020 
Bond Angles (°) 2.088 2.128 1.717 2.002 1.684 2.343 
B Factors (Å2)       
Average  B factor  22 33 67 33 49.5 36 
Ramachandran Statistics (%)       
Favoured Regions  99.3 98.2 93.8 98.2 95.5 97.3 
Allowed Regions  0.7 1.8 5.2 1.4 4.3 2.7 
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crystallisation  pH (pH 7.1). Although metal site M1 shows 100% occupancy, the more mobile M2 site 
in both Ca2+ and Mg2+ show a lower occupancy, of approximately 30%. The metal ion occupying the 
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M1  site, either Mg2+ or Ca2+, is octahedrally coordinated by Glu39, Asn98, Asp130, Asp160, a free 
oxygen from the scissile phosphate (P1) of CdG and the putative in-line attacking water molecule, 
WA1 (Fig.  6.23a and 6.23b). In the case of Mg2+-loaded PA3825 EAL, the M2 magnesium ion is 
octahedrally  coordinated by Asp161, Glu217, a P1 free oxygen and three waters, WA1, W2 and W3 
(Fig. 6.23a). On the other hand, in Ca2+-loaded PA3825 EAL the M2 calcium ion is trigonal 
bipyramidally coordinated by Asp160, Asp161, Glu217, a P1 free oxygen and one water, W2 (Fig. 
6.23b). It should be noted that in the Mg-CdG structure Asp160 coordinates to metal M1 only, rather 
than bridging both metal sites through the carboxylate fork as characteristically observed in 
bimetallic EAL domains (as well as in Ca-CdG PA3825-EAL). This variability in coordination may 
explain the poor occupancy and larger inter-metal distance of the M2 site. The position of the M1 
site is perfectly matched between Mg2+-PA3825-EAL and Ca2+-PA3825-EAL, as observed by 
superposition of the two structures; whereas the M2 site is displaced by approximately 0.4 Å 
between Mg2+-PA3825-EAL and Ca2+-PA3825-EAL (Fig. 6.23a and 6.23b). A review of other metal-
bound structures of EAL domains in the PDB shows there is a significant variation in the inter-metal 
M1-M2 distances (Fig. 6.24). The largest inter-metal distance observed between bimetallic substrate 
bound structures is 6.0 Å in Mg-PA3825-EAL (Fig. 6.24a) while the smallest distance, 3.9 Å, occurs in 
Mn-BlrP1 (Fig. 6.24n). All available bimetallic EAL domain structures, as of April 2015, are presented 
in figure 6.24. Bimetallic EAL structures have been solved over a range of activating and inhibitory 
pHs (4.5-9.0) and in the presence of activating and inhibiting metal ions. Overall there appears to be 
little correlation between EALs being active (Mg2+/Mn2+ ≥ pH 7.0) or inactive (Mg2+/Mn2+ < pH 7.0/ 
Ca2+ at any pH) and inter-metal distance. Inter-metal distances for Ca2+ inhibited structures vary 
considerably from 5.9 Å to 3.9 Å, although active Mn2+ structures are more limited in their variability, 
between 4.5 Å and 3.9 Å.  
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Two previously published structures of Mn-CdG-Blrp1 (table 2) were crystallised at pH 6 
and pH 9 (PDB codes 3GFZ and 3GG0, respectively), representing inactive and fast acting enzymes 
based on in vitro kinetic analysis of Blrp1 at corresponding pH values (Barends et al., 2009). These 
structures saw the inter-metal distance decrease with increasing pH from 4.2 Å to 3.9 Å, a difference 
of 0.3 Å. Based on this, the authors proposed a pH-dependent catalytic regulation mechanism based 
on a “tight” metal centre whereby deprotonation of the in-line attacking water for nucleophilic 
attack only occurs when inter-metal distances reach a critical proximity. However, this theory suffers 
from a small sample size, consisting of a single Blrp1 structure at each pH. Structures were also 
determined to medium resolution (2.05 Å and 2.55 Å for pH 6 and pH 9 structures respectively), 
making it difficult to make arguments based on something as precise as a 0.3 Å difference in metal 
distance. The intrinsic variability of M2’s position, even between chains of dimeric structures (Fig. 
6.24b and 6.24e, 6.24d and 6.24m (PA3825 Mn structure), also brings such a mechanism into doubt. 
In addition to this, the structure of Mn-Cdg-PA3825-EAL at pH 7.1 shows a larger inter-metal 
distance than Mn-CdG-Blrp1 despite being more catalytically active. Finally, the fast acting Blrp1 
structure crystallised in the presence of manganese at pH 9 displaying this “tight” conformation (PDB 
code 3GG0), shows an intact CdG molecule after being soaked in CdG for 24 hours. In vitro analysis 
of Blrp1 in solution in the presence of manganese at pH 9 shows conversion of CdG to pGpG with a 
kcat of approximately 7 s-1 (Barends et al., 2009), ample time for conversion of all available CdG to 
pGpG over 24 hours. A novel mechanism involving a new third metal site in the catalytic pocket, not 
observed in Blrp1 structures, may account for this paradox.  
6.3.4. PA3825-EAL pGpG Structure  
Soaking and co-crystallisation of tetragonal PA3825-EAL crystals with CdG and MnCl2 gave 
significantly different results. Crystal structures following soaking with 10 mM CdG and 0.2 M MnCl2  
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over ten days resulted in CdG bound in the catalytic pocket, with a fully occupied M1 site confirmed 
by anomalous manganese signal and the M2 site 20% occupied with no anomalous signal. Crystals 
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also underwent a space group change from tetragonal to hexagonal (Table 1) and a significant 
change in the dimeric interface in crystallo (Fig. 6.25), with hexagonal crystal B molecules (Fig. 6.25b,  
 
purple) shifting by approximately 45° relative to the A molecule when compared to tetragonal 
structures (Fig. 6.25b, green and orange). Crystals soaked over hours or 1-7 days showed the initial 
tetragonal space group and no CdG In the active site. On the other hand, co-crystallisation of metal-
free PA3825-EAL with CdG and Mn2+ over 4-5 weeks at 4°C yielded high resolution diffracting 
crystals, revealing that the phosphodiester bond of CdG coordinated by the catalytic metals had 
been cleaved, converting CdG (Fig. 6.22) to pGpG (Fig. 6.26a). This result is consistent with in vitro 
kinetics of Mn2+-loaded PA3825-EAL at pH 7.1 (crystallisation pH), which shows significant catalytic 
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activity (Fig. 6.14). The reasons why soaking and co-crystallisation resulted in substrate and product 
bound structures respectively are unclear, although the lower temperature could significantly lower 
the activity of PA3825-EAL making 10 days too short a time span to see conversion of enough CdG in 
crystallo to give well defined electron density. Alternatively, cleavage of CdG may have occurred 
prior to crystallisation, when metal-free PA3825-EAL was mixed with 10 mM CdG and Mn2+. 
Enzymatic activity may also have been inhibited by pseudo-dimerisation caused by crystal packing; a 
putative inhibitory dimerisation interface is discussed in more detail in the following section.  
Cleavage of the scissile phosphoester bond in CdG caused significant changes in the ternary 
complex of PA3825-EAL, with the M2 site along with the coordinating waters disappearing 
completely and a new metal site (M3) appearing (Fig. 6.26a and 6.26c). The M1 site remains 
unchanged, with coordination exactly the same as that of calcium- or magnesium-CdG ternary 
complexes (Fig. 6.23a and 6.23b, respectively). Despite the presence of excess manganese in the 
crystallisation drop, both metal sites show a low occupancy of only 30%. This may stem from 
increased flexibility of the phosphate group following cleavage destabilising the ternary complex to 
allow release of the product. M3 also shows an octahedral coordination sphere consisting of Asp160, 
Asp161, a P1 free oxygen, the hydrolysed O2’ Oxygen from the liganding sugar ring and two water 
molecules, WC4 and WC5 (Fig. 6.26a and 6.26c). Coordination of M3 to the P1 free oxygen and O2’ 
oxygen of the sugar moiety is of particular interest as both oxygens are involved in the formation of 
the scissile phosphoester bond cleaved by PA3825-EAL.  
The PDB has two more EAL domains reported in complex with pGpG, FimX-EAL from P. 
aeruginosa (4AFY) (Robert-Paganin et al., 2012) and CC3396-EAL from C. crescentus (3U2E) 
(unpublished). Inspection of the electron density maps of 4AFY based on structure factors shows 
considerable negative electron density for the pGpG bound to FimX-EAL (Fig. 6.27). In addition to 
extensive negative density, FimX-EAL is a degenerated EAL domain with a kcat of only 10-4 s-1 
(Kazmierczak et al., 2006).  
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The metal binding of all forty deposited EAL domain structures, both active and inactive 
and in the presence or absence of substrate, are presented in table 6.3. It is clear from table 6.3 that 
degenerated EAL domains such as FimX-EAL, LapD-EAL and YdiV have never been observed with 
bound metal in the active site, as expected from the mutations in the metal coordinating Asp 
residues (Fig. 6.17). Although catalysis is inhibited by these mutations the ability to bind CdG is 
retained, likely to allow the EAL domain to act as a sensory domain (Schmidt et al., 2005). It also 
appears that substrate is necessary to allow binding of M2 to the active site, which is never observed 
in metal-apo complexes. The conformation of pGpG in PA3825-EAL and CC3396-EAL are highly 
superposable (Fig. 6.28a), whereas 4AFY’s pGpG varies greatly and presents with stereochemical 
clashing issues (Fig. 6.28c). As a result the structure of 4AFY has been disregarded in comparisons of 
pGpG binding in PA3825-EAL and CC3396-EAL.  
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Table 6.3. Classification of all EAL domain structures in the PDB to date. Inactive EAL domains are 
indicated in italics. 
no metal  
CdG 
no metal 
no substrate 
1 metal (M1) 
no substrate 
1 metal (M1) 
CdG 
2 metals (M1 & M2) 
Cdg 
pGpG 
monomeric 
FimX-EAL (3HV8) 
FimX-EAL (4FOJ) 
FimX-EAL 
(4FOU) 
FimX-EAL (4FOK) 
FimX-EAL (4F3H) 
FimX-EAL (4F48) 
LapD-EAL 
(3PJW) 
LapD-EAL (3PJX) 
LapD-EAL (3PJU) 
 
dimeric 
LapD-EAL (3PJT) 
monomeric 
PA3825-EAL (4Y9M) 
DosP-EAL (4HU3) 
LapD-EAL (3PFM) 
FimX-EAL (3HV9) 
 
dimeric 
YkuI (2BAS) 
YdiV-EAL (3TLQ) 
Imo0131-EAL (4Q6J) 
MorA-EAL (4RNJ) 
MorA-EAL (4RNI) 
FimX-EAL (4AG0) 
monomeric 
Mg2+ 
CC3396-EAL (3S83) 
Ca2+ 
PA3825-EAL (4Y8E) 
 
dimeric 
Mg2+ 
TBD1265-EAL (2R6O) 
 
tetrameric 
Mg2+ 
RocR (3SY8) 
monomeric 
Mg2+ 
MorA-EAL (4RNH) 
 
dimeric 
Ca2+ 
Blrp1_B (3GFX) 
YkuI_AB (2W27) 
 
monomeric 
Mg2+ 
PA3825-EAL (4Y9Q) 
MucR-EAL (xxxx) 
Ca2+ 
CC3396-EAL (4HJF) 
 
dimeric 
Mg2+ 
TBD1265_EAL (3N3T) 
Ca2+ 
PA3825-EAL (4Y9P) 
Blrp1_A (3GFX) 
Blrp1 (3GG1) 
YahA (4LJ3) 
Mn2+ 
Blrp1 (3GFZ) 
Blrp1 (3GG0) 
monomeric 
Mn2+ 
PA3825-EAL (xxxx) 
 
dimeric 
Mg2+ 
CC3396-EAL (3U2E) 
no metal 
FimX-EAL (4AFY) 
 
Superposition of the ternary complexes of co-crystallised PA3825-EAL with CdG and pGpG 
in the presence of Mg2+ and Mn2+, respectively, present with a near identical conformation in the 
catalytic pocket, with the exception of M3 in the pGpG bound structure (Fig. 6.29a). The only other 
structure to present with M3 is the unpublished pGpG-bound CC3396-EAL (PDB code: 3U2E) (Fig. 
6.29a). CC3396-EAL was crystallised at pH 8 in the presence of magnesium so metals have been 
modelled as Mg2+ ions by the authors. Each Mg2+ ion coordinates to one of the available oxygen 
atoms from the hydrolysed phosphate group of pGpG (Fig. 6.26b and 6.26d). M1 and M2 sites 
correspond to previously observed M1 and M2 sites in other bimetallic EAL domain structures (Fig. 
6.29a), with aninter-metal distance of 4.4 Å. The position of PA3825-EAL’s M3 site corresponds with 
CC3396-EAL, as shown in figure 6.29b. However, the coordination of M2 and M3 varies between 
structures with M2 completely absent in PA3825-EAL. Instead, Glu217, a liganding residue of M2 
when present, coordinates to the free oxygen from pGpG’s phosphate (Fig. 6.26a and 6.26c). In the 
case of M3, no residues are involved in the octahedral coordination for CC3396-EAL. The 
corresponding Asp160 and Asp161 residues of PA3825-EAL are replaced with the O3’ oxygen of the 
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sugar ring and an additional water, WC6 (Fig. 6.26b and 6.26d). Despite these differences in M3 
coordination between structures both are coordinated to the two free oxygen atoms involved in 
forming the phosphoester bond of CdG prior to hydrolysis. The availability of this additional oxygen 
donor from pGpG may explain why the M3 site has only been captured in product bound structures. 
This novel M3 site is ideally placed to allow formation of a substrate transition state, suggesting EAL 
domains may possess a functional tri-metallic catalytic centre as opposed to previously suggested 
bimetallic centres.  
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6.3.5. MucR-EAL CdG-bound Structure and the Putative Inhibitory 
Dimerisation Interface 
In addition to PA3825-EAL in various states a high resolution structure of Mg2+-loaded CdG-
bound MucR-EAL was obtained. Data were collected and phased by the Tews group at the University 
of Southampton with refinement and validation of the structure performed for comparison with 
PA3825-EAL at the University of Liverpool/ Diamond light Source. Data processing, refinement and 
validation statistics are reported in Table 6.A1.  The αβ(βα)7 TIM-barrel fold of MucR-EAL (Fig. 6.30) 
is consistent with that of PA3825-EAL and other published structures including BlrP1 (Barends et al., 
2009), YahA (Sundriyal et al., 2014), FimX (Robert-Paganin et al., 2012) and RocR (Chen et al., 2012). 
Both metal sites are fully occupied and coordination is consistent with PA3825-EAL and other 
previously published bimetallic EAL domain structures. The M1 site is octahedrally coordinated by 
Glu65, Asn124, Asp156, Asp186, free oxygen from the scissile phosphate (P1) of Cdg and the in-line 
attacking water molecule, WA1. M2 is also octahedrally coordinated by Asp186, Asp187, Glu243, a 
P1 free oxygen and three waters, WA1, W2 and W3. As seen in other bimetallic EAL domains Asp186 
bridges the two metal ions as a carboxylate fork (Fig. 6.31).  
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Crystallisation of MucR was performed using purified protein with no co-crystallisation or 
soaking with CdG, however, the resulting MucR-EAL structure has a fully occupied catalytic pocket 
with two magnesium ions coordinating a CdG molecule; in agreement with the observed absorption 
at 270 nm suggesting bound nucleotide. Although earlier enzymatic assays confirmed MucR’s 
inactivity in solution, MucR is theoretically an active PDE EAL at the purification pH based on the 
presence of conserved catalytic residues in its sequence (Fig. 6.17). Structural comparisons of CdG-
bound MucR-EAL and CdG-/pGpG-bound PA3825-EAL show no significant differences that could 
explain this discrepancy in MucR’s catalytic activity. As eluded to earlier, the only difference 
between the structure of MucR-EAL and PA3825-EAL is that MucR-EAL is completely dimeric while 
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PA3825-EAL is predominantly monomeric based on SEC-MALS data. However, the mechanism by 
which dimerisation of MucR monomers would cause inhibition of PDE activity is unclear from 
structural data. Recently published work on the influence of allosteric changes on Blrp1 activity 
through EAL domain dimerisation (Winkler et al., 2014) may shed slight on the inhibition of MucR. 
Winkler et al 2014 demonstrated that Blrp1 EAL activity is coordinated through the EAL dimerisation 
interface; particularly the role of the “compound helix”, two short helices from each monomer, in 
metal coordination in the active site. Upon induction with light, Blrp1 undergoes a signalling cascade 
originating in the α1-β2B and region β5B which, depending on the metal coordination, can affect β4-
β5B, α5- α4B loops, β4B and EAL dimerisation (Winkler et al., 2014). These light-induced structural 
changes cause a clam-shell like opening and closing action between EAL dimers governed by the 
“compound helix”; an evolutionarily conserved dimerisation interface in catalytically active EAL 
domains, and some inactive domains (Barends et al., 2009, Tchigvintsev et al., 2010, Minasov et al., 
2009, Tarnawski et al., 2013, Chen et al., 2012). The dimerisation interface of MucR-EAL is highly 
conserved with Blrp1 (PDB code 3GG0) (Fig. 6.32), with the long helix 8 accounting for the main 
interactions. However, differences arise in the position of the short alpha helices that form the 
compound helix, circled in red in figure 6.33. In Blrp1 both helices run parallel to the long helix 8 (Fig. 
6.32b, pink) while MucR shows both helices pointing away from helix 8 at approximately 45° (Fig. 
6.32a).  
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Despite the conserved dimeric conformation, sequence identity between MucR and Blrp1 
is low at only 24%; while MucR and PA3825-EAL have a much higher sequence identity at 38% (Fig. 
6.33a). Superposition of a PA3825-EAL monomer with MucR-EAL chain A show significant differences 
in helix 8 including His198Ala and Lys209Thr in PA3825-EAL which may suffice in preventing 
dimerisation in solution as observed in SEC-MALS experiments despite high sequence identity (Fig. 
6.33b). If this dimeric conformation that is conserved throughout various EAL domains (Barends et 
al., 2009, Tchigvintsev et al., 2010, Minasov et al., 2009, Tarnawski et al., 2013, Chen et al., 2012) 
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does indeed convey an inhibitory effect, as seen in MucR-EAL, it may explain why Blrp1 crystal 
soaking experiments at pH 9 in the presence of Mn2+ coordinate CdG as opposed to the expected 
pGpG based on in vitro experiments (Barends et al., 2009). 
6.4. Conclusions  
EAL domains are crucial in the organisation of bacterial life cycles by regulating intracellular 
levels of the pivotal secondary messenger CdG. EAL domains are capable of coordinating pairs of 
calcium, magnesium or manganese ions through two highly conserved Asp residues on loop 6 
(Barends et al., 2009, Sundriyal et al., 2014, Schmidt et al., 2005). Of these metal complexes; Mn2+-
loaded are significantly faster enzymes than the Mg2+-loaded equivalents while calcium ions 
completely inhibit PDE activity (Sundriyal et al., 2014, Schmidt et al., 2005). Inhibition by calcium is 
arguably the result of Ca2+ acting as a weaker Lewis acid than Mg2+ and Mn2+ (Irving and Williams, 
1953), preventing activation of the in-line attacking water to hydrolyse the phosphoester bind in 
CdG. It is not uncommon for metal ions to act as Lewis acids in catalysis for various reactions 
including activation of electrophiles (carbonyl, nitrile and phosphoryl groups), activation of leaving 
groups (alkoxide ions, amide ions, sulphur derivatives and halides), activation of ambient acids 
(water, alcohols and amines) and nucleophilic attack via metal bound hydroxide ions at carbonyl, 
nitrile and most importantly in the case of PA3825-EAL, phosphoryl groups (Suh, 1992). Here I have 
demonstrated in vitro PA3825-EAL converts CdG to pGpG in the presence of magnesium and/or 
manganese, with reaction rates considerably faster in the presence of manganese while calcium 
completely inhibits PDE activity. Reaction rates decrease with more acidic pH, in agreement with 
other EAL domain work (Barends et al., 2009). 
Mg2+-CdG-PA3825-EAL was co-crystallised at the inactivating pH of 7.1. This structure 
shows considerable similarity to the ternary complex of MucR-EAL and TBD1265-EAL (Tchigvintsev et 
al., 2010), the only other Mg2+-loaded substrate bound EAL domain structures in the PDB (Table 6.3). 
Both structures were also obtained at an inactivating pH of 6.5. Although the catalytic pocket and 
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substrate orientation show significant similarities between all three proteins, the inter-metal 
distances between M1 and M2 vary considerably; with values of 4.0 Å, 4.4 Å and 4.2 Å for MucR-EAL, 
TBD1265-EAL and PA3825-EAL, respectively. This supports the idea proposed by Barends et al. 
(2009), that inter-metal distances may play a role in regulation of PDE activity, as all inhibited Mg2+ 
structures have a larger inter-metal distance than that observed in their highly active Mn2+-loaded 
CdG bound Blrp1 structure.  
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Early studies into the reaction mechanism of EAL domains were performed through 
mutation studies on RocR paired with structural studies of CdG bound YkuL. Enzyme activity was 
tested against various mutations involved in metal binding, although many mutations saw a 
reduction in binding affinity for magnesium and activity compared to the wild type, only E352 
proved absolutely essential for activity; remaining inactive even in the presence of 0.5 M Mg2+ (Rao 
et al., 2008). This led to a single metal general base catalyst mechanism with the essential glutamate 
residue acting as the general base to activate the in-line water for nucleophilic attack (Rao et al., 
2008, Minasov et al., 2009).  This model has since been expanded to a two metal catalytic 
mechanism in the light of CdG bound structures in the presence of pairs of Mg2+, Mn2+ or Ca2+; this 
suggests the metals act as a Lewis acid to activate the in-line attacking water (Tchigvintsev et al., 
2010, Schmidt et al., 2005, Tamayo et al., 2005, Barends et al., 2009). The pGpG-bound structures 
presented in this work have revealed a new level of complexity in EAL domains with the observation 
of a third metal site in the EAL domain which requires further investigation.  
A recent study has expanded further on the regulation of EAL domains through the effects 
of allosteric regulation of domain-domain dimerisation on PDE activity (Winkler et al., 2014). This 
may explain the presence of CdG in the crystal structure of Mn2+-loaded Blrp1 at pH 9 (Barends et 
al., 2009), with conversion of CdG being prevented by allosteric effects of the dimer in crystallo 
restricting the protein or substrate to prevent formation of the M3 site and transition state 
activation by the third metal to allow PDE activity. Building on this, two EAL domains known to 
possess PDE activity as part of their physiological roles have failed to be crystallised with pGpG under 
conditions favourable to catalysis, Blrp1 (Barends et al., 2009) and MucR-EAL (this work). Although 
Blrp1 and MucR-EAL show a low sequence homology both share a conserved dimeric interface in 
crystal structures (this work). On the other hand, pGpG is clearly seen in the close homologue, 
PA3825-EAL, which is unable to form a homodimer due to mutations in the dimerising helix. The 
evidence for a catalytic inhibitory mechanism in EAL domains through dimerisation requires further 
study and mutation studies on PA3825-EAL’s dimerisation helix may shed light on this observation. 
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However, PDE regulation by such a means would fit well with the physiological distribution of EAL 
domains, which are regularly found adjacent to a diguanylate cyclase GGDEF domain; known to 
require dimerisation for conversion of two GTP molecules to CdG (Paul et al., 2007). Therefore a 
DGC-PDE coupled protein able to switch on activity of the GGDEF domain, while at the same time 
inhibiting the PDE activity of an EAL domain, through dimerisation and vice versa, presents an 
efficient means to control synthesis and degradation of CdG and regulate biofilm formation.    
6.4. Appendix  
Table 6.1A: Crystallization, crystallographic data collection and structure refinement statistics. Values in 
parentheses refer to the highest resolution bin. 
Structure  MucR-EAL 
Data Collection  
Space Group  P1211 
Cell Axes (Å) a = 46.4,  
b = 116.1,  
c = 52.1 
Angles (°) β = 102.5 
Beamline  I04 
Wavelength (Å) 0.9795 
Resolution (Å) 45.27-2.27 (2.33-2.27) 
Unique Reflections (#) 24883 (1831) 
Redundancy 6.9 (6.9) 
Rpim (%) 6.9 (27.6) 
I/σ(I) 11.3 (2.9) 
Completeness (%) 99.9 (99.8) 
Refinement   
Molecules/AU 2 
Rwork/Rfree (%) 20.1/25.4 
Rmsd  
Bond Length (Å) 0.006 
Bond Angles (°) 1.853 
B Factors (Å2)  
Average  B factor  33 
Ramachandran Statistics (%)  
Favoured Regions  95.2 
Allowed Regions  4.6 
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Chapter 7 – Serial Data collection of a 
Nitrite Reductase Crystal: A Structural 
Movie of Nitrite Reduction 
 
 
 
 
 
 244 
 
7.1. Introduction  
Achromobacter cycloclastes is an aerobic Gram-negative straight rod shaped bacterium 
with several flagella. It belongs to the genus Achromobacter in the family Alcaligenaceae of the 
order Burkholderiales and is commonly found in fresh and marine water, soils and as a cell culture 
contaminant in laboratories (Gray et al., 2010). A. cycloclastes plays a key role in the nitrogen cycle, 
along with many other bacteria, which exclusively fix atmospheric dinitrogen to metabolically active 
forms to allow production of the amino acids, proteins and nucleic acids essential for life (Suzuki et 
al., 2000). The Nitrogen Cycle consists of six reactions, (1) the fixation of dinitrogen gas (N2) to 
ammonium (NH4+); (2) aerobic ammonium oxidation to hydroxylamine (NH2OH) by bacteria and 
archaea; (3) aerobic oxidation of nitrite (NO2-) to nitrate (NO3-); (4) denitrification of nitrite to nitric 
oxide (NO); (5) anaerobic ammonium oxidation of ammonium and NO to produce hydrazine (N2H4) 
and (6) dissimilatory nitrate and nitrite reduction to ammonium (Fig. 7.1) (Jetten, 2008). This work 
focuses on the mechanism by which nitrite reductases cleave nitrite to NO as part of denitrification. 
Denitrification is an important step in the nitrogen cycle whereby dissimilatory reduction of 
nitrate or nitrite via gaseous N-oxides produces dinitrogen. This process has widespread effects on 
agriculture through loss of essential nitrate and nitrite and on the environment; principally 
increasing the effects of global warming by transferring excess nitrogen from hydrological systems to 
the atmosphere as N2O and NOx (Zumft, 1997, Suzuki et al., 2000, Bouwman et al., 2013). Production 
of NO by bacteria (coupled with proton translocation and ATP synthesis (Zumft, 1997)) occurs in low 
oxygen environments and in the presence of nitrite, increasing the expression levels of the nitrite 
reductase enzymes that perform the first committed step in the dissimilarity denitrification pathway 
(Boulanger et al., 2000, Starkenburg et al., 2008).  Nitrite reductases are found in two structurally 
distinct forms defined by their catalytic centres, which contain either heme cd1 prosthetic groups or 
Cu centres. Three quarters of tested bacterial strains have been found to possess the tetraheme 
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protein cytochrome cd1 (cd1-NiR) with the remaining quarter expressing copper nitrite reductases 
(CuNiRs). Both NiRs are never found within the same cell (Zumft, 1997). 
 
cd1-NiRs are respiratory nitrite reductases made up of homodimers of 60 KDa subunits with 
a heme C and heme D1 domain. The heme D1 domain forms a β-propeller structure consisting of 8 
blades with heme D1 positioned close to the subunit interface. The heme C domain on the other 
hand is predominantly helical with heme C positioned approximately 20 Å away from heme D1. 
However, this study focuses on the structurally distinct CuNiRs so cd1-NiRs will not be discussed in 
further detail.  
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7.1.1. Copper Nitrite Reductases 
CuNiRs can be separated into three classes; (1) the type one blue copper proteins; (2) type 
two non-blue (green) copper proteins and (3) type three binuclear and EPR inactive copper proteins 
(Malkin and Malmström, 2006). The difference in colour stems from the T1Cu with blue enzymes 
showing absorbance in the 460 nm range and green enzymes with absorbance maxima around 460, 
595 and 700-750 nm. T1Cu liganding residues between blue and green enzyme are the same (Adman 
et al., 1995), the only major difference being a shift in the His-Cu-Met angle by 17° which may affect 
the electronic structure (Dodd et al., 1998, LaCroix et al., 1996). An alternate theory suggests Tyr in 
green enzymes being replaced with Thr in blue enzymes causes a shift in the polypeptide backbone 
around the Met T1Cu liganding residue causing the colour change (Inoue et al., 1998). The structure 
of CuNiRs differs significantly from cd1-NiRs with all CuNiRs showing a highly conserved trimeric 
structural arrangement (Fig. 7.2a) with each two domain subunit forming two “Greek key” β-barrel 
folds with each barrel stacked onto each other (Fig. 7.2b) (Godden et al., 1991, Zumft, 1997). Each 
subunit contains a T1Cu and T2Cu site. The tetrahedral type one copper (T1Cu) site buried in the N-
terminal domain of the protein is formed from four adjacent residues in domain one (His95Ac, 
Cys136Ac, His145Ac and Met150Ac) (Fig. 7.2c). The pseudohedral type two copper (T2Cu) ligand-
binding active site is formed from three histidine residues (His100Ac, His135Ac and His306BAc), two 
from domain one and one from the C-terminal end of domain two from an adjacent monomer in the 
trimer (Fig. 7.2c), and a forth distal water ligand (Godden et al., 1991, Kukimoto et al., 1994, Zumft, 
1997). The overall mechanism by which CuNiRs reduce nitrite involves the transfer of electrons from 
physiological electron donors, azurin for blue CuNiRs and pseudo-azurin for non-blue CuNiRs, to the 
T1Cu which is then transferred to the T2Cu approximately 12 Å away at the subunit interface (Hough 
et al., 2005, Kukimoto et al., 1994). This mechanism has been investigated for a number of bacterial 
CuNiRs through a variety of site directed mutagenesis studies paired with, crystallography, EXAFS 
and spectroscopic and other enzymatic methods.  
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Nishiyama et al. (1992) performed site directed mutagenesis on pseudo-azurin from 
Alcalegenes faecalis replacing Pro80 with Ala to alter binding of one of the four T1Cu liganding 
residues. Pro80Ala mutation caused a marked increase in pseudo-azurin’s reduction potential, 139 
mV higher than the native, and a considerable decrease in electron transfer to NiR. The crystal 
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structure of the Pro80Ala mutant revealed a previously unseen water molecule bound to the Cu 
atom, suggesting increased reduction potential through greater solvent accessibility to the Cu atom 
(Nishiyama et al., 1992). This study gave the first insight into the structural elements involved in 
electron transfer in NiRs. This work was expanded by crystal structures of Achromobacter 
cycloclastes NiR (AcNiR) (Godden et al., 1991) and the work of Libby and Averill (1992) and Abraham 
et al. (1993) which proved the presence of both the T1Cu and the active site T2Cu in nitrite 
reductases. Following this, Kukimoto et al. (1994) introduced Met150Glu and His135Lys mutations to 
Alacaligenes faecalis nitrite reductase (AfNiR) altering T1Cu and T2Cu binding, respectively, to test 
copper binding and nitrite-reducing activity. Met150Glu mutations resulted in the loss of the T1Cu, 
as determined by optical absorption spectroscopy and atomic absorption spectroscopy, low activity 
using methyl viologen as an electron donor and no activity with pseudo-azurin as the electron donor. 
This strongly suggests the T1Cu is not directly involved in nitrite reduction but serves as the electron 
acceptor from pseudo-azurin which is then transferred to the T2Cu (Kukimoto et al., 1994). 
His135Lys mutations at the T2Cu active site showed weaker copper binding but both T1Cu and T2Cu 
were present. However, nitrite reducing activity was completely abolished as a result of the altered 
T2Cu environment (Kukimoto et al., 1994).  
7.1.2. The Catalytic Mechanism 
With an increasing number of crystal structures of both green and blue CuNiRs (Adman et 
al., 1995, Dodd et al., 1997, Dodd et al., 1998, Godden et al., 1991, Kukimoto et al., 1994, Murphy et 
al., 1997), as well as steady state kinetics (Abraham et al., 1997), EXAFS (Strange et al., 1995) and 
ENDOR (Olesen et al., 1998) data, an ordered mechanism by which nitrite binds the oxidised T2Cu 
site prior to the T2Cus reduction by the T1Cu was proposed (Strange et al., 1999). This study also 
identified a Cys-His link between T1Cu and T2Cu which acts as an internal electron transfer route 
and a His-Asp-His peptide stretch to signal the presence of nitrite at the T2Cu (Strange et al., 1999). 
Comparison of CuNiRs with similar zinc sites from superoxide dismutase, thermolysin, astacin and 
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carbonic anhydrase identified a proton abstracting group residue (Asp98Ac) and a catalytic role for 
His255BAc as a proton donor in catalysis (Fig. 7.3) (Murphy et al., 1995, Strange et al., 1995, Murphy 
et al., 1997, Strange et al., 1999). To further investigate the roles of these residues, D98N, H255D 
and H255N were produced in AfNiR for structural, biochemical and biophysical analysis (Boulanger 
et al., 2000).  
All three mutants caused a significant reduction in the specific activity of AfNiR with a 94-, 
99- and 112-fold decrease for D98N, H255D and H255N, respectively. The crystal structure of AfNiR-
D98N shows a 1 Å displacement relative to the native Asp, preventing formation of a hydrogen bond 
with the water molecule at the T2Cu which has shifted by ~ 0.8 Å. This movement of the T2Cu-water 
in D98N from the native structure suggests a stabilising role for Asp98 in nitrite binding consistent 
with proton donation. The importance of Asp98 in substrate binding and maintaining the T2Cu 
geometry was investigated further through EPR spectroscopy and structural studies on D92N 
mutations in Alcaligenes xylosoxidans NiR (AxNiR) (an Asp98 equivalent) which lead to T2Cu centres 
with higher redox potentials and a lack of hydrogen bonding to the T2Cu-water ligand  (Prudêncio et 
al., 2001, Ellis et al., 2002).  Both H255D and H255N lead to the appearance of a new water molecule 
between the mutant residue and Asp98 and H255N causes the T2Cu-water to be displaced by 1.4 Å 
from the native position (Boulanger et al., 2000). The consistent incorporation of an additional water 
to replace the lost proton donor for the Asp98-His255B bridging water suggests an important role 
for His255B as a proton donor in the water network. The importance of the hydrogen bonded water 
network was investigated further by introducing a H254F mutation in AxNiR. Crystal structures 
revealed the loss of side chain nitrogen atoms from His254 caused a breakdown in the water 
network and the incorporation of zinc in place of the T2Cu, leading to a complete loss of activity 
(Ellis et al., 2002).   
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Although the essential role of Asp98 and His255B (and their equivalents) has been 
demonstrated through mutagenesis studies discussed above, another residue, Ile257B, has been 
found to play a key role in substrate recognition and orientation of nitrite at the active site. Six 
Ile257 mutations were introduced into AfNiR (I257V, I257L, I257A, I257T, I257M and I257G) and 
nitrite soaked crystal structures solved. Native, I257V and I257L mutants all show bidentate binding 
of nitrite through the oxygen atoms of nitrite, with I257V actually producing a more active form of 
the enzyme by producing a shorter hydrogen bond between nitrite and Asp98 (Boulanger and 
Murphy, 2003). I257A, I257G, I257T and I257M mutations on the other hand lead to a radical 
reorientation of nitrite which bound in a monodentate orientation to the T2Cu, disrupting the 
essential Asp98-nitrite hydrogen bond (Boulanger and Murphy, 2003). Based on this it can be 
concluded that Asp98 and His255B alone are not sufficient for effective nitrite binding without 
Ile257B.  
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Following this work, atomic resolution structures of AcNiR in the resting state, substrate 
bound and product bound states expanded on the role of Asp98 with the observation of alternate 
conformations suggesting a role in guidance of nitrite to the T2Cu as well as proton abstraction and 
formation/release of the product (Antonyuk et al., 2005, Tocheva et al., 2004). The appearance of 
multiple conformations pointing into the substrate entry pocket (gatekeeper conformation) and 
towards the substrate binding pocket (proximal conformation) (Fig. 7.3) with corresponding 
occupancies between the proximal conformation and nitrite at the T2Cu strongly suggests Asp98 
plays a role in “hand-shaking” nitrite and guiding it to the T2Cu (Antonyuk et al., 2005). Based on 
these high resolution structures at each stage of the reaction an enzyme mechanism was proposed. 
Resting state NiR is observed with water bound to the T2Cu stabilised by a hydrogen bond from 
Asp98 in the proximal position which is hydrogen bonded to a protonated His255B from an adjacent 
monomer via the bridging water discussed earlier (Scheme 1a). Protonated nitrite then binds the 
T2Cu by displacing the water molecule and reforming the H-bond with Asp98 (Scheme 1b). Nitrite 
binding increases the mid-point potential of the T2Cu to facilitate electron transfer from the T2Cu 
(Hough et al., 2005) and proton transfer from Asp98 to nitrite (Scheme 1c) followed by donation of 
the second proton from the imidazolium group of His255 to cleave the O-NO bond to form NO and 
water (Scheme 1d) (Antonyuk et al., 2005).  
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Experiments on AxNiR measuring changes in the phenol red spectrum (a pH indicator) 
during substrate turnover have shown approximately two protons are consumed over the course of 
the reaction (Brenner et al., 2009). Putative proton channels have been identified in AxNiR and 
AcNiR, one which connects the active site to the surface of the molecule via Asn90Ax and a second 
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which runs along the monomer-monomer surface via His254Ax (Dodd et al., 1998, Antonyuk et al., 
2005). Disruption of the His254 pathways by H254F mutations caused zinc to bind in the active site 
but had no effect on catalytic activity when zinc is replaced with copper. On the other hand, 
mutation of Asn90 to serine caused a ~ 70% reduction in activity (Wijma et al., 2006, Leferink et al., 
2011). Crystal structures of AxNiR N90S, H254F and N90S-H254F mutants show disruptions in their 
respective proton channels. N90S and N90S-H254F mutants see a shift in Pro132 which moves away 
from the T1Cu coordinating His139 towards the mutated Ser90 residue, likely causing the 60 mV 
increase in the redox potential of the T1Cu (Leferink et al., 2011). Nitrite soaked structures of AxNiR 
N90S show a more dramatic structural change from the native with Ala131 and Pro132 moving away 
from the T1Cu allowing Glu133 to move towards Ser90 and restore the proton delivery channel. 
Dramatic loss of activity and considerable structural changes upon nitrite binding suggest that the 
“Asn90Ax” channel is the major provider of protons to the T2Cu active site but protons are still able 
to leak into the active site, as evident from the retention of some catalytic activity in N90S mutants 
(Leferink et al., 2011, Leferink et al., 2012b).  
The electron transport between the T1Cu and T2Cu has been shown to be of paramount 
importance in the mechanism of CuNiR, whose metal site is otherwise ready to carry out the 
reaction (Moura et al., 2008). Of particular importance is nitrite binding prior to reduction of the 
T2Cu to increase the midpoint potential of the T2Cu to facilitate electron transfer from the T1Cu and 
drive catalysis (Hough et al., 2005). Control of this process has been attributed to the substrate 
sensor loop (His94Ax-Asp92Ax-His89Ax) leading to electron transfer through a highly conserved 
Cys130Ax-His129Ax bridge between the T1Cu and T2Cu (Strange et al., 1999). Introduction of mutants 
at the T1Cu (M144LAx, M144QAx and C130A Ax) have been shown to disrupt the finely balanced set of 
redox potentials between azurin/pseudo-azurin, T1Cu and T2Cu. M144L mutations cause a 96 mV 
increase in redox potential, 31 mV higher than azurin and actually increasing the rate of catalysis 
through an increase in the positive ΔE value. M144Q on the other hand reduced the redox potential 
of AxNiR by 132 mV rendering the protein completely inactive but still able to bind nitrite. C130A 
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mutation was much more disruptive, resulting in a completely empty metal site at the T1Cu centre 
and a mixture of nitrite bound Cu/Zn at the T2Cu centre. Together this study elegantly demonstrates 
loss of electron transfer from azurin to the T1Cu is the root cause of inactivity and azurin cannot 
transfer electrons directly to the T2Cu centre which could prematurely reduce the T2Cu before 
nitrite binding (Hough et al., 2005).  
Despite this extensive structural knowledge of CuNiRs certain mechanistic aspects have 
been the subject of significant controversy, particularly whether nitrite binds the T2Cu prior to 
electron transfer (Adman et al., 1995, Hough et al., 2005, Murphy et al., 1997, Strange et al., 1999), 
binds after electron transfer (Abraham et al., 1997, Averill, 1996, Wasser et al., 2002) or if the two 
routes work in parallel (Averill, 1996, Wasser et al., 2002). Steady state kinetics data from CuNiRs at 
different pHs and in the presence of low and high nitrite fitted a random-sequential model where in 
low nitrite the T2Cu was reduced before nitrite binding. In high nitrite the T2Cu was reduced after 
binding, at pHs < 6 with 1 mM nitrite the T2Cu is reduced after nitrite binding and at pHs > 6 the 
T2Cu is reduced before nitrite binding (Wijma et al., 2006). The authors suggest this stems from the 
presence of different ligands bound at the T2Cu, in more alkaline conditions water is bound to the 
T2Cu which is easily displaced by nitrite while in more acidic conditions water is converted to OH- 
which is more difficult for nitrite to displace so the T2Cu is reduced first (Wijma et al., 2006). 
However, a study combining X-ray crystallography, online optical X-ray absorption spectroscopy 
(XAS) and optical spectroscopy on AxNiR crystals has since provided compelling evidence to the 
contrary in favour of an ordered mechanism in CuNiRs. Optical spectroscopy prior to exposure to X-
rays shows T1Cu in the oxidised Cu(II) form. Following X-ray data collection with an estimated dose 
of 1.5x106 Gy the T1Cu had been reduced, as evident from the loss of the characteristic optical 
absorption peak at 595 nm (Hough et al., 2008b). Following a second data set on the same protein 
crystal an XAS spectrum was collected which showed no shoulder at 8985 eV characteristic of a 
reduced T2Cu centre (Strange et al., 1999, Wijma et al., 2006, Hough et al., 2008b). Analysis of 
various high resolution crystal structures (> 1.4 Å) also demonstrated an increase in the Cu-Cys bond 
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length of 0.09-0.13 compared to the distances determined for the oxidised T1Cu site as determined 
by XAS (Hough et al., 2008b). These data unambiguously demonstrate the mechanism of an ordered 
mechanism with gated electron transfer through binding of nitrite to the T2Cu centre.  
Further study of the gated electron transfer mechanism using laser flash photolysis to 
rapidly reduce the T1Cu by reducing solvated electrons and other radicals. Initial reduction occurs 
with a κobs ~ 3000 s-1, resulting in a colourless T1Cu, followed by a slower re-oxidation at ~ 370 s-1 
representing redistribution of electrons to the T2Cu. For complete redistribution to occur, bound 
nitrite is required (Leferink et al., 2012b, Leferink et al., 2012a). In N90S mutated AxNiR, rapid 
reduction of the T1Cu shows no subsequent recovery in the apo state and a much slower recovery 
compared to the native in the presence of excess nitrite. This corroborates the idea that nitrite 
binding increases the redox potential of the T2Cu to facilitate electron transfer (Strange et al., 1999, 
Olesen et al., 1998, Leferink et al., 2012a). Analysis of proton transfer with phenol red in native 
AxNiR following laser flash photolysis gave transfer rates of 305 and 176 s-1 in the absence and 
presence of nitrite, respectively; while N90S mutants showed no transfer in the absence of nitrite 
and very slow transfer in the presence of nitrite (Leferink et al., 2012a). These results demonstrate 
tight coupling between electron and proton transfer in CuNiRs with a very similar dependence on 
nitrite binding. Leferink et al. (2012a) have also demonstrated that protonation occurs before 
electron transfer by chemically reducing AxNiR with penanazine at pH 9, to give a colourless reduced 
T1Cu, which returns to its original blue colour and produces NO when the pH is reduced to 6.7. This 
shows that protonation, in the form of the pH drop, has triggered the electron transfer to the T2Cu 
to allow the production of NO.  
Building on the evidence that the T1Cu is rapidly reduced by X-rays, this work seeks to 
introduce a sequential data collection technique whereby radiolysis by X-ray radiation initiates the 
electron transfer process to allow the catalytic mechanism of CuNiRs to be followed through high 
resolution crystallographic data to better understand the dynamic processes that the important 
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residues discussed above go through. This collection method produces a dose-dependent series of 
structures allowing a “structural movie” of catalysis to be made by X-ray induced radiolysis. Of 
paramount importance is that X-ray induced redox state changes occur at much lower X-ray doses 
than classical radiation damage. This potentially allows many (from tens to hundreds, depending on 
the system) of sequential structures to be determined while the crystal continues to diffract to high 
resolution.  
X-ray radiation damage has been a long standing problem in structural biology (Garman, 
2003a, Garman, 2010, Garman and Owen, 2006, Ravelli and Garman, 2006). However, the rapid 
reduction of redox centres has only become widely recognised recently, occurring before 
deteriorating diffraction resolution and damage to disulphide bridges, thiols and other side chains 
(Yano et al., 2005a, Beitlich et al., 2007, Antonyuk and Hough, 2011).  Although these X-ray induced 
changes can complicate analysis of redox-active systems through mis-assignment of functional states 
or stages in catalytic mechanisms, limiting the X-ray dose can allow structures to be determined in 
specific redox states relevant to catalytic or other important protein mechanisms (Schlichting et al., 
2000, Hough et al., 2008b). This work has been made feasible thanks to the recent introduction of 
fast shutterless PILATUS detectors (Rajendran et al., 2011a) at synchrotron sources which allow rapid 
measurement of large number of sequential datasets from the same region of a protein crystal at 
the low dose per dataset required. AcNiR has been selected as a test sample as it has been shown to 
diffract to atomic resolution (Antonyuk et al., 2005) and is resistant to radiation damage. The 
development of streamlined automated data processing pipelines such as Xia2 (Winter et al., 2013) 
and easily scriptable software such as XDS (Kabsch, 2010a, Kabsch, 2010b) and AIMLESS (Evans and 
Murshudov, 2013) have made it possible to work with the terabytes worth of diffraction data that 
are generated by the sequential method of data collection used here. Such an approach is heavily 
reliant on using these automated software and computer clusters effectively. 
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7.2. Methods  
7.2.1. Protein Production and Purification  
An AcNiR gene codon optimised for expression in E. coli cloned into a pet26b plasmid was 
purchased from Genscript and transformed into BL21 E. coli cells in the presence of 30 μg/ml 
kanamycin. LB cultures were grown with 2 mM CuSO4 to an OD600 of 0.4-0.6 and induced with 2 mM 
IPTG at 18°C for 16 hours. Cultures were spun at 5000 rpm (Sorvall SLC6000 rotor) for 10 minutes at 
4°C for 10 minutes and pellets resuspended in 20 mM Tris-HCl pH 7.5 and 150 mM NaCl. Cells were 
lysed by sonication for 5 cycles of 30 seconds on and 30 seconds off and clarified by centrifugation at 
16,000 rpm (Sorvall SS34 rotor) for 15 minutes at 4°C. Cleared lysate was dialysed for 3 hours against 
2 mM CuSO4 and 20 mM Tris-HCl pH 7.5 at 4°C. CuSO4 was removed by dialysis against 20 mM Tris-
HCl pH 7.5 giving a distinct green colour.  
Cleared dialysed lysate was loaded onto a homemade gravity flow hydroxyapatite column 
(Biorad, Hercules, California, USA) pre-equilibrated in 20 mM Tris-HCl pH 7.5 and washed with 20 ml 
of 20 mM Tris-HCl and 20 ml of 10 mM potassium phosphate. AcNiR was eluted with increasing 
potassium phosphate from 10 mM to 150 mM by observing the green band of protein moving down 
the column. Eluted protein was concentrated and further purified by ammonium sulphate 
precipitation. 120 μL of protein was added to 240 μL of 20 mM Tris-HCl pH 7.5 and 40 μL of 100 mM 
sodium acetate pH 4.75. 25 μL of 4 M ammonium sulphate was added to the protein solution and 
left for 10 minutes at room temperature before pelleting precipitated protein by centrifugation at 
14,000 rpm for one minute at room temperature. The supernatant was pipetted into a fresh 
Eppendorf tube and the process repeated until the pellet appeared green. Excess Ammonium 
sulphate was added to precipitate all AcNiR protein which was pelleted by centrifugation and 
resuspended in 0.5 ml of 50 mM MES pH 6.5.   
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7.2.2. Crystallisation and NO2/NO Soaking  
Purified AcNiR in 50 mM MES pH 6.5 was concentrated to 15-20 mg/ml as quantified by 
absorbance at 280 nm. Dark green regular trigonal pyramid shaped crystals in space group P213 
were grown by hanging drop vapour diffusion at 19°C. 6 µL drops consisting of 3 µL protein solution 
and 3 µL 1.2-1.7 M ammonium sulphate and 100 µM sodium acetate pH 4.5 were equilibrated 
against 500 µL of 1.2-1.7 M ammonium sulphate and 100 µM sodium acetate pH 4.5 for several 
days. Small AcNiR crystals were used as seeds to produce large single crystals by the same method 
described above. 
Nitrite (NO2) soaked crystals were produced by transferring large crystals into drops 
consisting of 2.4 M ammonium sulphate, 100 mM sodium acetate pH 5.5 and 100 mM sodium 
nitrite. Crystals were left for one hour at room temperature before flash cooling crystals in 100 mM 
nitrite and 3.5 M sodium malonate pH 5. Nitric oxide (NO) soaked crystals were produced by 
transferring crystals to drops containing  2.4 M ammonium sulphate and 100 mM sodium acetate pH 
4.5 and equilibrating against 500 µL of 2.4 M ammonium sulphate, 100 mM sodium acetate pH 4.5 
and 100mM sodium nitrite. Crystals were left at room temperature for several hours to allow the 
acidic conditions to produce NO gas. Crystals were harvested and flash frozen in 3.5 M sodium 
malonate pH 5 over 2-8 hours after sodium nitrite was added to the reservoir solution.           
7.2.3. Serial Crystallographic Data collection  
Serial datasets were collected from six nitrite soaked crystals and two NO soaked crystals 
to give a total of 159 datasets. Datasets for nitrite soaked crystals were collected at 100 K on 
Diamond Light Source beamline I04 using a Pilatus 6M detector. A total angular range of 38 degrees 
was collected with 0.1° oscillations and 0.05 s exposures per image at λ = 0.97 Å wavelength with a 
90 µm x 45 µm beam and 20% transmission. This gave a total exposure time of 19 seconds and an 
average dose of 0.69 MGy per dataset as calculated by RADDOSE-3D (Zeldin et al., 2013) based on a 
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measured flux of 2e12 ph/s. NO soaked serial datasets were collected on Diamond Light Source 
beamline I02 using a Pilatus 6M detector over a total angular range of 30° at λ = 0.9795 Å 
wavelength with an 82 µm by 21 µm beam. Crystals had a total exposure of 30 seconds and average 
dose of 0.03 MGy per datasets as calculated by RADDOSE-3D (Zeldin et al., 2013) based on a 
measured flux of 2e10 ph/s. Serial datasets were collected of the same 38/30 degree regions of each 
nitrite and NO soaked crystal, respectively. Initial analysis of the starting structures from the eight 
crystals used was performed to determine the ‘best’ (i.e. highest occupancy) ligand-bound form. A 
total of 45 datasets were then selected from the ‘best’ nitrite soaked crystal along with 5 datasets 
from the ‘best’ NO soaked crystal, allowing for a detailed analysis of the proposed in-situ X-ray 
induced reaction mechanism of AcNiR.      
7.2.4. Data Processing  
All datasets were integrated and scaled with XDS (Kabsch, 2010b) and merged with 
AIMLESS (Evans and Murshudov, 2013) to individual maximum high resolution limits based on mean 
I/σ(I) > 2 in the highest resolution bin. Similar scripts to those used in Chapters 2 and 3 were used to 
deal with the high volume of data to be processed. The structure of ligand-bound AcNiR was solved 
to atomic resolution by Antonyuk et al. (2005) (PDB code 2BWI) and here dataset 1 of the nitrite and 
NO soaked crystals were refined against 2BWI, with the nitrite removed, using REFMAC5 
(Murshudov et al., 2011). Model building was carried out using COOT (Emsley et al., 2010). 
Subsequent datasets were refined against the final model of the previous dataset, i.e. the final 
model of dataset 8 was used as the starting model for dataset 9 etc. Nitrite, NO and water were 
modelled into the T2Cu active site Fo-Fc difference density. Model validation was performed using 
Molprobity (Chen et al., 2010). Figures of all structures were prepared with PyMol version 1.3r1 (The 
PyMOL Molecular Graphics System, Version 1.7.4 Schrödinger, LLC).       
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7.3. Results and Discussion   
7.3.1. Protein Production, Purification and Crystallisation 
Production and purification of AcNiR has been refined through previous studies giving up 
to 90 mg/ml of protein from 2 litres of LB culture. Samples of the supernatant were run on SDS-PAGE 
at various stages of ammonium sulphate precipitation, shown in Figure 7.4. Ammonium sulphate 
was gradually increased in samples shown between lanes 2 and 6 in Figure 7.4 until all AcNiR 
precipitated (Fig. 7.4, lane 7), when the AcNiR was resuspended in 50 mM MES pH 6.5 (Fig. 7.4, lane 
9). Although not 100% pure AcNiR is easily crystallised, with initial crystal trials producing small 
crystals (Fig. 7.5a). These were used as seeds to produce larger crystals over a few days at 19°C for 
high resolution data collection (Fig. 7.5b).     
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7.3.2. Serial Data Collection Statistics 
Repeated exposure of the same region of the nitrite soaked crystal naturally caused a 
steady reduction in diffraction resolution and an increase in overall B-factors and unit cell 
parameters with increasing dose, as shown in figure 7.6a, b and c respectively. The high resolution 
limit decreased from atomic resolution, 1.07 Å initially, to 1.51 Å at 20 MGy exposure (the 
Henderson limit) (Henderson, 1990), and to 1.65 Å at the D1/2, or Garman limit (Owen et al., 2006b), 
where the resolution drops to half that of the initial crystal resolution. This occurred after an 
average dose of 27.6 MGy (Fig. 7.6a). High resolution limit shows an unexpected decrease between 
datasets 7 and 10 (Fig. 7.6a) before returning to a value in step with initial data collections which 
continues to gradually decrease with increasing dose. As the high resolution returns to around 1.1 Å 
following this anomaly it is likely a result of data being cut unnecessarily during semi-automated 
processing. A similar event is seen in B-factors between datasets 7 and 10 with an unexpected rise 
which falls back to initial levels (Fig. 7.6b). Unit cell parameters remain fairly constant throughout 
the repeated exposures, varying by approximately 0.5 Å, including the unusually high first dataset, 
and approximately 0.4 Å if this dataset is considered as an outlier (Fig. 7.6c). The initial high 
resolution data allowed the position of nitrite to be modelled with relatively high certainty, but 
modelling becomes more difficult with decreasing resolution around the Henderson limit, and the 
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electron density is very difficult to interpret at the Garman limit, as discussed later in this chapter. 
Even with the initial atomic resolution data there are alternative interpretations that can be 
modelled based on electron density alone.           
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7.3.3. Ligand Modelling 
7.3.3.1. T2Cu NO2 Modelling 
Even at the high starting resolution of 1.07 Å the difference electron density at the location 
of ligand binding at the T2Cu site can be interpreted in various ways (Fig. 7.A1). Initial modelling of a 
single high occupancy nitrite molecule (70%) with a lower occupancy water molecule (30%) to give a 
fully occupied T2Cu site presents with no positive or negative difference density (Fig. 7.7a-b). 
However, B-factors for the central N-atom are approximately 5-6 Å2 higher than those of the flanking 
oxygen atoms. The conformation of bound nitrite is thought to be variable from earlier studies 
(Antonyuk et al., 2005) and, consistent with this, the ligand difference density can be modelled using 
an oscillating/rotating ligand model with two nitrite molecules at 40% occupancy each (NO2a and 
NO2b) and a water molecule with 20% occupancy (Fig. 7.7c-d). Again, this model produces no 
significant positive or negative difference electron density and B-factors are more consistent for all 
the atoms of the nitrite molecules (~ 3-4 Å2 difference between N and O atom values) compared to a 
single higher occupancy nitrite molecule. This represents a choice between two models: a simple 
one nitrite bound model and a more complex one with two alternate bound nitrite conformations. 
The irregular shaped electron density was modelled above in both cases with a water 
molecule included to account for partial difference density. However, the density can also be 
modelled using a third nitrite molecule (NO2c) with the O1 and N atoms interacting with the T2Cu 
and O2 pointing away from the T2Cu. Modelling three nitrite molecules (33% occupancy each) 
produces no positive or negative difference density and stable B-factors through all nitrite 
molecules. However, the conformation of NO2c and its interactions with the T2Cu atom make little 
chemical sense so is unlikely to be even a partial or transient true state of the active site. Based on 
these observations, the first three datasets measured on the crystal were modelled with two nitrite 
molecules (NO2a and NO2b) to represent the oscillating/rotating N atom of the nitrite ligand (Fig. 
7.7c-d). The water molecule seen in dataset one is not observed in datasets two and three. By 
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dataset four the nitrite molecule has stabilised into the “side-on” symmetrical orientation, labelled 
NO2b in this study, which was previously observed by Antonyuk et al. (2005). From this point a single 
nitrite molecule in the NO2b conformation at an occupancy of 60% is modelled up to dataset ten 
(Fig. 7.10d).  
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By dataset eleven the nitrite soaked crystal has been exposed to a 7.59 MGy dose of X-ray 
radiation and is still diffracting to around 1.1 Å resolution (Fig. 7.6a) when new positive difference 
density is observed in the active site suggesting a previously unseen active site conformation (Fig. 
7.8a).  As with dataset one the active site density has several possible interpretations (Fig.7.8). This 
density can be modelled as a side on nitrite molecule with two water molecules (Fig. 7.8b), a lower 
occupancy side on nitrite molecule and NO molecule at the T2Cu with two water molecules (Fig. 
7.8c), a side on nitrite molecule with an NO molecules leaving the T2Cu site with a water (Fig. 7.8d), 
a side on nitrite and NO molecule at the T2Cu site and a second NO molecule leaving the T2Cu site 
(Fig. 7.8e), one NO molecule at the T2Cu site and one leaving the T2Cu site (Fig. 7.8f) and finally one 
NO molecule at the T2Cu site, one leaving the T2Cu site and a water molecule (Fig. 7.8g).  
The characteristic curved shape of the density by dataset eleven, apparent in all side on 
views in Figure 7.8 (left hand side images), suggests the nitrite remains in the active site, so on the 
basis of the structural interpretation alone the NO-NO (Fig. 7.8f) and NO-NO-W (Fig. 7.8g) models 
are unlikely. The split occupancy of Asp98 proximal and gatekeeper conformations is also not 
characteristic of a solely NO occupied T2Cu (NO-NO and NO-NO-W); or a completely nitrite occupied 
T2Cu site (NO2-W-W (Fig. 7.8b)) (Antonyuk et al., 2005). This leaves the NO2-NO-W-W (Fig. 7.8c), 
NO2-NO-W (Fig. 7.8d) and NO2-NO-NO (Fig. 7.8e) T2Cu site models to be considered. The presence of 
NO bound to the T2Cu in a bidentate manner in later datasets suggests NO is not leaving the T2Cu at 
this stage so the NO2-NO-W (Fig. 7.8d) and NO2-NO-NO (Fig. 7.8e) models can be discounted. This 
leaves the NO2-NO-W-W model (Fig. 7.8c) which makes chemical sense and could be justified based 
on the observed Asp98 conformation. The following “catalytic movie” was generated with this NO2-
NO-W-W model.  
7.3.4. NO2 Soak Movie 
Over the course of the forty-five datasets collected from the same nitrite soaked crystal 
the T2Cu active site goes through several conformational changes that can be observed thanks to 
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the high resolution diffraction data, even if difficulties remain in interpretation. Over the first three 
datasets nitrite appears to oscillate/rotate horizontally with the O1 and O2 atoms fixed in place and 
the N atom moving between two positions labelled NO2a and NO2b in Figure 7.10a-c. This explains 
the higher B-factors observed of the N atom when a single high occupancy nitrite molecule was 
modelled into the difference density. In dataset one the electron density covers all atoms in both the 
proximal and gatekeeper conformations of Asp98, with both positions modelled at 50% occupancy 
(Fig. 7.10a). The density decreases slightly in the gatekeeper conformation for the Oδ1, Oδ2 and Cγ 
atoms over datasets two to four (Fig. 7.10b-c) so was modelled with 40% occupancy, with 60% for 
the proximal conformation. At this stage nitrite has stabilised as NO2b (Fig. 7.10d), referred to as the 
“side on” conformation by Antonyuk et al. (2005). Nitrite remains in this position for a further six 
datasets where it is optimally positioned for His255 to donate the second proton for cleavage of the 
O-NO bond. Between dataset one and dataset four the distance between His255 Nε2 and T2Cu 
decreased by 0.08 Å from 4.17 Å to 4.09 Å when nitrite has stabilised in the NO2b conformation. At 
this point the crystal has been exposed to a total average dose of 2.76 MGy (13.8 % of the 
Henderson limit) and the resolution has remained constant around 1.1 Å (Fig. 7.6a).  
At dataset eleven a previously unseen T2Cu-ligand conformation is observed with a new 
water appearing, labelled WPc in Figure 7.10e. Based on the position of WPc at the T2Cu catalytic 
centre and the dual occupancy of Asp98 in the proximal and gatekeeper positions this has been 
modelled as an intermediate stage where both nitrite, NO and a water are present in the crystal at 
30% occupancy each to give a total occupancy of 90% for the T2Cu active site (Fig. 7.10a). At this 
stage the crystal has been exposed to a total average dose of 7.59 MGy and the high resolution limit 
is still unchanged around 1.1 Å. W2 in Figure 7.10 appears and disappears over the course of the 
next five datasets (Fig. 7.10e-i). Based on the split occupancy of substrate and product at the T2Cu 
active site this water may represent the final water in the water chain between the T1Cu and T2Cu 
to allow proton transfer and reduction of the T2Cu site to facilitate the second protonation and 
cleavage of nitrite. The water chain will be discussed in more detail later in this chapter. By dataset 
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sixteen the crystal has been exposed to 11.04 MGy (55.2 % of the Henderson Limit), the resolution 
has decreased to 1.21 Å and the occupancy of Asp98 favours the proximal conformation at 60% (Fig. 
7.9b).  
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By dataset seventeen the occupancy of Asp98 in the proximal position has reached 65%, 
NO occupancy has been modelled in line with this occupancy in the active site (Fig. 7.9). The curved 
density shape typical of a nitrite bound T2Cu site, coloured in orange in figure 7.11, has become 
more flat relative to the copper atom, shown as blue density in Figure 7.11. At this stage the crystal 
has been exposed to an average dose of 11.73 MGy and the high resolution limit is 1.23 Å. Previously 
the mode of binding of the enzymatically generated NO product at the T2Cu centre has been met 
with lively discussion. Spectroscopic data suggests an end-on mode of binding while the first NO 
soaked structure of a CuNiR from A. facaelis (Tocheva et al., 2004) demonstrated a side-on mode. 
The non-enzymatic origin of the NO and the discovery that exposure to excess NO gas can cause a 
reversible reaction, as demonstrated by the production of red coloured NiR species (Ghosh et al., 
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2007), complicated the analysis further. Endogenous side-on T2Cu-NO was also reported for AcNiR 
by Antonyuk et al. (2005), however it was unclear if the presence of NO was the result of in vivo 
catalysis or X-ray induced turnover (Hough et al., 2008b). The structures presented here provide 
powerful evidence to resolve this issue with initial soaked nitrite being converted to a stable side on 
NO molecule in the crystal with near equidistant Cu-N and Cu-O bonds.  
Following dataset seventeen there is no significant change in the appearance of the 
electron density until dataset thirty (Fig. 7.10l) where all density for the gatekeeper conformation of 
Asp98 has gone and NO moves closer to Asp98. However, at this stage in the data collection electron 
density at the active site is becoming very weak after being exposed to a total average dose of 20.70 
MGy (103.5% of the Henderson Limit) and the high resolution limit decreasing to 1.49 Å. Electron 
density above the T2Cu decreases further over the remaining fifteen datasets and modelling 
becomes increasingly uncertain. A water molecule was modelled in dataset forty but by this stage 
the initial resolution has almost halved to 1.65 Å and the crystal had been exposed to a dose of 138% 
of the Henderson limit. To better investigate the T2Cu site serial data collection was attempted on a 
NO soaked crystal. Data processing and refinement statistics for all NO2 soak movie structures are 
presented in Tables 5.A1-3.  
7.3.5. NO-soaked crystals 
The idea was to obtain higher resolution NO-bound structures than those resulting from 
the radiolysis experiment. However, the NO soaked crystals suffered considerably during the soaking 
and harvesting processes, with the best crystal obtained reaching a high resolution limit of only 1.76 
Å. NO soaking was performed by mixing sodium nitrite with acidic conditions to cause the unstable 
nitrite to breakdown and produce NO gas in the sealed well. Crystals soaked for longer periods of 
time (24 hours) also showed a significant drop in high resolution diffraction suggesting the NO gas 
had a detrimental effect on the crystals. As with the nitrite modelling, there were multiple 
interpretations of the ligand density at the T2Cu site, exacerbated by the relatively low resolution 
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data. A single 100% occupancy NO molecule fitted into the electron density map at the T2Cu site 
resulted in positive difference density at 3σ (coloured green in Figure 7.12a) at either end of the N 
and O atoms, which suggests additional molecules, or a single longer molecule are present at the 
active site. Modelling an NO molecule with a water molecule at 65% and 35% occupancy, 
respectively, produces some positive difference density and exceedingly low B-factors for the water 
molecule (6.86 Å), almost two times lower than the T2Cu. Modelling both the NO and water 
molecule with an occupancy of 90% each, representing the products of nitrite cleavage, shows no 
difference density (Fig. 7.12b). However, both NO bonds are occupied by the T2Cu atom so the 
water has no ligands and could only be present as an alternate conformation not a liganding 
molecule to NO and the T2Cu. The density is large enough and has the three dimensional shape to 
accommodate two NO molecules, however, two NO molecules at 50% occupancy each resulted in 
positive difference density at 3σ (Fig. 7.12c). Finally, a nitrite molecule was modelled in the density 
(Fig. 7.12d) at 75% occupancy. Based on the length of the density and curved shape around the 
copper, although the resolution is not high enough to show a distinct separation from the copper 
atom electron density - like that observed in Figure 7.11 – bound nitrite is the most likely 
explanation. Thus, it appears that NO soaking was unsuccessful and nitrite has bound to the T2Cu 
instead. It is likely that some nitrite from the reservoir solution was no broken down to NO by the 
acidic conditions and diffused into the crystals. As a result the NO soaked data was not used further 
for the movie. Due to time constraints on this thesis the NO-soaking experiment was not repeated. 
However, this is a clear objective for future work. 
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7.3.6. The Role of Asp98 in Ligand Sensing 
Over the course of the in-crystallo catalytic reaction the occupancy of Asp98 in the 
gatekeeper and proximal conformations varies in line with the presence of the ligand binding in the 
T2Cu active site, be it either dual occupancy water/nitrite, nitrite, dual occupancy nitrite/NO or NO 
(Fig. 7.9). As observed in previous nitrite bound structures (PDB code: 2BWI), Asp98 shows equal 
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dual conformations of the gatekeeper and proximal positions, likely due to the incomplete 
incorporation of nitrite as evident by the presence of a water molecule at the T2Cu (Fig. 7.10a). By 
datasets two and three the water molecule has left, leaving dual conformation nitrite molecules and 
60% occupancy of proximal Asp98, in line with the decreasing 2Fo-Fc density at σ = 1 for Asp98-Oδ2 
and –Cγ in the gatekeeper conformation (Fig. 7.10b-c). This occupancy remains in line with NO2 
occupancy up to dataset eight when Asp98-Oδ1, -Oδ2 and –Cγ 2Fo-Fc density at σ = 1 decreases for 
the gatekeeper conformation and occupancy is reduced to 35% (Fig. 7.9b). By dataset eleven 2Fo-Fc 
density at σ = 1 has returned to similar levels observed in dataset one and occupancy has returned 
to an even split between gatekeeper and proximal conformations (Fig. 7.9b). This is attributed to the 
dual occupancy of nitrite and NO (Fig. 7.9a) in the active site and persists up to dataset fifteen when 
2Fo-Fc density at σ = 1 for Asp98-Oδ1 in the gatekeeper conformations begins decreasing again (Fig. 
7.10i). The occupancy of the gatekeeper conformation of Asp98 was reduced to 40% occupancy in 
dataset sixteen and further to 35% in dataset seventeen when NO is presented with 70% occupancy. 
Following dataset seventeen the occupancy of NO gradually reduces from 70% to 50% by dataset 
thirty nine when water is modelled in thereafter (Fig. 7.9a). Over this period Asp98 occupancy varies 
between 50-65% occupancy for the proximal conformation with all density lost for the gatekeeper 
conformation following dataset twenty nine (Fig. 7.9b). However, it is unclear if this is attributed to 
the presence of NO in the active site or radiation damage preventing accurate modelling of the 
residue.  
Over the course of thirty datasets, when the crystal reached the Henderson dose limit, the 
proximal conformation of Asp98 correlates with the presence of different ligands at the T2Cu. 
Occupancy of the proximal conformation increases as nitrite stabilises in the side on conformation 
then drops with the dual occupancy of nitrite and NO only to rise again as nitrite is lost leaving T2Cu-
NO in the active site. This suggests that Asp98 plays a role in sensing/guiding/stabilising the T2Cu 
ligand in place. The single conformation of Asp98 in the proximal positions following dataset twenty 
nine may be a true conformational change as it has been observed in high resolution NO soaked 
 275 
 
AcNiR structures before (PDB code: 2BW4). However, the presence of dual conformations of Asp98 
in previously published native AcNiR structures (PDG code: 2BW4) suggests the loss of the Asp98 
gatekeeper conformations in dataset 40 onward in serial data collections is likely the result of 
radiation damage and not a true conformational change. In the following section T1Cu and T2Cu 
active sites have been compared with previously published data to further investigate these changes 
in the active site.  
7.3.6.1. Comparison with Published Ligand Positions 
Atomic resolution structures of nitrite bound, NO bound and native states (PDB codes: 
2BWI, 2BW5 and 2BW4, respectively) by Antonyuk et al. (2005) were used for comparison with 
complementary stages of the reaction as observed through the serial data collection. The overall 
fold of the protein is unchanged.  Comparison of the T1Cu site between published data and serial 
data collected from nitrite and NO bound crystals shows little to no variation between the positions 
of the metal coordinating His95, Cys136, His145 or Met150 at all stages of the reaction (Fig. 7.13a, c 
and e). All structures from serial data collection have a Cu-Cys-Sγ bond length of 2.2 Å, consistent 
with a reduced T1Cu site (Hough et al., 2008b, Ellis et al., 2002). T1Cu-ligand bond lengths for the 
structures used in the nitrite soak movie (Fig. 7.10) are listed in Table 7.A4-7. 
Nitrite bound AcNiR shows little variation between the T2Cu liganding residues (His100, 
His135 and His306B), the secondary proton donor (His255B) or the ligand guiding Asp98 with the 
side chain in both the proximal and gatekeeper conformations in both structures (Fig. 7.13b) 
(Antonyuk et al., 2005). Nitrite in 2BWI (coloured in blue in Figure 7.13b) is modelled at 40% 
occupancy with the water molecule W1 accounting for the remaining occupancy as the fourth ligand 
to the T2Cu atom. Nitrite bound in dataset one from the serial data collections shows a much higher 
occupancy of bound nitrite with a total of 80% from the two alternate conformations and a water 
molecule at 20% occupancy. This may be the result of more effective uptake of nitrite through 
prolonged soaking times with higher occupancy producing this previously unseen dual conformation 
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of nitrite. Both 2BWI and dataset one were refined to around 1.1 Å so a dual occupancy should have 
been observed in 2BWI if it was present in the crystal. The nitrite conformation observed in 2BWI is 
similar to the NO2b conformation observed in dataset one (Fig. 10a) with both binding the T2Cu in a 
bidentate manner with Cu-O distances of 1.98/2.19 Å, 2.07/2.05 Å and 2.06/2.04 Å for 2BWI nitrite, 
dataset one NO2a and dataset one NO2b, respectively.  
The NO bound T2Cu active site from 2BW5 and dataset seventeen of the nitrite soak serial 
data collection again show little to no variation between the T2Cu liganding residues His100, His135 
and His306B or the second proton donor His255B (Fig. 7.13d). Asp98 from 2BWI is in the proximal 
conformation with atomic resolution data allowing two proximal conformations to be modelled. 
Dataset seventeen on the other hand shows both gatekeeper and proximal conformations of Asp98, 
likely the result of incomplete occupancy of NO in the active site (Fig. 7.13d). However, Asp98 
occupancy is in favour of the proximal conformation at 60% (Fig. 7.9a). NO molecules for 2BW5 and 
dataset seventeen are in similar side on orientations to T2Cu with N/O-T2Cu distances of 2.1 Å and 
2.0 Å, respectively. Distances from Asp98 vary slightly more with 2WB5 at 2.7 Å and dataset 
seventeen at 2.4 Å. The similarity between ligand modelling of both nitrite and NO between soaked 
structures and serial data collections suggests fast data collections could be a valuable tool for 
tracking the catalytic processes carried out by metallo-proteins. However, the technique does suffer 
for gradual loss of resolution and radiation damage with increasing dose. This drawback is evident 
when modelling the final step of the reaction where NO dissociated and is replaced by a water 
molecule to returning the enzyme to its native state. This problem might be successfully addressed 
in the future by using faster X-ray detectors for more rapid data collection. 
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The published high resolution native structure of AcNiR shows a single water molecule 2.1 
Å from the T2Cu and 2.8 Å from the proximal conformation of Asp98. The water modelled into serial 
dataset forty is closer to both the T2Cu and Asp98 at 1.9 Å and 2.1 Å, respectively (Fig. 7.13f). At this 
stage, dataset forty has reached 138% of the Henderson limit and the high resolution limit has 
decreased by almost half the initial high resolution limit to 1.65 Å. Although this is still high enough 
resolution to model well conserved waters with confidence, continued exposure has clearly 
decreased the quality of the electron density maps. To better understand how AcNiR returns to the 
resting state, high resolution data from an NO soaked crystal is necessary as data quality has 
suffered to the point where modelling cannot be performed unambiguously and with confidence. 
Alternatively, data collection performed at higher cryogenic temperatures than the standard 100K 
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used here may allow a faster turnover of substrate with equivalent dose, permitting the full reaction 
to be observed over fewer data collections and less damage.  
7.3.7. T1Cu-T2Cu Water Chain, a Possible Hydrogen Bonded Chain/ Proton 
Wire 
A water chain lies on the interface between monomers of the trimer structure, Figure 7.14 
shows the surface of monomer A (dataset one from the nitrite soaked series) and an approximately 
30 Å long water channel connecting the T1Cu (buried under the surface) to the T2Cu site. Analysis of 
serial datasets of AcNiR demonstrates a well conserved chain of approximately nine water molecules 
between the T1Cu and T2Cu (Fig. 7.15). W8Pa-c and WG in Figure 7.14 represent partial occupancy 
waters present with the proximal and gatekeeper conformations of Asp98, respectively. I.e. in unit 
cells with the proximal conformation, W8P occupies this position as the gatekeeper is not there to  
 
 279 
 
 
 280 
 
displace it. The water chain between W1-W7 is well conserved with waters remaining in fairly 
constant positions over repeated exposures. A double conformation of W7 is seen in dataset one 
(Fig. 7.15a) but is not observed in later datasets. After W7 the water chain becomes more variable, 
particularly W8P which can be seen in three different positions over the serial data collection. This is 
most notable in dataset eleven (Fig. 7.15e) where W8Pa, W8Pb and W8Pc are all seen and the W1-
W9 chain to the T2Cu is complete. W10 represents a partial occupancy water as the fourth ligand of 
T2Cu where either both nitrite and NO have left the active site or were not present from the 
beginning so is not likely a part of the water chain.  
The water chain may represent a “hydrogen bonded chain” or “proton wire” as described 
by Nagle and Morowitz (1978) and seen in the D pathway of Cytochrome c Oxidase (Lee et al., 2010, 
Henry et al., 2009) and the gramicidin A channel (Pomès and Roux, 1996); which act via a Grotthuss 
mechanism to transfer protons via hydrogen bonded water molecules (de Grotthuss, 2006, Henry et 
al., 2009). A potential scheme for this proton transfer is shown in Scheme 2, adapted from Pomès 
and Roux (1996)’s proton wire. The T1Cu is quickly reduced following exposure to X-rays (I) and free 
radicals are generated by hydrolysis of water (see Fig.3.20) (II). These radicals cause a series of 
proton transfers between water molecules, paired with electron transfer as demonstrated by laser 
flash photolysis on N90S mutations in AxNiR (Leferink et al., 2012a, Leferink et al., 2011, Leferink et 
al., 2012b), until it is released at the T2Cu site and binds the Asp bound nitrite (CuNOOH) complex 
(III). Donation of the second proton generates a water molecule and the product NO (IV).  
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Based on the currently accepted reaction mechanism where nitrite binding leads to 
electron transfer between copper atoms (Strange et al., 1999, Hough et al., 2008b) you would expect 
the water chain to be better conserved with nitrite bound to the T2Cu than the native or product 
bound state; ready to transfer a proton to form water and NO. Datasets one and two show complete 
water chains with dual nitrite conformations present (Fig. 7.15a-b), however, W9 is not observed in 
datasets three or four (Fig. 7.15c-d) where nitrite has stabilised in the side-on conformation. 
Following this the presence of W9 is intermitant in the presence of dual conformation nitrite and NO 
ligands and not observed in the presence of the product alone. This is not entirely unexpected as a 
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proton has been donated by this stage so the water chain has carried out its intended function. 
Density for W5 in dataset seventeen (NO bound) has decreased significantly compared to dataset 
sixteen (nitrite/NO bound), as seen in Figure 7.15j-k. The average dose between these datasets saw 
an increase by 0.69 MGy from 11.04 MGy to 11.73 MG, not likely to cause any significant differences 
between datasets so far below the Henderson limit. This loss of density for W5 and complete loss of 
W9 may represent the relaxation of the water chain after proton donation. Following dataset 
seventeen there is a steady loss of density for W2, W4 and W5 (Fig. 7.15l-n), however, this becomes 
more difficult to judge as a true conformational change with increasing average dose.  
Comparison of previously published AcNiR structures in nitrite and NO bound states show a 
similarly conserved water chain between W1-7 as observed in serial data collections. Figure 7.16 
shows superpositions of nitrite bound 2BWI (grey) and dataset one (purple) and NO bound 2BW5 
(blue) against models from datasets seventeen (green) and eleven (orange). As expected, differences 
arise beyond W7. 2BWI shows an almost identical water chain with the exception of W8 which 
shows a third position not seen in dataset one (Fig. 7.16a). 2BW5 on the other hand displays several 
deviations from dataset seventeen with additional positons for W7, W8 and W9 (Fig. 7.16b). Of 
particular interest is the appearance of a fourth position for W8 (W8Pd), suggesting W8Pc is in fact a 
separate water molecule to W8Pa/b. The atomic resolution of this structure may explain why these 
waters were not observed in any other structures. The appearance of these extra waters suggests 
radiation damage may be too severe to allow study of the changes in the water chain with serial 
data collection. Although 2BWI’s water chain differs in many ways to dataset seventeen, it does 
share many similarities with dataset eleven where W8Pc was first observed. However, 2BWI does 
still show additional positions for W7 and W9 not seen in dataset eleven (Fig. 7.16c). Comparison of 
five other nitrite reductases from other organisms shows varying levels of conservation of the water 
chain between copper atoms, (1) AcNiR-NO2 vs AxNiR (1WA2/1OE1) with 7/6 waters in similar 
positions (Fig. 7.17a); (2) AcNiR-NO2 vs GtNiR (3WNJ/4ZK8) with 7/7 conserved waters (Fig. 7.17b); 
(3) AcNiR-NO2 vs AfNiR (1SJM/1SNR/3H56) with 8/6/4 conserved waters (Fig. 7.17c); (4) ) AcNiR-NO2 
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vs RsNiR (1MZY/2DWS) with 6/2 conserved waters (Fig. 7.17d) and (5) AcNiR-NO2 vs RpNiR (3ZIY) 
with 1 conserved water (Fig. 7.17e). The highest resolution structures available were used but some 
structures may lack water molecules as a result of lower resolution data. Overall comparison 
suggests a water chain is present in several nitrite reductases so may play a role on the reaction 
mechanism. 
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7.4. Conclusions  
This study has used a single metallo-protein crystal at cryo temperatures diffracting to 
atomic resolution to probe the reaction mechanism of nitrite reductases by X-ray induced turnover 
of nitrite. The nature of this technique places certain requirements on the quality of the samples 
that can be analysed, such as near atomic resolution diffraction, resistance to radiation damage, high 
occupancy ligands and preferably a high symmetry space group for fast data collections. This serial 
data collection method has been made possible thanks to high throughput data collection 
developments at MX beamlines, particularly through the use of high speed detectors that allowed 
single datasets to be collected in 19 seconds. Automated data processing pipelines at Diamond Light 
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Source also allowed the “best” crystal to be easily identified for further analysis and made 
processing of the resulting 50 datasets a much less arduous task. However, use of automatic 
processing with minimal human intervention does have its downsides, as evident in Figure 7.9a 
where data appear to have been unnecessarily cut during processing. Overall the pros of automation 
easily outweigh the cons.   
Increasing X-ray dose has been shown to result in the conversion of nitrite to NO at the 
T2Cu before incurring any significant radiation damage in the form of decreased resolution. 
Variation in the T2Cu-ligand density can clearly be seen over a number of datasets with two new 
conformations being observed; the dual conformation of nitrite representing the oscillation of the 
central N-atom before stabilising in the side on conformation and the appearance of the N02-NO-W-
W model observed in datasets eleven and fourteen. Although modelling is not always straight 
forward this technique has allowed clear changes in the T2Cu site to be investigated. Furthermore, 
this study has shown evidence of the generation of an enzymatically stable side on symmetrical 
binding conformation for T2Cu-NO previously thought to be an end-on conformation by 
spectroscopic techniques. However, after the generation of NO, radiation damage becomes a more 
significant issue with maps becoming increasingly sparse and more difficult to interpret with 
confidence.  
As well as evidence of substrate turnover in the active site and the side on conformation of 
NO this study has shown links between the conformation of Asp98 and the ligand present at the 
T2Cu active site. Although mixed occupation of the active site due to incomplete incorporation of 
ligands and incomplete turnover at any one time in the whole crystal make interpretation more 
difficult there appears to be a correlation between the presence of NO and an increase in the 
proximal conformation of Asp98. Study of the T1Cu-T2Cu water chain proved more difficult with 
radiation damage and loss of high resolution data limiting analysis of the full chain throughout the 
series, as shown by the additional waters seen in previously published atomic resolution structures. 
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However, this study has identified a highly conserved seven water chain which becomes more 
variable towards the T2Cu, likely as a result of the dual conformation of Asp98 which can impede the 
position of later waters in the chain. Similar water chains are observed in other nitrite reductases 
and mutation of residues in AxNiR disrupting this water chain suggests this is the primary route for 
proton donation in CuNiRs. Based on this a mechanism for proton donation via the water chain has 
been proposed.  
Future work to overcome the drawback of increased dose in later stages of the metallo-
protein reactions could include the use of higher temperature (> 170K) or even room temperature 
data collections to allow faster X-ray induced substrate turnover. This would also remove the limited 
conformational flexibility incurred from use of cryogenic temperatures to give a more true to life 
picture if the reaction mechanism. AcNiR crystals have been tested at room temperature and found 
to provide high resolution diffraction data without high levels of radiation damage. Use of ultra-fast 
detectors (> 100 Hz) and new developments in stable fast goniometry speeds up to 500°/s allowing a 
complete dataset to be collected in less than one second present an exciting opportunity for dose- 
and time-series kinetic crystallography studies of AcNiR and other metallo-proteins.  
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7.5. Appendix 
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Table 7.A1: Crystallization, crystallographic data collection and structure refinement statistics for nitrite 
soaked AcNiR structures. Values in parentheses refer to the highest resolution bin. 
Structure  Dataset 1 Dataset 2 Dataset 3 Dataset 4 Dataset 11 
Data Collection      
Space Group  P213 P213 P213 P213 P213 
Cell Axes (Å) 95.77  95.35 95.38 95.40 95.27 
Angles (°) 90 90 90 90 90 
Wavelength (Å) 0.92 0.92 0.92 0.92 0.92 
Resolution (Å) 67.72- 
1.12 
67.42-
1.12 
42.66-
1.09 
42.66-
1.11 
67.37-  
1.11 
Unique Reflections (#) 116299 
(8473) 
122220 
(8104) 
116591 
(8452) 
110606 
(8182) 
110072 
(8144) 
Redundancy 4.0 (3.1) 4.0 (2.7) 4.0 (3.1) 4.0 (3.1) 4.0 (3.1) 
Rpim (%) 2.4 (25.7) 2.4 (30.8) 2.4 (28.9) 2.5 (28.0) 2.2 (27.8) 
I/σ(I) 18.0 (2.6) 17.2 (2.2) 17.1 (2.5) 16.9 (2.6) 19.1 (2.6) 
Completeness (%) 92.82 
(97.50) 
96.9 
(87.5) 
97.6 
(95.9) 
97.28 
(97.85) 
97.17 
(97.67) 
CC(1/2) 0.999 
(0.813) 
0.999 
(0.793) 
0.999 
(0.769) 
0.999 
(0.788) 
0.999 
(0.813) 
Refinement       
Molecules/AU 1 1 1 1 1 
Rwork/Rfree (%) 13.4/16.6 10.8/13.2  10.8/13.1  10.8/13.2 12.0/14.7 
Rmsd Bond Length (Å) 0.029 0.035 0.033 0.034  0.034 
Rmsd Bond Angles (°) 2.74 2.72 2.53 2.73 2.71 
Average  B factor (Å2)  14.2 13.0 13.5 14.2 14.2 
Ramachandran 
Statistics (%) 
     
Favoured Regions  97.34 97.48 97.49 97.39 97.43 
Allowed Regions  2.66 2.52 2.51 2.61 2.66 
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Table 7.A2: Crystallization, crystallographic data collection and structure refinement statistics for nitrite 
soaked AcNiR structures. Values in parentheses refer to the highest resolution bin. 
Structure  Dataset 12 Dataset 13 Dataset 14 Dataset 15 Dataset 16 
Data Collection      
Space Group  P213 P213 P213 P213 P213 
Cell Axes (Å) 95.29 95.35 95.31 95.31 95.42 
Angles (°) 90 90 90 90 90 
Wavelength (Å) 0.92 0.92 0.92 0.92 0.92 
Resolution (Å) 42.61-1.12 67.42-1.17 67.39-1.16 67.93-1.18 67.47-1.21 
Unique 
Reflections (#) 
107356 
(7988) 
102004 
(7656) 
96679 
(7299) 
91699 
(6851) 
85341 
(6441) 
Redundancy 4.1 (3.8) 4.1 (3.9) 4.1 (3.8) 4.1 (3.8) 4.1 (3.8) 
Rpim (%) 2.3 (27.1) 2.3 (29.3) 2.2 (33.9) 2.2 (37.4) 2.2 (35.9) 
I/σ(I) 19.4 (2.7) 18.8 (2.6) 19.0 (2.3) 18.8 (2.0) 19.1 (2.2) 
Completeness (%) 97.7 (98.3) 97.7 (99.4) 97.6 (99.3) 97.5 (98.5) 97.5 (99.7) 
CC(1/2) 0.999 
(0.820) 
0.999 
(0.788) 
0.999 
(0.756) 
0.999 
(0.706) 
0.999 
(0.733) 
Refinement       
Molecules/AU 1 1 1 1 1 
Rwork/Rfree (%) 14.7/16.1 11.9/14.6  11.7/14.7  11.9/14.4 11.4/14.2 
Rmsd Bond 
Length (Å) 
0.031 0.033 0.031 0.034  0.031 
Rmsd Bond 
Angles (°) 
2.54 2.70 2.67 1.98 2.64 
Average  B factor 
(Å2)  
13.2  14.5 15.5 16.0  16.6 
Ramachandran 
Statistics (%) 
     
Favoured Regions  97.67 97.34 97.01 98.01 98.01 
Allowed Regions  2.33 2.66 2.99 1.99 1.99 
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Table 7.A3: Crystallization, crystallographic data collection and structure refinement statistics for nitrite 
soaked AcNiR structures. Values in parentheses refer to the highest resolution bin. 
Structure  Dataset 17 Dataset 30 Dataset 40 
Data Collection    
Space Group  P213 P213 P213 
Cell Axes (Å) 95.43 95.54 95.60 
Angles (°) 90 90 90 
Wavelength (Å) 0.92 0.92 0.92 
Resolution (Å) 67.47-1.21 67.56-1.49 67.60-1.65 
Unique Reflections (#) 85341 (6441) 45371 (3436) 31632 (2327) 
Redundancy 4.1 (3.8) 4.2 (4.2) 4.2 (4.2) 
Rpim (%) 2.2 (35.9) 2.3 (38.0) 2.3 (41.1) 
I/σ(I) 19.1 (2.2) 18.0 (2.2) 17.8 (2.3) 
Completeness (%) 97.5 (99.7) 96.1 (98.4) 94.5 (95.9) 
CC(1/2) (0.999) 0.727 0.999 (0.710) 0.999 (0.706) 
Refinement     
Molecules/AU 1 1 1 
Rwork/Rfree (%) 12.1/14.4 15.4/18.0  15.6 (18.1) 
Rmsd Bond Length (Å) 0.033 0.031 0.023 
Rmsd Bond Angles (°) 2.70 2.29 2.15  
Average  B factor (Å2)  17.4 22.9 27.1  
Ramachandran 
Statistics (%) 
   
Favoured Regions  98.01 98.05 98.07 
Allowed Regions  1.99 1.95 1.93 
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Table 7.A4: T1Cu bond distances and angles for datasets 1-14 of the nitrite soaked AcNiR structures. 
Structure  1 2 3 4 11 12 13 14 
Resolution (Å) 1.12 1.07 1.09 1.11 1.11 1.12 1.14 1.16 
Bond length (Å) 
     
   
T1Cu-His95 Nδ1 2.05 2.02 2.03 2.02 2.03 1.96 2.02 2.01 
T1Cu-His145 Nδ1  2.04 2.02 2.02 2.02 2.01 2.02 2.03 2.03 
T1Cu-Cys136 Sγ 2.21 2.21 2.21 2.21 2.21 2.21 2.21 2.21 
T1Cu-Met150 Sδ  2.52 2.49 2.5 2.5 2.5 2.49 2.5 2.49 
Bond angle () 
     
   
His95 Nδ1-T1Cu- His145 Nδ1 100 101 100.9 101 100.9 101 101.2 101.2 
His145 Nδ1- T1Cu-Cys136 Sγ 105.6 106.8 107.7 108.1 107.2 108 107.9 107.8 
Cys136 Sγ- T1Cu-Met150 Sδ 107.2 107.3 107.2 107.2 107.3 107.1 107.5 107.5 
Met150 Sδ- T1Cu-His95 Nδ1 87.3 85.9 85.9 86.4 86.6 86.5 86.6 87 
Cys136 Sγ- T1Cu- His95 Nδ1 130.7 129.6 129.1 128.7 129.1 128.3 127.9 127.9 
Met150 Sδ- T1Cu- His145 
Nδ1 
128.6 128 127.4 126.7 127.3 127.2 126.9 126.7 
 
 
Table 7.A5: T1Cu bond distances and angles for datasets 15-40 of the nitrite soaked AcNiR 
structures. 
Structure  15 16 17 30 40 
Resolution (Å) 1.18 1.21 1.23 1.49 1.65 
Bond lengths (Å) 
  
   
T1Cu-His95 Nδ1 2.00 2.01 2.02 2.05 2.05 
T1Cu-His145 Nδ1  2.03 2.04 2.05 2.06 2.04 
T1Cu-Cys136 Sγ 2.21 2.22 2.22 2.22 2.24 
T1Cu-Met150 Sδ  2.49 2.49 2.49 2.48 2.42 
Bond angle () 
  
   
His95 Nδ1-T1Cu- His145 Nδ1 101.1 100.9 102.1 102.4 101.2 
His145 Nδ1- T1Cu-Cys136 Sγ 108 108.4 107.9 108.1 109.3 
Cys136 Sγ- T1Cu-Met150 Sδ 107.6 107.6 107.9 108.1 108.7 
Met150 Sδ- T1Cu-His95 Nδ1 87.1 87 86.9 87.8 88.2 
Cys136 Sγ- T1Cu- His95 Nδ1 127.9 128 127.7 127.4 127.8 
Met150 Sδ- T1Cu- His145 Nδ1 126.4 125.9 125.3 123.9 121.9 
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Table 7.A6: T2Cu bond distances for datasets 1-13 of the nitrite soaked AcNiR structures. 
Structure  1 2 3 4 11 12 13 
T2Cu-
His100 Nε2 
2.04 2.01 2 2.01 2.01 2 2.01 
T2Cu-
His135Nε2 
2.08 2.06 2.04 2.05 2.06 2.05 2.05 
T2Cu-
His306 Nε2 
2.02 2.01 2.04 2.03 2.03 2.01 2.04 
T2Cu -
His255Nε2 
4.17 4.13 4.09 4.09 4.08 4.43 4.08 
Cu – Nitrite 
A (O1/O2) 
2.07/2.05 2.05/2.07 2.03/2.12 N/A N/A N/A N/A 
Cu – Nitrite 
B (O1/O2) 
2.06/2.04 2.05/2.07 2.04/2.12 2.05/2.12 2.05/1.98 2.11/1.97 2.18/1.93 
Cu-O/N 
(NO) 
N/A N/A N/A N/A 1.89/1.93 2.02/1.91 1.91/1.99 
Cu-H2O N/A N/A N/A N/A 2.49 2.5 2.85 
Asp98 
OD2-Nitrite 
O1 A 
(proximal) 
2.38 2.3 2.37 2.1 N/A N/A N/A 
Asp98 
OD2-Nitrite 
O1 B 
(proximal) 
2.41 2.32 2.21 N/A 2.22 2.19 1.85 
Asp98-NO  
(proximal) 
N/A N/A N/A N/A 2.45 2.49 2.38 
Asp98 
occupancy 
A/B 
0.5/0.5 0.6/0.4 0.6/0.4 0.6/0.4 0.5/0.5 0.5/0.5 0.5/0.5 
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Table 7.A7: T2Cu bond distances for datasets 14-40 of the nitrite soaked AcNiR structures. 
Structure  14 15 16 17 30 40 
T2Cu-His100 
Nε2 
2.01 2.02 2.01 2 2.03 2.05 
T2Cu-
His135Nε2 
2.04 2.03 2.04 2.04 2.04 2 
T2Cu-His306 
Nε2 
2.05 2.05 2.06 2.06 2.04 2.05 
T2Cu -
His255Nε2 
4.08 4.09 4.07 4.05 4.03 4.07 
Cu – Nitrite A 
(O1/O2) 
N/A N/A N/A N/A N/A N/A 
Cu – Nitrite B 
(O1/O2) 
2.22/1.88 2.24/2.02 2.23/2.02 N/A N/A N/A 
Cu-O/N (NO) 2.17/1.85 1.9/1.99 2.23/1.96 2.03/2.02 2.37/2.07 N/A 
Cu-H2O 2.51 2.35 2.54 N/A N/A 2.09 
Asp98 OD2-
Nitrite O1 A 
(proximal) 
N/A N/A N/A N/A N/A N/A 
Asp98 OD2-
Nitrite O1 B 
(proximal) 
1.81 1.7 1.77 N/A N/A N/A 
Asp98-NO  
(proximal) 
2.34 2.21 2.16 2.38 1.82 N/A 
Asp98 
occupancy A/B 
0.5/0.5 0.5/0.5 0.65/0.35 0.65/0.35 0.6/0.0 0.6/0.0 
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Chapter 8 – Concluding Remarks   
This thesis has investigated the viability of the use of a humidity controlled stream to 
preserve protein crystals to allow removal of excess surrounding solvent and found that additional 
sample handling and exposure to the humid air stream are not detrimental to the quality of 
diffraction data obtained from large populations of crystals analysed with robust statistical 
techniques. Applying the same sample transfer method and statistical analysis, large populations of 
crystals were produced with and without excess surrounding solvent and diffraction data were 
collected at standard MX wavelengths (~ 1 Å) and longer wavelengths (~2 Å). Data quality indicators 
demonstrated a protein dependent effect between long wavelength X-rays and excess surrounding 
solvent with PA3825-EAL showing no significant difference in data quality indicators while BPM2 
showed a significant decrease in the quality of data collected at ~ 2 Å with excess surrounding 
solvent. This effect is likely to become more pronounced as longer wavelengths are achieved upon 
completion of I23 at Diamond.  
The importance of a specialised long wavelength beamline has also been demonstrated 
through the unsuccessful attempts at solving the structure of AxUDT by S-SAD phasing. In line with 
the studies on AxUDT the structure of AxABH is presented in this thesis. The crystal structure of 
AxABH in several crystal forms has a well conserved α/β hydrolase fold with eight β-sheets flanked 
by five α-helices to position the catalytic triad in the active site which is formed by a novel fold of 
two helix turn helix motifs and one long α-helix. The specific hydrolase function conveyed by this 
novel fold remains unknown. 
In addition to the long wavelength data quality experiments performed on PA3825-EAL this 
thesis investigated the regulation of EAL domain catalytic activity through structural and biochemical 
methods. The high resolution crystal structures of PA3825-EAL in its resting state, active state, 
substrate bound state and product bound state are presented here. Comparison of the active 
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monomeric and dimeric structures of PA3825-EAL with the inactive dimeric MucR-EAL points 
towards an EAL domain inhibition through the dimerisation interface at helix 8. The presence of 
bulky residues on helix 8 of PA3825-EAL prevent it forming the dimeric conformation observed in 
MucR-EAL and other EAL domain crystal structures where CdG bound in activating conditions. The 
pGpG bound structure of PA3825-EAL also shows the presence of a novel third metal binding site 
coordinated to the two oxygen atoms involved in formation of the CdG scissile phosphoester bond. 
The importance of this third metal in the active site is not yet clear but these structural data suggests 
it plays a role in activation of the transition state for bond cleavage.  
Finally, this thesis demonstrates the use of serial data collection of atomic resolution data 
from a single nitrite reductase crystal soaked with nitrite at cryogenic temperatures. This work was 
made possible by significant advances on MX beamlines which allowed complete datasets to be 
collected in 19 seconds and the use of automated data processing software to assess the presence 
of nitrite at the T2Cu active site from terabytes of data. From this data a 45 dataset series from a 
single crystal diffracting to 1.07 Å at first were used to generate a movie of the reaction mechanism 
of AcNiR as it reduced nitrite to NO. Over 45 datasets resolution decreased to 1.65 Å but the 
transition from nitrite to NO and the interaction of Asp98 with the bound ligand could be observed. 
A 30 Å water chain connecting the T2Cu active site to the surface was also identified with seven 
highly conserved waters which became more variable closer to the active site due to interactions 
with the dual conformation Asp98. This thesis presents a mechanism by which this proton wire 
donates the second proton in the reaction mechanism to form NO and water. This technique has the 
potential to investigate the reaction mechanism of a variety of metallo-proteins given initial 
high/atomic resolution diffraction data.  
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